C

ontents003

Welcome Message

004

Program at a Glance008

Scientific Programs- Daily Program

048

Organization- Organizing Committee- The Asian Pacific Society of Nephrology Executive- The Korean Society of Nephrology Executive

053

Floor Plan

055

Congress Information

060

List of Invited Guests

069

Poster Exhibition List

125

Sponsors & Exhibition- Sponsors- Exhibition layout- Professional Societies' Corner- Industry symposium- Exhibitor spotlight

Supported by

Welcome Message
Dear colleagues,
It is our great honor and pleasure to welcome you to the 22nd Asian Pacific Congress of Nephrology, held in conjunction withthe 44th Annual Meeting of the Korean Society of Nephrology (APCN & KSN 2024). We are especially excited to host APCN &KSN 2024 as a fully physical congress in Seoul, the vibrant capital city of Korea, a nation known for both cutting-edge innovationand deep cultural heritage and tradition.
With the firm support of everyone, APCN & KSN 2024 has already achieved remarkable success by reaching a record numberof 1,528 abstract submissions and over 3,400 pre-registrants from fifty-one countries. In return for your support, the ScientificCommittee has devoted the utmost effort to create a high-quality scientific program covering the latest research in the
management of kidney health. We hope all participants will be able to make the most of the scientific program to advance theirknowledge in the understanding and treatment of kidney diseases and share thoughts and ideas with renowned speakers andcolleagues.
We are particularly excited to announce that APCN & KSN 2024, held under the theme of "Promoting Sustainable Kidney Health:
The Asia-Pacific and Beyond,” is dedicated to sustainability. In line with this commitment, we have prepared sessions on Green
Nephrology that focus on the management of kidney health with sustainable kidney care practices. Additionally, the overall
congress is organized in an eco-friendly manner. We hope you will be inspired and experience first-hand the innovations insustainable kidney care at APCN & KSN 2024.
In addition to the scientific program, there is an exhibition on the 3rd floor of COEX where all participants can enjoy coffee andrefreshments while attending exhibitor spotlight sessions, the poster exhibition, and a Seoul pop-up booth offering diverse
activities. We have also arranged a social event, the Opening Ceremony & Welcome Reception, on the evening of Thursday,June 13, which promises to provide an excellent networking opportunity.
Once again, we warmly welcome you to APCN & KSN 2024 and hope you enjoy all the programs we have prepared for you.
Sincerely yours,

Chun Soo Lim, M.D., Ph.D.

Sydney Tang, M.D., Ph.D.

President,
Korean Society of Nephrology

President,
Asian Pacific Society of Nephrology

Seung Yeup Han, M.D., Ph.D. Jung Pyo Lee, M.D., Ph.D.

003

Congress President,
Korean Society of Nephrology

Chair,
Organizing Committee of
APCN & KSN 2024

Program at a glance
Thursday, June 13
KOR → ENG Interpretation
Time

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

Room 1Room 2

Room 3

Room 4

Room 5

Room 6

Room 7

GRB 101-102

GBR 103

GBR 104-105

Room 201

Room 202

Room 203

Auditorium

Comprehensive
Nephrology
Education (Dialysis)

Comprehensive Nephrology Education(Fluid & Electrolyte)

Comprehensive
Nephrology
Education (Kidney
Transplantation)

KSN Cooperative
Study

Industry
Symposium 1(Hanmi)Industry Symposium 2(Vera Therapeutics)

Industry
Symposium 3(Astellas Pharma
Korea)

Comprehensive
Nephrology
Education (CKD)

Comprehensive Nephrology Education(Glomerular Disease)

Comprehensive
Nephrology
Education (AKI)

11:00 - 12:30(90')

12:30 -13:30(60')

ENG → KOR Interpretation

Interventional
Nephrology
Hands On Session(Class 1, 2)*Class 1 will be heldfrom 11:00 to 12:30.
*Class 2 will be heldfrom 13:30 to 15:00.

13:30 - 15:00(90')

15:00 - 15:30(30')

KSN Guideline

Nominees for APSN
Young Nephrologist
AwardsRenal Conservative
Care(Geriatrics 1)

Oral
Communications
3 (Dialysis /Interventional
Nephrology)

Coffee Break and Poster Visiting

Oral
Oral
Communications 2
Communications 1(Kidney(Acute Kidney Injury)
Transplantation)

15:30 - 17:00(90')

Basic Research 1

17:00 - 17:30(30')

Green Nephrology- A Position
Statement andRecommendationsfor Sustainable
Kidney Care

17:30 - 18:20(50')

Plenary Lecture 1(Katherine R. Tuttle)

18:20 - 18:30
(10')

Break

18:30 - 21:00(150')

Opening Ceremony& Welcome
Reception004

Friday, June 14
KOR → ENG Interpretation

Time

08:30 - 10:00(90')

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

Room 1Room 2

Room 3

Room 4

Room 5

Room 6

Room 7

PosterExhibition

GRB 101-102

GBR 103

GBR 104-105

Room 201

Room 202

Room 203

Auditorium

3F, Hall D

Nutrition 1

Introduction of
the International
Society of
Glomerular
Disease09:00-10:00

Acute Kidney
Injury 1

Green
Nephrology

10:00 - 10:30(30')

Chronic Kidney Disease 1

KSN Research
Fund Project

Exhibitor
Spotlight
09:00-09:30
ALPINE Immune
Sciences
Exhibitor
Spotlight
10:00-11:00
Everest
Medicines

Coffee Break and Poster Visiting

10:30-12:00(90')

Acute Kidney
Injury 2

APSN-ISPD Joint
Symposium 1

Chronic Kidney Disease 2

KidneySpecial Lecture
Basic Research 2
Transplantation 1 (Tobias B. Huber)

12:00 - 13:00(60')

Industry
Symposium 4(HK inno.N)

Industry
Symposium 5(Baxter)Industry Symposium 6(Daewon Pharm)Industry
Symposium 7(SK chemicals)

Exhibitor
Spotlight
11:00-12:00
Billy (BI+Lilly)

13:00-13:30(30')

Award Ceremony(PriscillaKincaid-Smith
Award, Kirpal
Chugh Award,
Nephrology
Journal Awards)

13:30 - 14:20(50')

Plenary Lecture 2(Jonathan Barrat)

14:20 - 15:00(40')

15:00 - 16:30(90')

14:20 - 15:00
PosterPresentation

Coffee Break and Poster Presentation

APSN-YNC
Debate Session
on Green
Nephrology

16:30 - 17:00(30')

17:00 - 18:30
Glomerulonephritis 1(90')

Kidney HealthPlan 2033

Oral
Oral
Oral
Oral
Communications
Satellite
Communications Communications Communications
7
Symposium
645(Chronical Kidney IgA Nephropathy(Glomerulonephritis) (Basic Research)(Dialysis 2)
Disease 1)

Coffee Break and Poster Visiting

Chronic Kidney Disease 3(Diabetic Kidney Disease)

Pediatric
Nephrology 1005

Exhibitor
Spotlight
13:10-14:10
Bayer

Renal
Conservative Care
(Geriatrics 2)

Saturday, June 15
KOR → ENG InterpretationTime

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Room 1Room 2

Room 3

Room 4

Room 5

GRB 101-102

GBR 103

GBR 104-105

Room 201

Room 202

Room 6

Room 7

PosterExhibition

Room 203

Auditorium

3F, Hall D

Council Meetingof the KSN

07:00 - 08:30(90')

08:30 - 10:00 Glomerulonephritis APSN - ISN Joint
2
Symposium(90')

10:00 - 10:30(30')

Dialysis 1(Hemodialysis)

Chronic Kidney
Disease 4(Hypertension and
Vascular Biology)

Nutrition 2

Exhibitor
Spotlight
10:00-11:00
DaewonCoffee Break and Poster Visiting

Glomerulonephritis
APSN-ISRNM
10:30-12:00
3
Joint Symposium(90')(Pathology)

12:00 - 13:00(60')

Plenary Lecture & Official Program

Industry
Symposium 8(Bayer Korea)

Industry
Symposium 9(Fresenius
Medical Care)

10:20-11:40
Dialysis 2 (Peritoneal Dialysis)

11:40-12:00
KSPD/KSN/JSPD MOU Ceremony

Industry Symposium 10(Kyowa Kirin Korea)

Exhibitor
Spotlight
11:00-12:00
CSL Vifor

APSN-KDIGOAPSN-ESPN Joint
KidneyJoint Symposium
Symposium
Transplantation 2
1

Industry
Symposium 11(Nipro Dongduk
Medical)

13:00-13:30(30')

Award Ceremony(YoungInvestigatorAward, Haiyan
Wang LectureAward)

13:30 - 14:20(50')

Plenary Lecture 3(Melissa Little)
14:20 - 15:00
PosterPresentation

14:20 - 15:00(40')

Coffee Break and Poster Presentation

15:00 - 16:30
(90')

Oral
Oral
Oral
Oral
Communications
Communications
APSN-KDIGO Communications
Communications
9
11
Joint Symposium
810(Renal(Diabetic/
2(Nutrition/Green(Pediatrics/
Conservative
Hypertensive
Nephrology)
Genetics)
Care/Geriatrics)
Kidney Disease)

Home
Hemodialysis

17:00 - 18:30 APSN-ISPD Joint(90')
Symposium 2

Satellite
Symposium
ADPKD

KOR

16:30 - 17:00(30')

Coffee Break and Poster Visiting

Advancing
Nephrology
Trials: The
KSN Young
Investigator
Symposium

Interventional Nephrology

Pediatric
Nephrology 2006

Exhibitor
Spotlight
13:10-14:10
VUNO

KSN General
Assembly

KORDS Report/
Dialysis Center
Accreditation

Award Session
17:00-17:30

Sunday, June 16
KOR → ENG Interpretation
Time

08:30 - 10:00(90')

10:00 - 10:30(30')

10:30-12:00(90')

12:00-12:20(20')

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

Room 1Room 2

Room 3

Room 4

Room 5

Room 6

Room 7

GRB 101-102

GBR 103

GBR 104-105

Room 201

Room 202

Room 203

Auditorium

Dialysis Specialist
Physician Course 1

Dialysis Nurse Course 1

KOR

KRCP The Current andthe Future

Asian Nephrology
Forum

KOR

Education Symposium(Ethics)
08:30-10:30

Coffee BreakDialysis Specialist
Physician Course 2

Coffee Break

KOR

Dialysis Nurse Course 2

APSN-ERAJoint
Symposium

Disaster Response
Symposium

Closing Ceremony

007

APSN-APSDA-ASDIN
Joint Symposium:
Intervention
Nephrology

KidneyTransplantation
Special Session
09:00-12:00

Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

Day 1 June 13 (Thu)Interventional Nephrology Hands On Session
Day 1 June 13 (Thu)

11:00-15:00

ENG*Class 1 will be held from 11:00 to 12:30.
*Class 2 will be held from 13:30 to 15:00.

Room 1 (GBR 101-102)

Narae Joo
Hanmaeum Hospital

Sangeon Gwoo
Lifeline Vascular Clinic

Jin Ho Lee
Leesin Hemodialysis and Intervention Clinic

Vascular Access US

YongSeon Choi
Bundang Jesaeng General Hospital

Do Hyoung Kim
Hallym University Kangnam Sacred Heart Hospital

Jeonghwan Lee
Seoul National University

Chang Min Heo

Simulator (Vascular access BFR)
11:00-12:30,
13:30-15:00

Inje University Haeundae Paik Hospital

Hyung Duk Kim

Simulator (Catheter insertion)

The Catholic University of Korea, Eunpyeong St. Mary's
Hospital

Lung USIn Soo Kim

IVC US

Dong Hee Lee

Hallym University Sacred Heart Hospital

Hallym University Sacred Heart Hospital

Hyung Seok Lee
Hallym University Sacred Heart Hospital

VeXUS (hepatic, portal V)

Gwangho Choi
Hallym University Chucheon Sacred Heart Hospital

VeXUS (renal,intrarenal,A V, RI)

Hoon Suk Park

FoCUS

Eun Jung Kim

Kidney US (kidney biopsy)

Hae Ryong Yun

The Catholic University of Korea, Seoul St. Mary's Hospital

Hallym University Dongtan Sacred Heart Hospital

Yongin Severance Hospital

11:00-12:30

Comprehensive Nephrology Education (Dialysis)

Chair(s)Sung Gyun Kim Hallym University Sacred Heart Hospital

11:00-11:30

Dialysis Membranone in HD Beyond the Basic

ENG→KOR

Room 2 (GBR 103)

Soonkil Kwon
Chungbuk National University Hospital008

Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

11:30-12:00

Peritoneal Membrane Dysfunction: Evaluation and Management

Jwa-kyung Kim

12:00-12:30

Anemia Management in Patients on Dialysis: Current and Future
Perspectives

Sung Gyun Kim

11:00-12:30

Comprehensive Nephrology Education(Fluid and Electrolyte)

Chair(s)Gheun-Ho Kim Hanyang University Medical Center
Soo Wan Kim Chonnam National University Hospital

11:00-11:30

Molecular Basis for Renal Tubular Acidosis

Tae-Hwan Kwon

11:30-12:00

Sodium Intake and Chronic Kidney Disease: The Lower the Better?

Ji Yong Jung

12:00-12:30

Benefits VS. Risks of Potassium Intake in Chronic Kidney Disease

Sang Heon Suh

11:00-12:30

Comprehensive Nephrology Education(Kidney Transplantation)

Chair(s)Jong Soo Lee Ulsan University Hospital

11:00-11:30

What's New at 2022 Banff Meeting?

11:30-12:00

Role of Complement Binding Assay

12:00-12:30

Optimal Maintenance Immunosuppression Regimen for Long Term
Allograft Outcome

Kajohnsak Noppakun

11:00-12:30

KSN Cooperative Study

ENG→KOR

Chair(s)Jin Seok Jeon Soonchunhyang University Seoul Hospital
Hoon Young Choi Gangnam Severance Hospital

12:00-12:30

ENG→KOR

Room 3 (GBR 104-105)

Kyungpook National University School of Medicine

Gachon University Gil Medical Center

Chonnam National University Hospital

ENG→KOR

Room 4 (201)Yong-Jin Kim
Kyungpook National University Hospital

Hye Eun Yoon
The Catholic University of Korea, Incheon St. Mary's
Hospital

Chiang Mai University[2022년 연구회지원사업] 당뇨병콩팥병 예후 예측을 위한 코호트 구축

Sang Youb Han

The Korean Diabetic Kidney Disease (K-DKD) Cohort Study

Inje University Ilsan Paik Hospital[2023년 열린재의료재단 기부금 연구]인공신장실 재난대응시스템 구축을 위한 조사 연구

11:30-12:00

Hallym University Sacred Heart Hospital

Development and Evaluation of a Disaster Response System for
Hemodialysis Units: A Collaborative Study by the Korean Society ofNephrology[2020년 한국보건의료연구원 과제/2023 협동연구과제]만성콩팥병 환자 투석방법 선택을 위한 공동의사결정 임상시험 (SDM-ART)

Shared Decision-Making Clinical Trial for Choosing Renal Replacement
Therapy in Chronic Kidney Disease Patients

009

Room 5 (202)Kyung Don Yoo
University of Ulsan College of Medicine

Sejoong Kim
Seoul National University Bundang Hospital

Day 1 June 13 (Thu)

11:00-11:30

Hallym University Sacred Heart HospitalDetailed Program
KOR → ENG Interpretation

Day 1 June 13 (Thu)

12:30-13:30

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Industry Symposium 1

Plenary Lecture & Official Program

Room 2 (GBR 103)

ENG→KOR

Hanmi

Chair(s)Eun Young Seong Pusan National University Hospital
Ki Ryang Nah Chungnam National University Hospital

12:30-12:55

Optimal Comorbidity Management for CV Protection in Hypertensive
Patients With Dyslipidemia

Hyun Suk Kim

12:55-13:20

Ideal Treatment Option to Manage LDL-C in CKD PatientsJi Yong Jung

13:20-13:30

Discussion

Hallym University Chucheon Sacred Hearth Hospital

Gachon University Gil Medical CenterIndustry Symposium 2 (Vera Therapeutics)
12:30-13:30

Targeting the Source of IgA Nephropathy: Focus on BAFF and APRIL
Pathways

ENG→KOR

Chair(s)Adrian Liew Mount Elizabeth Novena Hospital
Sydney Tang The University of Hong Kong

12:30-12:45

Introduction

Adrian Liew

12:45-13:05

Overview of the Pathogenesis and The Role of Cytokines BAFF andAPRIL in IgAN

Sydney Tang

13:05-13:20

Atacicept: Investigative Therapies Targeting BAFF and APRIL

Adrian Liew

13:20-13:30

Q&A

12:30-13:30

Room 3 (GBR 104-105)

Mount Elizabeth Novena HospitalIndustry Symposium 3

The University of Hong Kong

Mount Elizabeth Novena Hospital

ENG→KORAstellas Pharma Korea

Chair(s)Seungyeup Han Keimyung University Dongsan Medical Center

12:30-13:30

What Is the Optimal Tacrolimus Trough Level to Maintain Renal
Function in Transplant Recipients?

Hanbi Lee

13:30-15:00

Comprehensive Nephrology Education (CKD)

ENG→KOR

Chair(s)Hyo Wook Gil Soonchunhyang University Cheonan Hospital

13:30-14:00

Prevention and Early Detection of Chronic Kidney Disease (CKD) in
High-Risk Populations

So-Young Lee

14:00-14:30

Blood Pressure Control and CV Complication Management in Chronic
Kidney Disease (CKD) Patients: Balancing Risks and Benefits

Yaeni Kim

14:30-15:00

Current Best Approaches for CKD: Prevention of CKD Progression and
Related Complications

Su Woong Jeong

010

Room 4 (201)The Catholic University of Korea, Seoul St. Mary's Hospital

Room 2 (GBR 103)

CHA University Bundang Medical Center

The Catholic University of Korea, Seoul St. Mary's Hospital

Kyung Hee University Hospital at Gangdong

Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

13:30-15:00

Comprehensive Nephrology Education(Glomerular Disease)

Chair(s)Hee Gyung Kang Seoul National University Hospital

13:30-14:00

New Modalities to Treat IgA Nephropathy other than Systemic
Immunosuppression

Yaerim Kim

14:00-14:30

Recent Advance In Management Of FSGSSe Won Oh

14:30-15:00

Management of TMA in Glomerular Disease

Sunhwa Lee

13:30-15:00

Comprehensive Nephrology Education (AKI)

Chair(s)Manish Kaushik Singapore General Hospital

13:30-13:50

Global Epidemiology and Outcomes of AKI

Shin Young Ahn

13:50-14:10

Applications and Clinical Utility of AKI Biomarkers

Sadudee Peerapornratana

14:10-14:30

AKI in the Elderly: Challenges and Strategies for Care

Hyung Woo Kim

14:30-14:50

Nephrotoxin Stewardship and AKI Prevention

Sandra Kanes Gill

14:50-15:00

Q&A

13:30-15:00

KSN Guideline

Chair(s)Sungjin Chung The Catholic University of Korea, Yeouido St. Mary's Hospital
Jong Woo Yoon Hallym University Chucheon Sacred Hearth Hospital

14:40-15:00

ENG→KOR

Room 4 (201)

Korea University Guro Hospital

Chulalongkorn University

Severance Hospital

University of Pittsburgh

KOR→ENG

Issues and Update Directions of the KSN 2023 Diabetic Kidney Disease
Guideline

Significance of Guidelines for Deciding on Renal Replacement Therapy
for Elderly CKD Patients

Room 5 (202)Young Youl Hyun
Kangbuk Samsung Hospital

Jae Won Yang
Yonsei University Wonju Severance Christian Hospital인공신장실 감염관리 지침 개정판 해설

Young-Ki Lee

Revised Guidelines for Infection Control in Dialysis Units

Hallym University Kangnam Sacred Heart Hospital우리말신장학용어집 소개

Gheun-Ho Kim

Korean Nomenclature Glossary for Clinical Nephrology

Hanyang University Medical Center

011

Day 1 June 13 (Thu)

14:15-14:40

Keimyung University School of Medicine

Kangwon National University Hospital노인 말기콩팥병 신대체요법 결정에 대한 지침의 의의

13:55-14:15

Room 3 (GBR 104-105)

Korea University Anam Hospital당뇨병콩팥병 진료지침 쟁점과 개정 방향의 제시

13:30-13:55

ENG→KORDetailed Program

Day 1 June 13 (Thu)

KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

13:30-15:00

Nominees for APSN Young Nephrologist Awards

Chair(s)Kornchanok Vareesangthip Siriraj Hospital, Mahidol University
Jack Ng The Chinese University of Hong Kong

13:30-13:39

Dicoumarol protects against kidney fibrosis by targeting caveolin-1
accelerated TGFRs degradation

Haoyi Zheng

13:39-13:48

Liver elasticity in elderly heart failure patient -the role of kidney incardio-hepatic interaction-

Hirohito Sugawara

13:48-13:57

Quantitative analysis of the vorticity of the flow and vascular accesssounds in a pseudo-vessel stenosis model

13:57-14:06

Antioxidative Activity of Synbiotic Beverage to Improve Oxidative Stressand Fraction Area of Degeneration and Necrosis in The Kidney Tissue of Rafik Prabowo
Region General Hospital of Rokan Hulu
The Hyperlipidemic Rats Model

14:06-14:15

Hyperuricemia Treatment Reduces ESKD Risk and Mortality in CKDPatients: A Causal Inference Analysis Using the G-Formula Approach

Ara Ko14:15-14:24

Role of Magnetic Resonance Elastography and biomarkers in Early
Chronic Kidney Disease-A hospital based study

Naveen Kumar Medi

14:24-14:33

Level of Proteinuria Before and After Spironolactone in combination
with Angiotensin-Converting Enzyme-Inhibitors or Angiotensin
II Receptor Blockers in Filipinos with Chronic Kidney Disease: A
Retrospective Cohort Study

14:33-14:42

Valsartan ameliorates tacrolimus-induced vascular injury via cellularsenescence

Lingyan Fei

14:42-14:51

Nutrition Support Impact on Kidney Function in Renal Transplant
Recipients: A Transition Phase Analysis

Nguyen Thu Ha

14:51-15:00

Rituximab therapy in childhood steroid-resistant nephrotic syndrome:an international, multi-centre study

Eugene Yu-hin Chan

15:00-15:30

Coffee Break and Poster Visiting

15:30-17:00

Oral Communications 1

University of Macau

Showa University Northern Yokohama Hospital

KAZUMA SASAKI
Faculty of Medical Technology, Department of ClinicalEngineering and Medical Technology, Niigata University of
Health and Welfare

Seoul National University Hospital

Virinchi Hospitals, Hyderabad

Ellani Louise Huilar
St. Luke's Medical Center - Global City

Department of Nephrology, Center of Kidney and Urology,
the Seventh Affiliated Hospital, Sun Yat-sen University

108 Military Central HospitalHong Kong Children's Hospital

ENG

Acute Kidney Injury

Chair(s)Won Min Hwang Konyang University Hospital
Vin-Cent Wu National Taiwan University Hospital

15:30-15:37

Flt3L from Tubular Epithelial Cells Drives Dendritic Cell Responses
in Acute Kidney Injury: A Protective Mechanism for Novel
Immunotherapeutic Strategies

15:37-15:44

Effects of Dietary Salt Intake on Intrarenal Immune cells And Sodium
Buffer in Ischemic Acute Kidney Injury

012

Room 6 (203)

ENG

Room 3 (GBR 104)

Na Li
Sun yat-sen unveristy

Kyungho Lee
Samsung Medical Center, Cell and Gene Therapy
Institute, Sungkyunkwan University School of Medicine

Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

15:44-15:51

Inhibition of PTP1b via milk exosome-mediated siRNA delivery is a
novel therapeutic approach for acute kidney injury

Hochung Jang

15:51-15:58

FK506-Binding Protein 5 Regulated the Gut-Kidney Axis andExhibited a Renal Protective Effect in Acute Kidney Injury Induced by
Lipopolysaccharide

Yu-Chin Huang

15:58-16:05

Development of Machine Learning Models for Predicting CRRT in
Bacteremia Patients Admitted to the ICU, with a Focus on the Impact ofVancomycin Administration using MIMIC-III data

Min Woo Kang

16:05-16:12

Tonsil-derived Mesenchymal Stem Cells preserve Renal Function and
Fibrosis in Gentamicin-induced Acute Kidney Injury (AKI) by Alleviating
Oxidative Stress and Apoptosis

Dal-Ah Kim

16:12-16:19

Development and Validation of an Artificial Intelligence Model for thePrediction of Acute Kidney Injury, Acute Kidney Disease, and Chronic
Kidney Disease After General Anesthesia Surgery

16:19-16:26

Outcomes of Continuous Renal Replacement Therapy Versus Peritoneal
Dialysis as a Renal Replacement Therapy Modality in Patients
Undergoing Extracorporeal Membrane Oxygenation

16:26-16:33

Computed Tomography-Measured Subcutaneous Adiposity as
Protective Factor in Patients with Sepsis-Associated Acute Kidney Injury Haeun Lee
Presbyterian Medical Center
Undergoing Continuous Renal Replacement Therapy
Teerawat Sriwalosakul

16:33-16:40

Optimal Early Systolic Blood Pressure and Renal Outcome of Sepsisassociated Acute Kidney Injury in Non-critically Ill Patients: A
Retrospective Cohort Study

16:40-16:47

The Impact of the Visceral-to-Subcutaneous Adipose Tissue Ratio on
Renal Function Assessment after Nephrectomy in Kidney Donors

Hyeran Park

Oral Communications 2

Taoyuan General Hospital, Ministry of Health and Welfare,
Taoyuan 33004, Taiwan

Seoul National University Hospital

Ewha Womans University Medical Center

Jiwon MinThe Catholic University of Korea Bucheon St. Mary's
Hospital

Peerapat Thanapongsatorn
Thammasat University Hospital

Division of Nephrology, Department of Internal Medicine,
Faculty of Medicine, Chiang Mai University, Chiang Mai,
ThailandThe Catholic University of Korea Seoul St. Mary's Hospital

ENG

Kidney Transplantation

Chair(s)Henry Pleass The University of Sydney
Hye Eun Yoon The Catholic University of Korea, Incheon St. Mary's Hospital

15:30-15:37

The investigation of metabolic profile to differentiate chronic versus
acute renal allograft rejection using nuclear magnetic resonance(NMR)-based serum metabolomics

15:37-15:44

Discovering the mechanism of tacrolimus induced pancreatic beta cell
injury by using single-cell RNAseq analysis

15:44-15:51

The Prospective Multicenter pOKRA Study: Diagnosing Allograft
Rejection via Combined Novel biomarkers and Linking Donor-Derived
Cell-Free DNA to Interstitial Fibrosis and Tubular Atrophy Severity inPediatric Kidney Transplant Rejection

15:51-15:58

Discovering Molecular Signatures in ATMR: Single-cell RNA-sequencing
Analysis of Human Blood and Tissue Spatial Transcriptomics

013

Room 3 (GBR 105)

Mantabya Singh
SGPGIMS

Sang Hun Eum
Incheon St. Mary's Hospital, The Catholic University of Korea

Vikas Dharnidharka
Washington University School of Medicine in StlouisJeongin Song
Dongguk University Ilsan Hospital

Day 1 June 13 (Thu)

15:30-17:00

Korea Institute of Science and Technology (KIST)Detailed Program

Day 1 June 13 (Thu)

KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

15:58-16:05

Synergy of PDE5-inhibitor and 5-HT2B receptor Mitigates Fibrotic
Potential of Human Renal Allograft Fibroblasts

Akhilesh Jaiswal

16:05-16:12

Bisphosphonates as a Tacrolimus-Sparing Strategy in Kidney
Transplantation

Hee Byung Koh

16:12-16:19

Impact of Recipient-Donor Body Mass Index Mismatch on Deceased
donor kidney transplantation

Suyeon Hong

16:19-16:26

Early Hemoglobin Levels after Kidney Transplantation Predict Clinical
Outcomes: A Nationwide Cohort Study

You Hyun Jeon

16:26-16:33

Comparison of the Survival Outcomes Between Kidney Transplant andDialysis in Patients with Previous Cancer Diagnosis

Guohua He

16:33-16:40

Impact of Cold Ischemic Time on Deceased Donor Kidney Transplants:
Pioneering Asian Paired Donor Kidney Analysis

Nuttasith Larpparisuth

16:40-16:47

Determining The Role Of Complement Pro-Inflammatory Factors
And Regulatory Proteins In Antibody-Mediated Rejection (ABMR) In
Paediatric Kidney Transplant Recipients

Stephen Marks

16:47-16:54

Organ Procurement Organization Structure and Function in Mongolia

15:30-17:00

Basic Research 1

Sanjay Gandhi Post Graduate Institute of Medical Sciences,
Lucknow, India

Catholic Kwandong University International St. Mary's
Hospital

The Catholic University of Korea Uljeongbu St. Mary's
Hospital

Kyungpook National University Hospital

The First Affiliated Hospital, Sun Yat-sen University

Faculty of Medicine Siriraj Hospital, Mahidol University

UCL Great Ormond Street Institute of Child Health, London,
UK

Battsetseg Gonchigjav
Regulatory Department of Cell, Tissue and Organ
Transplantation Center for Health Development

ENG→KOR

Renal Genomics

Chair(s)Heon Yung Gee Yonsei University College of Medicine

15:30-15:50

Genetics of ADPKD, ADTKD, and Adult Proteinuria

Daw-Yang Hwang

15:50-16:10

Navigate Childhood Kidney Disease through Genotyping andPhenotyping

Jia Rao

16:10-16:30

Genomic Diagnostics in Nephrology

Hugh McCarthy

16:30-16:50

Clinical Application of Genome Testing in Kidney Disease

Beom Hee Lee

16:50-17:00

Q&A

15:30-17:00

Room 4 (201)National Institute of Cancer ResearchChildren's Hospital of Fudan University

University of Sydney

Renal Conservative Care (Geriatrics 1)
Conservative Care in Kidney Patients

Chair(s)Bum Soon Choi The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Eun Hui Bae Chonnam National University Hospital

15:30-15:50

Dialysis Care for the Patient's Entire Life

Asan Medical Center

ENG→KOR

Ikuto Masakane
Yabuki Hospital

014

Room 5 (202)Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

15:50-16:10

Conservative Kidney Management: When Why and For Whom?

Chenlei-Kelly Li

16:10-16:30

Treatment Preferences for Serious Illness Among Patients Receiving
Peritoneal Dialysis

Chun-Fu Lai

16:30-16:50

Elderly Dialysis vs Conservative Treatment: Cochran Review

Jae Won Yang

16:50-17:00

Q&A

Oral Communications 3

St George Hospital

National Taiwan University Hospital

Yonsei University Wonju Severance Christian Hospital

ENG

Dialysis/Interventional Nephrology

Room 6 (203)

Chair(s)Hoon Suk Park The Catholic University of Korea, Seoul St. Mary's Hospital
Khurtsbayar Damdinsuren The First Central Hospital

15:30-15:37

Post-dialysis Fatigue And Symptom Burden Among Maintenance
Hemodialysis Patients: A Multi-centre Study

Muhammad Ali Amanullah

15:37-15:44

Utility of Calcaneal Quantitative Ultrasound in Evaluating Bone Mineral
Density in Patients on Peritoneal Dialysis

Gordon Chun Kau Chan

15:44-15:51

One-year clinical course of patients initiating hemodialysis for kidneydisease associated with plasma cell dyscrasia

Seung Min Song

15:51-15:58

Comparison of Bleeding Complications between Selective Serotonin
Reuptake Inhibitors and Other Antidepressant Use among End-Stage
Kidney Disease Patients

15:58-16:05

High Malondialdehyde Predicts Inadequate Erythropoietin Therapeutic
Response in Regular Hemodialysis Patients

16:05-16:12

Factors Affecting Unplanned Dialysis Initiation - A Cross-Sectional
Survey On Patient-Identified Barriers

Samantha Hui Ling Cheong

16:12-16:19

Ultrasound Guided Endo-vascular Procedures - "Revisiting an Old
Friend" - Experience from a Tertiary Care Center in South India

ATHISH M N

16:19-16:26

Sharp recanalization with transseptal needle for failure standard
recanalization in chronic central vein occlusion

KEERATI HONGSAKUL

16:26-16:33

Severe Left Ventricular Dysfunction after Flow Reduction Operation for
High-flow Fistula in a Hemodialysis Patient and Recovery Trajectory of
3years

16:33-16:40

Patency of hemodialysis vascular access in the elderly over 80 years ofage

16:40-16:47

Efficacy of Peritoneal Dialysis Catheter Partial Replantation in Managing Seyoung Ryou
The Catholic University of Korea Seoul St. Mary's Hospital
Catheter-Related Infection and Mechanical Damage

015

Nephrology

The Chinese University of Hong Kong

Samsung Medical Center

Jun Young Lee
Wonju Severance Christian Hospital

Gede Wira Mahadita
Nephrology and Hypertension Division, Faculty of
Medicine Udayana University, Prof. IGNG Ngoerah General
Hospital, Denpasar-Bali

National University Hospital, Singapore

RGUHS

Prince of Songkla University

Narae Joo
Hanmaeum Hospital

Hyung Duk Kim
The Catholic University of Korea Eunpyeong St. Mary's
Hospital

Day 1 June 13 (Thu)

15:30-17:00

Plenary Lecture & Official ProgramDetailed Program

Day 1 June 13 (Thu)

KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

17:00-17:30

Green Nephrology - A Position Statement andRecommendations for Sustainable Kidney CareMC

Gang Jee Ko Korea University Guro Hospital

17:00-17:05

Background for Implementation of "Green Nephrology" in KSN

17:05-17:20

Establishment of "Environmentally Sustainable Design (ESD) Guidelines
for Kidney Care Facilities" in Australian and New Zealand Society ofNephrology (ANZSN)

17:20-17:30

A Position Statement and Recommendations for Sustainable Kidney
Care From KSN

Gang Jee Ko

17:30-18:20

Plenary Lecture 1

ENG→KOR

Chair(s)Chun Soo Lim Seoul National University
Lily Mushahar Hospital Tuanku Ja'afar

17:30-18:20

Kidney Health and CKD Prevention Herald a Sea Change in Nephrology

18:20-18:30

Break

18:30-21:00

Opening Ceremony & Welcome Reception

016

ENG→KORPlenary Lecture & Official Program

Room 7 (Auditorium)

Sharon Ford
Deputy Director Nephrology, Austin Health

Korea University Guro Hospital

Room 7 (Auditorium)

Katherine R. Tuttle
University of Washington

ENG

Room 7 (Auditorium)Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

Day 2 June 14 (Fri)
08:30-10:00

Acute Kidney Injury 1

Room 1 (GBR 101-102)

ENG→KOR

Comprehensive Insights into AKI Management

Chair(s)Seung Seok Han Seoul National University Hospital
Nattachai Srisawat Chulalongkorn University

08:30-08:50

Volume Measurement and Management in AKI

Jung Nam Ahn

08:50-09:10

Management of Sepsis Associated AKI

Kent Doi

09:10-09:30

Progression from AKD or AKI to CKD: Mechanisms and ClinicalImplications

Vin-Cent Wu

09:30-09:50

Post-AKI Survivors Care: Who, When and How?

Nattachai Srisawat

09:50-10:00

Q&A

08:30-10:00

Green Nephrology

Chair(s)Duk-Hee Kang Ewha Womans University Seoul Hospital
Kyungho Choi Seoul National University

08:30-08:50

Optimisation of Water Treatment in Haemodialysis Units for Water andEnergy Savings

Shaundeep Sen

08:50-09:10

Residential Green and Kidney Diseases

Jer Ming Low

09:10-09:30

Air Pollution and Kidney Disease: Mechanisms Proposed for the Effectof Particulate Matter on Renal Health

Duk-Hee Kang

09:30-09:50

Integrating Telemedicine in Green Nephrology: Building a Sustainable
Big Data and AI Ecosystem for Intelligent Kidney Care

Joseph Chin-Chi Kuo

09:50-10:00

Q&A

Hallym University Sacred Heart Hospital

The University of Tokyo Graduate School of Medicine

National Taiwan University Hospital

Concord Repatriation General Hospital

Hospital Sultan Haji Ahmad Shah

Ewha Womans University Seoul Hospital

China Medical University

Chronic Kidney Disease 1
08:30-10:00

Room 2 (GBR 103)

ENG→KOR

Advances in Understanding the Mechanisms and Therapies for Kidney
Fibrosis

ENG→KOR

Room 3 (GBR 104-105)

Chair(s)Yusuke Suzuki Juntendo University Faculty of Medicine
Desmond Yat Hin Yap Queen Mary Hospital

08:30-08:50

Understanding the Mechanism of Interstitial Fibrosis in the Kidney

Yasunori Iwata

08:50-09:10

Unraveling the Role of YAP/TAZ Signaling in Kidney Fibrosis

Seunghyeok Choi

09:10-09:30

Gut Dysbiosis and CKD

Sang-Kyung Jo

Kanazawa University

The Catholic University of Korea Seoul St. Mary's Hospital

Korea University Anam Hospital017

Day 2 June 14 (Fri)

Chulalongkorn University

Detailed Program

Day 2 June 14 (Fri)

KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

09:30-09:50

The Injury Mechanism and Possible Treatment Options for Podocytes in Katsuhiko Asanuma
Chiba University Graduate School of Medicine
CKD

09:50-10:00

Q&A

08:30-10:00

KSN Research Fund Project

Chair(s)Byung Ha Chung The Catholic University of Korea Seoul St. Mary's Hospital
Hoon Young Choi Gangnam Severance Hospital

08:30-08:37

Gait of CKD Patients

Hyun Suk Kim

08:37-08:44

Elucidation of Podocyte Apoptosis Mechanisms in Diabetic
Nephropathy Using Multi-omics Approaches

Ju-Young Moon

08:44-08:51

Vitamin D as a Molecular Treatment Candidate to Prevent VascularAccess Stenosis in Hemodialysis Patients

Jung Hwa Ryu

08:51-08:58

Modeling of Endothelial Cell Dysfunction Using Patient-Derived
Induced Pluripotent Stem Cells

Hanbi Lee

08:58-09:05

Identification of DICAM’s Role and Pathophysiological Mechanism inAcute Kidney Injury

Jeong-Hoon Lim

09:05-09:12

Standards for Facilities and Operations for Infection Control in
Hemodialysis Units in Korea

Won Min Hwang

09:12-09:19

Expression of Lysyl Oxidase Related Protein and Effect of Lysyl Oxidase
Inhibition in Cyclosporine Induced Nephropathy Mouse Model

Hyo Jeong Kim

09:19-09:26

Role of B Cell Metabolism in Ischemic Acute Kidney Injury Repair

Kyungho Lee

09:26-09:33

Improvement of Blood Glucose Levels and Variability Using Continuous
Glucose Monitoring in Chronic Kidney Disease With Diabetes

Sua Lee

09:33-09:40

The Effect of HNF4A on Podocytes

Su Woong Jeong

09:40-09:47

Single Cell Transcriptomics in Childhood Onset Lupus Nephritis

Seong Heon Kim

09:47-09:54

Necrox-7 Improves Kidney Tissue Damage Caused by Fibrosis During
Renal Ischemia-Reperfusion

Young Rok Ham

08:30-10:00

ENG→KOR

Room 4 (201)Hallym University Chucheon Sacred Hearth Hospital

Kyung Hee University Hospital at Gangdong

Ewha Womans University Seoul Hospital

The Catholic University of Korea, Seoul St. Mary's Hospital

Kyungpook National University Chilgok Hospital

Konyang University Hospital

Gangnam Severance Hospital

Samsung Medical Center

Daejeon Eulji Medical Center, Eulji University

Kyung Hee University Hospital at Gangdong

Nutrition 1

Seoul National University Hospital

Chungnam National University Hospital

ENG→KOR

Diet Intervention in CKD

Chair(s)Gang Jee Ko Korea University Guro Hospital
Kamyar Kalantar-Zadeh Harbor-UCLA Medical Center

08:30-08:50

Dietary Risk Factors for CKD: Result from Prospective Cohort

Young Su Joo

08:50-09:10

Finding the Sweet Spot: The Role of Diet in Diabetic Kidney Disease

Connie Rhee

018

Room 5 (202)

Yongin Severance Hospital

University of California, Los Angeles

Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

09:10-09:30

Should Plant Based Diet be the Preferred Dietary Approach to
Ketoanalogue-supplemented Diet in CKD?

K S Nayak

09:30-09:50

Plant Based Diet and Mediterranean Style Diet

Kelly Lambert

09:50-10:00

Q&A

09:00-10:00

Introduction of the International Society of Glomerular
Disease09:00-09:10

Welcome and Get Together

09:10-09:25

Perspectives of the ISGD

Tobias B. Huber

09:25-09:30

Brief Introduction of ISGD Centers of Excellence

Sydney Tang

09:30-09:35

Welcome Remark

Hyeong Cheon Park

09:35-09:50

Short Presentation by the KSN’s Glomerular Disease Working Group

Sehoon Park

09:50-10:00

Discussion and Get Together

10:00-10:30

Coffee Break and Poster Visiting

University of Wollongong

Room 6 (203)

ENG

President of ISGD

ISGD Committee Lead, President of APSNAPSN Honorary Secretary

Acute Kidney Injury 2
Enhancing the CRRT Practice to Improve Outcomes

Seoul National University Hospital

ENG→KOR

Room 1 (GBR 101-102)

Chair(s)Sejoong Kim Seoul National University Bundang Hospital
Marlies Ostermann King's College Hospital

10:30-10:50

KSN Recommendations for CRRT Management

Sejoong Kim

10:50-11:10

Updates on Current Ongoing Clinical Trials in CRRT

Kathleen Liu

11:10-11:30

Citrate Anticoagulation in Crrt: How to Monitor?

Marlies Ostermann

11:30-11:50

How to Run CRRT in ECMO Patients?

Manish Kaushik

11:50-12:00

Q&A

10:30-12:00

Seoul National University Bundang Hospital

University of California San FranciscoKing's College Hospital

Singapore General Hospital

APSN-ISPD Joint Symposium 1

ENG→KOR

Outcomes of PD: Where Are We Over the Years?

Chair(s)Adrian Liew Mount Elizabeth Novena Hospital
Yong-Lim Kim Kyungpook National University Hospital

10:30-10:50

Advantages of PD Over HD: Patient-reported Outcomes

019

Room 2 (GBR 103)

Yeoungjee Cho
Princess Alexandra Hospital

Day 2 June 14 (Fri)10:30-12:00

Virinchi Hospitals

Detailed Program
KOR → ENG Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

10:50-11:10

Advantages of PD Over HD: Clinical Outcomes

Jeong-hoon Lim

11:10-11:30

Outcomes of EPS: What Can Be Done?

Sunita Bavanandan

11:30-11:50

How to Achieve Improvement of PD Penetration?

Talerngsak Kanjanabuch

11:50-12:00

Q&A

10:30-12:00

Day 2 June 14 (Fri)ENG → KOR Interpretation

Kyungpook National University Chilgok Hospital

Hospital Kuala Lumpur

King Chulalongkorn Memorial Hospital

Chronic Kidney Disease 2

ENG→KOR

Translational Research and Nover Therapeutic Targets in CKD

Room 3 (GBR 104-105)

Chair(s)Cheuk Chun Szeto The Chinese University of Hong Kong
Kook-Hwan Oh Seoul National University Hospital

10:30-10:50

GWAS Studies in Chronic Diseases

Soo Heon Kwak

10:50-11:10

Proteomics in CKD

Eugene Rhee

11:10-11:30

Stem Cells and Chronic Kidney Disease

Cai-Mei Zheng

11:30-11:50

Tertiary Lymphoid Tissues: A Novel Kidney Inflammation Marker andTherapeutic Target

Motoko Yanagita

11:50-12:00

Q&A

10:30-12:00

Seoul National University Hospital

Massachusetts General Hospital

Taipei Medical University Shuang-Ho Hospital

Basic Research 2

Kyoto University

ENG→KORFor Kidney Disease

Chair(s)Carol Pollock North Shore Private Hospital
Reiko Inagi The University of Tokyo Graduate School of Medicine

10:30-10:50

Stem Cells as Therapy in AKI

Xin-Ming Chen

10:50-11:10

Organelle Cross Talk on Kidney Cell Fate

Reiko Inagi

11:10-11:30

Kidney Organoids Uses and Limitations

Yun Xia

11:30-11:50

Targeting the Beta-Catenin/TCF/Foxo1 Axis for Treatment of CKD

Guoping Zheng

11:50-12:00

Q&A

10:30-12:00

Room 4 (201)

University of Sydney

The University of Tokyo Graduate School of Medicine

Nanyang Technology University

Kidney Transplantation 1
Advances in Diagnostics and Treatment in Kidney Transplantation

Chair(s)Chul Woo Yang The Catholic University of Korea, Seoul St. Mary's Hospital
Chan-Duck Kim Kyungpook National University Hospital

10:30-10:50

Clinical Significance of Molecular Matching

University of Sydney

ENG→KOR

Room 5 (202)

Eun-Jee Oh
The Catholic University of Korea Seoul St. Mary's Hospital020

Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

10:50-11:10

Performance Characteristics of Cell Free DNA

Vikas Dharnidharka

11:10-11:30

Advances in Anti-humoral Therapy

Jaeseok Yang

11:30-11:50

Cellular Therapies in Kidney Transplantation

Stephen Alexander

11:50-12:00

Q&A

10:30-12:00

Special Lecture

Chair(s)Ho Jun Chin Seoul National University Bundang Hospital
Yaerim Kim Keimyung University School of Medicine

10:30-11:00

Nephrin Autoantibodies in Idiopathic Nephrotic Syndrome: Mechanism, Tobias B. Huber
University Medical Center Hamburg-Eppendorf
Marker, Clinical Implications

11:00-12:00

Extended Discussion

Severance HospitalChildren's Hospital at Westmead

Industry Symposium 4

ENG→KORHK inno.N

Chair(s)Kwon Wook Joo Seoul National University Hospital

12:30-13:30

Clinical Implications of Uremic Toxins and AST-120

12:00-13:00

Room 6 (203)

ENG

Industry Symposium 5

Room 1 (GBR 101-102)

Ran-hui Cha
National Medical Center

Room 2 (GBR 103)

ENG→KOR

BaxterChair(s)Yong-Lim Kim Kyungpook National University Hospital

12:00-12:30

The Future of PD: PD in 2024 and Beyond

Rajnish Mehrotra

12:30-13:00

Remote Monitoring, Maximizes Patient Management | Sharesource &MyPD

Yong Chul Kim

12:00-13:00

University of Washington School of Medicine

Industry Symposium 6

ENG→KOR

Daewon Pharm

Chair(s)Eun Hui Bae Chonnam National University Hospital

12:00-13:00

Uremic Toxins as a Potential Therapeutic Target for Kidney, Heart, andBeyond

12:00-13:00

Industry Symposium 7
Ho Sik Shin Kosin University Gospel Hospital

12:00-13:00

Nafamostat as an Anticoagulant on CRRT

Room 3 (GBR 104-105)

Jwa-kyung Kim
Hallym University Sacred Heart Hospital

ENG→KORSK chemicals

Chair(s)Seoul National University Hospital

Room 4 (201)Jung Nam Ahn
Hallym University Sacred Heart Hospital021

Day 2 June 14 (Fri)

12:00-13:00

Washington University School of Medicine in St.LouisDetailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official ProgramAward Ceremony (Priscilla Kincaid-Smith Award)

ENG

Room 7 (Auditorium)Award Ceremony (Kirpal Chugh Award)

ENG

Room 7 (Auditorium)Award Ceremony (Nephrology Journal Awards)

ENG

Room 7 (Auditorium)

13:30-14:20

Plenary Lecture 2

ENG→KOR

Room 7 (Auditorium)

Chair(s)Seung Hyeok Han Severance Hospital
Sydney Tang The University of Hong Kong

13:30-14:20

How will Treatment for IgA Nephropathy Evolve over the Next 5 Years?

14:20-15:00

Coffee Break and Poster Presentation

14:20-15:00

Best Poster Presentation 1

Chair(s)Hyung Woo Kim Severance Hospital
Chan-Young Jung Asan Medical Center
Chung Hee Baek Asan Medical Center

14:20-14:24

Inhibition of PCSK9 attenuates renal lipotoxicity by activating the
AMPK-PGC-1a-FoxO3a signaling in diabetic kidney disease

Yu Ah Hong

14:24-14:28

Synergistic Effects of Folate and Riboflavin on Vascular Calcification
Amelioration in Uremic Rats

Shin Young Ahn

14:28-14:32

Association of Uremic Toxins with Immunosenescence in Patients with
Chronic Kidney Disease

Ting-Yun Lin

14:32-14:36

Comparison between the Frequency of Interventional Procedures for
Flow-related Dysfunction in Tapered Grafts and Straight Grafts: Analysis Jin Ha Jang
Based on the Korean National Health Insurance Database from 2011 to Hallym University Sacred Heart Hospital
2018

14:36-14:40

Reducing Water Usage, Carbon Emissions, and Waste Generation in
Dialysis Units: A Closed-Loop Water Recycling Approach for Sustainable Sahnaz Vivinda PutriInternational University Semen Indonesia
Renal Care

14:40-14:44

AI-Driven Precision Nutrition for Chronic Kidney Disease Management
Through Machine Learning Prediction of Phosphorus Bioavailability

13:00-13:30
13:00-13:10
13:00-13:30
13:10-13:20
13:00-13:30

Day 2 June 14 (Fri)

13:20-13:30

Jonathan Barratt
Leicester General Hospital

ENG

022

Exhibition HallThe Catholic University of Korea Daejeon St. Mary's
Hospital

Korea University Guro Hospital

Taipei Tzu Chi Hospital

Rifaldy Fajar
Karlstad University

Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

APSN-YNC Debate Session on Green Nephrology
15:00-16:30

PD Is More Environmental Friendly Than HD: PD Can Save the Earth,
Not HD!

Chair(s)Kornchanok Vareesangthip Siriraj Hospital, Mahidol University
Jihyun Yang Kangbuk Samsung Hospital

Judge(s)Jack Ng The Chinese University of Hong Kong
Lydia Kamaruzaman University Kebangsaan Malaysia
Hyeong Cheon Park Gangnam Severance Hospital
Lily Mushahar Hospital Tuanku Ja'afar
Yong Chul Kim Seoul National University Hospital

15:00-15:10

Introduction to APSN-YNC

ENG→KOR

Room 1 (GBR 102)

Kornchanok Vareesangthip
Siriraj Hospital, Mahidol University

Jihyun Yang
Introduction to the APSN-YNC Debate Session (Topic, Team, Rules)

Kornchanok Vareesangthip
Siriraj Hospital, Mahidol University

Proposition
Arunkumar Subbiah
All India Institute of Medical Sciences

Winston Fung
The Chinese University of Hong Kong

Jer Ming Low
Hospital Sultan Haji Ahmad Shah

Phunphai Somkearti
15:20-15:50

Debates: Proposition VS Opposition

Chiang Mai University

Opposition
Fan-Chi Chang
National Taiwan University Hospital

Solos Jaturapisanukul
Vajira Hospital Navamindradhiraj University

Ji-Won Min
The Catholic University of Korea, Bucheon St. Mary's
Hospital

15:50-16:00

Audience Participation (Floor Discussion)
Duk-Hee Kang

16:00-16:10

Ewha Womans University Seoul Hospital

Wrap up From Each Team Leader

Muh Geot Wong
Concord Repatriation General Hospital

16:10-16:30

Announce the Winning Team and the Best Debater

023

Sydney TangThe University of Hong Kong

Day 2 June 14 (Fri)

Kangbuk Samsung Hospital

15:10-15:20

Detailed Program

Day 2 June 14 (Fri)

KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

15:00-16:30

Kidney Health Plan 2033

Chair(s)Chun Soo Lim Seoul National University
Sydney Tang The University of Hong Kong

15:00-15:20

Progress of KHP2033 in Korea

Sun-Hee Park

15:20-15:40

International Efforts Against CKD Pandemic

Masaomi Nangaku

15:40-16:00

Past, Present, and Future of Policies for Chronic Disease Control

Eun-kyung Jeong

16:00-16:20

Policies to Reduce Medical Costs in ESKD Care. Experience With PD First
PolicyPhilip Kam-Tao Li

16:20-16:30

Q&A

15:00-16:30

Room 2 (GBR 103)

ENG→KOR

Kyungpook National University Hospital

The University of Tokyo Graduate School of Medicine

Oral Communications 4

Seoul National University College of Medicine

Prince of Wales Hospital

ENG

Dialysis 2

Room 3 (GBR 104)

Chair(s)Vuddhidej Ophascharoensuk Chiang Mai University Thailand
Soonkil Kwon Chungbuk National University Hospital

15:00-15:07

Effect of Expanded Hemodialysis with Theranova Dialyzer on
Preservation of Residual Kidney Function: The THREAD Randomized
Controlled Trial

Jeong-Hoon Lim

15:07-15:14

Comparison Of Evocalcet With Cinacalcet In East Asian Patients With
Severe Secondary Hyperparathyroidism Undergoing Hemodialysis: A
Post-Hoc Analysis Of ORCHESTRA Study

Tak Mao Daniel Chan

15:14-15:21

Diagnosis of heart failure with preserved ejection fraction inhemodialysis patients by heart failure scoring system, a retrospectivecohort study

15:21-15:28

Development of a Real-time Autonomous Ultrafiltration Control Agent
Using Deep Reinforcement Learning

Min Woo Kang

15:28-15:35

Calcification of branches is superior to abdominal aortic calcification inpredicting mortality of hemodialysis patients

Wen Shi

15:35-15:42

Anticoagulation in patients with end-stage kidney disease and atrial
fibrillation: a national population-based study

Jun Young Lee

15:42-15:49

Hemoglobin, albumin, lymphocyte, and platelet (HALP) score predicts
the clinical prognosis of patients with end-stage kidney disease on
hemodialysis

15:49-15:56

Interdialytic blood pressure variability and all-cause mortality inpatients undergoing maintenance hemodialysis: a multicenter study
using the DialysisNet

024

Kyungpook National University Medical Center

The University of Hong KongJIHOON PARK
Kyung Hee University Hospital at Gangdong

Seoul National University Hospital

Zhong Da Hospital, School of Medicine, Southeast
University, Nanjing, Jiangsu, China

Wonju Severance Christian HospitalJin Sug Kim
Kyung Hee University Medical Center

Hyo Jin Kim
Pusan National University HospitalDetailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

15:56-16:03

Potential role of cytokines, adhesion molecules, and Toll-like receptors
predicting relapsing peritonitis in peritoneal dialysis patients.

16:03-16:10

Influence of Serum Klotho level on Mortality in Hemodialysis Patients

16:10-16:17

Prognostic Utilty of Monocyte-to-Lymphocyte Ratio for All-Cause
Mortality in Patients with Chronic Kidney Disease on Maintenance
Hemodialysis: A Single Retrospective Cohort Study From North
Sumatera, Indonesia

16:17-16:24

Association between absolute blood volume based on dialysate
dilution and body composition using bioimpedance analysis of patients Tanaka Tomoyuki
Jikei University of Health Care Scicences
undergoing hemodialysis

15:00-16:30

Oral Communications 5

Mantabya Singh
SGPGIMS

Sherzod Abdullaev
Republican specialized scientific and practical medical
center of nephrology and kidney transplantation

Riri Andri Muzasti
Faculty of Medicine, University of North Sumatera

ENG

Glomerulonephritis
Se Won Oh Korea University Anam Hospital
Jicheng Lv Peking University First Hospital

15:00-15:07

Hematuria Resolution with the APRIL-Blocking Monoclonal Antibody,
Sibeprenlimab, in Patients with IgA Nephropathy in a Phase 2
Randomized Controlled Trial

Muh Geot Wong

15:07-15:14

Single-nucleus RNA-seq reveals cell-type specific molecular signaturesand links to genome-wide risk variants of IgA nephropathy

Jeong Min Cho

15:14-15:21

Updated Results from the RUBY-3 Study of Povetacicept, an
Enhanced Dual BAFF/APRIL Antagonist, in Autoantibody-AssociatedGlomerulonephritis

Jonathan Barratt

15:21-15:28

Investigation of molecular insights into the disease-specificpathophysiology of IgA nephropathy using the single cell RNAsequencing analysis

Soojin Lee

15:28-15:35

SBP1-associated pathogenesis in IgA nephropathy

Samel Park

15:35-15:42

Single Nucleus RNA-sequencing and Mendelian Randomization
Analysis of IgA Nephropathy Progression from Onset to Chronic Kidney
DiseaseJunpeng You

15:42-15:49

Dapagliflozin alter EVs miRNAs in patients with IgA nephropathy

Kootae Park

15:49-15:56

Clinicopathologic Features and Long-Term Prognosis of Lupus
Podocytopathy

Yuhan Su

15:56-16:03

Immunosuppression Response and Relapse among a Diverse Cohort of
Adults with Primary Focal Segmental Glomerulosclerosis (FSGS) in the
United States

025

Concord Repatriation General Hospital

Seoul National University Hospital

University of Leicester

Eulji University Hospital

Soon Chun Hyang University Cheonan Hospital

The First Affiliated Hospital of Zhengzhou University

Soon Chun Hyang University Seoul Hospital

The First Affiliated Hospital of Sun Yat-sen University

John Sim
Kaiser Permanente Los Angeles Medical CenterDay 2 June 14 (Fri)

Chair(s)Room 3 (GBR 105)

Detailed Program
KOR → ENG Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

Sojung Youn

16:03-16:10

Optimizing Management of Immune Checkpoint Inhibitor-Induced
Renal Events: The Role of Kidney Biopsies

16:10-16:17

Clinical Profile And Outcomes Of Atypical Haemolytic Uremic Syndrome Vamsidhar Veeranki
Assistant Professor
in a resource limited setting: A Retrospective, Single-center Study

16:17-16:24

Deep Reinforcement Learning-Based Personalized Treatment Strategies Rifaldy Fajar
Karlstad University
for IgA Nephropathy

15:00-16:30

Day 2 June 14 (Fri)ENG → KOR Interpretation

Oral Communications 6

The Catholic University of Korea Bucheon St. Mary's
Hospital

ENG

Basic Research

Chair(s)Tae-Hyun Yoo Severance Hospital
Carol Pollock North Shore Private Hospital

15:00-15:07

Targeting VEGF isoform change by VEGF188 inhibition ameliorates
kidney fibrosis through attenuating inflammation

Fan-Chi Chang

15:07-15:14

Small extracellular vesicles derived from damaged muscle aggravate
the progression of kidney fibrosis

SONGLING JIANG

15:14-15:21

Tmem30a Protects Against Podocyte Injury Through Suppression of
Pyroptosis

Yanpei Hou

15:21-15:28

Deciphering Kidney Pathology in Type 1 Diabetes: Insights from Spatial
Metabolomics and Oxidative Metabolism Analysis

Ye Ji Choi

15:28-15:35

AI-Based Drug Repositioning Technologies: The Role of 17-DMAG in
Mitigating Kidney Fibrosis by Targeting METTL3 mRNA Synthesis

Myoung Seok Lee

15:35-15:42

Urosepsis Modeling on kidney and lung-on-a-chip system

EUN-JEONG KWON

15:42-15:49

Pre- and Postnatal Chronic Exposure to Airborne Particulate
Matter: Focus on Renal Fibrogenesis and the Role of Vitamin D
Supplementation

Hyung Eun Yim

15:49-15:56

GWAS of extreme creatinine and cystatin C levels provides genetic
insights into kidney function

15:56-16:03

Myocardial hypertrophy and fibrosis are associated with tissue
phosphorus accumulation, PIT1/ERK and progenitor cell regulatory
molecule expression in mild CKD

16:03-16:10

Modeling of allograft rejection using human induced pluripotent stem
cell-derived kidney organoid system

Sun Woo Lim

16:10-16:17

Phosphodiesterase V Inhibitor Attenuates the Fibrotic Gene Expressionof Human Renal Fibroblast derived from Kidney Biopsy Tissue

Manas Ranjan Behera

026

Room 4 (201)National Taiwan University Hospital

Ewha Womans University

Sichuan Provincial People's Hospital

University of Colorado Anschutz Medical Campus

Seoul National University

Seoul National University Bundang Hospital

Korea University Ansan Hospital

Woo-yeong Park
Keimyung University Dongsan Medical Center

Evdokia Bogdanova
Pavlov University

The Catholic University of Korea School of Medicine

Sanjay Gandhi Postgraduate Institute of Medical Sciences

Detailed Program
KOR → ENG Interpretation

15:00-16:30

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

ENG

Room 5 (202)

Oral Communications 7
Chronical Kidney Disease 1

Chair(s)Sang Youb Han Inje University Ilsan Paik Hospital
Motoko Yanagita Kyoto University

15:00-15:07

Socioeconomic Impact of Chronic Kidney Disease in Malaysia:
Work Productivity among Advanced Non-Dialysis Patients

15:07-15:14

Metabolomic profiles in urine and blood revealed differences inmetabolic pathways among patients with varying degrees of kidney
dysfunction

15:14-15:21

Association of Accelerometer-measured Physical Activity with All-cause
Byounghwi Ko
and Cause-specific Mortality in Individuals with or without Chronic
Severance Hospital
Kidney Disease: the UK Biobank Study

15:21-15:28

Time-in-target range of systolic blood pressure and all-cause mortality
in chronic kidney disease population in Korea

Soo-Young Yoon

15:28-15:35

Residual Lifetime Risk of End-Stage Kidney Disease in Chronic Kidney
Disease under One Multidisciplinary Care Program

Ming-Yen Lin

15:35-15:42

Association of Weekend-to-Weekday Sleep Duration Ratio with Kidney
Function

Wanprapit Noree

15:42-15:49

Risk for Proteinuric Chronic Kidney Disease in Cigarette Smokers:
Analysis of the 2017 2020 National Health and Nutrition Examination
Survey15:49-15:56

FollowME Fabry Pathfinders Registry: Renal Effectiveness in a Cohort ofPatients on Migalastat Treatment for at Least Three Years

15:56-16:03

CORRELATION BETWEEN ESTIMATED GLOMERULAR FILTRATION RATE(eGFR) AND LEFT ATRIAL FUNCTION IN PATIENT WITH PRADIALYTIC
CHRONIC KIDNEY DISEASE

16:03-16:10

Rapid increase in ESA resistance is a risk factor of poor renal prognosis
in pre-dialysis CKD patients. BRIGHTEN STUDY sub-analysis

Shinya Kawamoto

16:10-16:17

Optimal cutoffs of NT-proBNP for risk prediction in new-onset heart
failure in chronic kidney disease across eGFR category

Yi Lu

16:17-16:24

Impact of retinal photography-based deep learning system on risk
stratification for chronic kidney disease progression

Young Su Joo

15:00-16:30

Satellite Symposium (IgA Nephropathy)

ENG

Chair(s)Seung Hyeok Han Severance Hospital

15:00-15:05

Opening Remark

15:05-15:35

Current Treatment and the Updates in IgA Nephropathy

Faculty Of Medicine, Universiti Kebangsaan Malaysia

Hongquan Peng
Kiang Wu Hospital

Kyung Hee University Medical Center

Kaohsiung Medical University Hospital, Kaohsiung Medical
University

University of Illinois Chicago

Tatchaya Kanthajan
Srinakharinwirot University

Simon McErlane
Amicus Therapeutics Pty Ltd

Dian Pritasari Jeger
Indonesian Society of Internal Medicine

Dokkyo Medical University Nikko Medical

The Third Affiliated Hospital of Southern Medical
University, Guangzhou, China

Yongin Severance HospitalHong Zhang
Peking University First Hospital

Room 6 (203)

Day 2 June 14 (Fri)027

Lydia Kamaruzaman

Detailed Program
KOR → ENG Interpretation

Oral Communication & Room 6 (English only)

15:35-16:05

Understanding the Pathological Role of APRIL in IgA Nephropathy

16:05-16:30

Q&A

16:30-17:00

Coffee Break and Poster Visiting

17:00-18:30

Day 2 June 14 (Fri)ENG → KOR Interpretation

Glomerulonephritis 1
Status of Management for Glomerular Diseases

Plenary Lecture & Official Program

Yusuke Suzuki
Juntendo University Faculty of Medicine

Room 1 (GBR 101-102)

ENG→KOR

Chair(s)Sydney Tang The University of Hong Kong
Ho Jun Chin Seoul National University Bundang Hospital

17:00-17:20

Debate on Treatment for IgA Nephropathy

Jicheng Lv

17:20-17:40

Update in Management of ANCA-Associated Vasculitis

David R.W. Jayne

17:40-18:00

Current and Future Prospects for Management of Membranous
Nephropathy

Daniel C Cattran

18:00-18:20

Avoiding Steroid in Treatment of Minimal Change Disease

Yong Chul Kim

18:20-18:30

Q&A

17:00-18:30

Peking University First Hospital

Chronic Kidney Disease 3 (Diabetic Kidney Disease)What's

New in DKD?

Cambridge University Hospitals

University of Toronto

Seoul National University Hospital

ENG→KOR

Room 3 (GBR 104-105)

Chair(s)Eun Young Lee Soonchunhyang University Cheonan Hospital
Katherine R. Tuttle University of Washington

17:00-17:20

State-of-art Treatment for DKD

Katherine R. Tuttle

17:20-17:40

New Pathogenesis of DKD: Mechanosensitive Injury Signaling

Tobias B. Huber

17:40-18:00

Novel Next-Generation Drugs for DKD in the Pipeline

David Z. I. Cherney

18:00-18:20

New Biomarker for DKD: Urinary EV

Dongsic Choi

18:20-18:30

Q&A

17:00-18:30

University of Washington

ENG→KOR

Pediatirc Nephrotic Syndrome
Eugene Yu-Hin Chan Hong Kong Children's Hospital
Aditi Sinha All India Institute of Medical Sciences

17:00-17:20

Pathogenesis of Pediatric Nephrotic Syndrome

Toronto General Hospital Research Institute

Soonchunhyang University College of Medicine

Pediatric Nephrology 1

Chair(s)University Medical Center Hamburg-Eppendorf

Room 4 (201)

Tomoko Horinouchi
Kobe University Graduate School of Medicine028

Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

17:20-17:40

Genetics of Congenital/Infantile Nephrotic Syndrome

Ng Kar Hui

17:40-18:00

Difficult to Treat Nephrotic Syndrome

Arvind Bagga

18:00-18:20

Recurrent Glomeruolonephritis after Transplant

Stephen Marks

18:20-18:30

Q&A

17:00-18:30

Plenary Lecture & Official Program

National University Hospital

All India Institute of Medical Sciences

Great Ormond Street Hospital

Renal Conservative Care (Geriatrics 2)
Enjoy Life in Older Adults with CKD

ENG→KOR

Chih-Kang Chiang National Taiwan University Hospital
Soon Hyo Kwon Soonchunhyang University Seoul Hospital

17:00-17:20

Role of Senescence of Aging Kidney

Helen Healy

17:20-17:40

How to Manage Sarcopenia in CKD Patients?

Reshma Aziz Merchant

17:40-18:00

Frailty Renal Phenotype: Identify and Manage Those in Need

Chia-Ter Chao

18:00-18:20

A Pragmatic Randomized Clinical Trial: Twice Weekly VS Thrice Weekly
Incident Hemodialysis in Elderly Patients

Haekyung Lee

18:20-18:30

Q&A

University of Queensland

National University Health System

029

National Taiwan University Hosptial

Soonchunhyang University Seoul Hospital

Day 2 June 14 (Fri)

Chair(s)Room 5 (202)Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

Day 3 June 15 (Sat)07:00-08:30
08:30-10:00

Glomerulonephritis 2
Perspective on the Pathophysiology of Glomerular Diseases

Room 1 (GBR 101-102)

ENG→KOR

Chair(s)Bum Soon Choi The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Sunhwa Lee Kangwon National University Hospital

08:30-08:50

Insight into Glomerular Filtration and Albuminuria

David J. Salant

08:50-09:10

Complement Activation in Glomerular Diseases

Nick Medjeral-Thomas

09:10-09:30

Target Antigens in Membranous Nephropathy

Sanjeev Sethi

09:30-09:50

Biobank-driven Multi-omics Analyses of Glomerular Diseases

Dong Ki Kim

09:50-10:00

Q&A

08:30-10:00

Day 3 June 15 (Sat)Council Meeting of the KSN

Boston University School of Medicine

Hammersmith Hospital / Imperial College London

Mayo Clinic

APSN-ISN Joint Symposium

Seoul National University Hospital

Room 2 (GBR 103)

ENG→KOR

Cardio-reno-metabolic Axis

Chair(s)Hyeong Cheon Park Gangnam Severance Hospital
Masaomi Nangaku The University of Tokyo Graduate School of Medicine

08:30-08:50

Cardiovascular Risk Factors Associated with Kidney Disease

Robert J. Walker

08:50-09:10

Current and Future of Telemedicine and Telenephrology

Masaomi Nangaku

09:10-09:30

BP Control in Advanced CKD

Seung Hyeok Han

09:30-09:50

Optimizing Potassium Management for Cardio-kidney-metabolic
Complications

Angela Yee-Moon Wang

09:50-10:00

Q&A

08:30-10:00

Otago Medical School University of Otago

The University of Tokyo Graduate School of Medicine

Severance Hospital

Dialysis 1 (Hemodialysis)Duke-NUS Medical School

ENG→KOR

Unresolved Issues in the Care of HD Patients

Room 3 (GBR 104-105)

Chair(s)Mai-Szu Wu Taipei Medical University
Yang Wook Kim Inje University Haeundae Paik Hospital

08:30-08:50

The Effects of Uremic Toxin on Heart Functions in HD Patients

Hongli Lin

08:50-09:10

Hemodiafiltration and Expanded Hemodialysis: A Look Towards the
FutureHideki Kawanishi

030

First Affiliated Hospital of Dalian Medical University

Tsuchiya General HospitalDetailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

09:10-09:30

Uremic Toxins and Clinical Outcomes in Hemodialysis

I-Wen Wu

09:30-09:50

Hemodialysis in the Elderly Patients: Practical Concerns andConsiderations

Soon Hyo Kwon

09:50-10:00

Q&A

08:30-10:00

Chronic Kidney Disease 4(Hypertension and Vascular Biology)

Shuang Ho Hospital, Taipei Medical University

Soonchunhyang University Seoul Hospital

ENG→KOR

Room 4 (201)Hypertension and Kidney Disease
Chair(s)Muh Geot Wong Concord Repatriation General Hospital
Minghui Zhao Peking University First Hospital

08:30-08:50

Blood Pressure Management in Elderly CKD Patients

Eunjin Bae

08:50-09:10

Appropriate Use of Diuretics to Control Blood Pressure in CKD

Eun Sil Koh

09:10-09:30

Digital Hypertension in CKD

Akihiro Nomura

09:30-09:50

Sympathetic Overactivity and Cardiovascular Morbidity in Dialysis
Patients

Robert J. Walker

09:50-10:00

Q&A

The Catholic University of Korea, Yeouido St. Mary's Hospital

Kanazawa University

Nutrition 2

Otago Medical School University of Otago

ENG→KOR

Sarcopenia and Obesity in Kidney Disease

Chair(s)K S Nayak Virinchi Hospitals
S. Russ Price East Carolina University

08:30-08:50

Clinical Applications of Body Composition and Muscle Strength in CKDJung Nam Ahn

08:50-09:10

Muscle Energetics and Function in Kidney Disease

Alp Ikizler

09:10-09:30

The Sarcopenic Obesity Paradigm in CKD

Csaba Kovesdy

09:30-09:50

Pathophysiology and Potential Treatment of Uremic Sarcopenia

Chih-Kang Chiang

09:50-10:00

Q&A

10:00-10:30

Coffee Break and Poster Visiting

Room 5 (202)Hallym University Sacred Heart Hospital

Vanderbilt University School of Medicine

University of Tennessee Health Science Center

031

National Taiwan University Hospital

Day 3 June 15 (Sat)08:30-10:00

Gyeongsang National University Changwon HospitalDetailed Program
KOR → ENG Interpretation

Day 3 June 15 (Sat)10:30-12:00

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Glomerulonephritis 3 (Pathology)

Plenary Lecture & Official Program

Room 1 (GBR 101-102)

ENG→KOR

Renal Pathology

Chair(s)Suxia Wang Peking University First Hospital
Beom Jin Lim Gangnam Severance Hospital

10:30-10:50

Histologic Classification of IgA Nephropathy: It's Role in Patient Care

Ian S D Roberts

10:50-11:10

Renal Pathology Associated with Monoclonal Gammopathy

Suxia Wang

11:10-11:30

Glomerular Diseases with Nonamyloid Fibrillar Deposits

Kelly D Smith

11:30-11:50

Digital Platform and Artificial Intelligence in Renal Pathology

11:50-12:00

Q&A

10:30-12:00

APSN-ISRNM Joint Symposium

Chair(s)S. Russ Price East Carolina University
Jung Eun Lee Yongin Severance Hospital

10:30-10:50

Pathophysiological Mechanisms Leading to Muscle Loss in Chronic
Kidney Disease

S. Russ Price

10:50-11:10

Cachexia and Chronic Kidney Disease

Kamyar Kalantar-Zadeh

11:10-11:30

Promising Way to Mitigate Sarcopenia in CKD: Exercise

Jun Chul Kim

11:30-11:50

Reconciling Nutrition Support Supplementation with the
Deeper Metabolic Picture of Muscle Wasting in Dialysis Patients Understanding the Science of Nutrition Intervention

Tilakavati Karupaiah

11:50-12:00

Q&A

10:20-11:40

Oxford University Hospitals NHS Foundation Trust

Peking University First Hospital

University of Washington

Heounjeong Go
Asan Medical Center

Room 2 (GBR 103)

ENG→KOR

East Carolina University

Harbor-UCLA Medical Center

Dialysis 2 (Peritoneal Dialysis)

Gumi CHA Hospital

Taylor's University

ENG→KOR

Challenges and the Potentials for PD

Room 3 (GBR 104-105)

Chair(s)Sung Gyun Kim Hallym University Sacred Heart Hospital
Hideki Kawanishi Tsuchiya General Hospital

10:20-10:40

How to Treat Renal Anemia in Peritoneal Dialysis Patients in Japan:
Lessons from JSDT Data Analysis

Takahiro Imaizumi

10:40-11:00

How to Improve the Outcome of Peritoneal Dialysis? Salt Is a New
Poison for PD

Yasuhiko Ito

11:00-11:20

Benefits of Remote Monitoring in PD: Review of Clinical Trials

Gang Jee Ko

11:20-11:40

Smart Peritoneal Dialysis Program for PD Quality Control

Zhiming Ye

032

Nagoya University

Aichi Medical University

Korea University Guro Hospital

Guangdong Provincial People's HospitalDetailed Program
KOR → ENG Interpretation

11:40-12:00
10:30-12:00

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

KSPD/KSN/JSPD MOU Ceremony
APSN-ESPN Joint Symposium
Hematuria and IgA Nephropathy in Children

Plenary Lecture & Official Program

ENG→KOR

Room 3 (GBR 104-105)

ENG→KOR

Room 4 (201)

Chair(s)Dieter Haffner Hannover Medical School
Ji Hong Kim Gangnam Severance Hospital

10:30-10:50

When Do We Do Gene Tests in Children with Hematuria?

Jun Oh

10:50-11:10

Is Kidney Biopsy Necessary to Diagnose IgA Nephropathy in Children?

Jae Il Shin

11:10-11:30

When Do We Use Immunosuppression in Children with IgANephropathy?

Hee Gyung Kang

11:30-11:50

Do We Treat IgA Nephropathy and IgAVN Differently?

Dieter Haffner

11:50-12:00

Q&A

10:30-12:00

Kidney Transplantation 2
Organ Shortage and Equity Issues in Kidney Transplantation

University Medical Center Hamburg-Eppendorf

Severance Hospital

Seoul National University Hospital

Hannover Medical School

ENG→KOR

Chair(s)Sunita Bavanandan Hospital Kuala Lumpur
Germaine Wong Westmead Hospital

10:30-10:50

Use of Suboptimal Kidney Donors in Tx

10:50-11:10

ABO Incompatible Kidney Transplantation in Asia Pacific

11:10-11:30

Gender Disparity in Kidney Transplantation in Asia PacificYunmi Kim

11:30-11:50

Development of an Equity Framework in Transplantation

Camilla Nonterah

11:50-12:00

Q&A

10:30-12:00

APSN-KDIGO Joint Symposium 1

Chair(s)Seung Hyeok Han Severance Hospital
Carol Pollock North Shore Private Hospital

10:30-10:45

Setting the Scene

Daniel C Cattran

10:45-11:00

Managing IgAN in Asia

Sang-Ho Lee

11:00-11:15

New Therapies and a New Paradigm

Jonathan Barratt

Room 5 (202)Henry Pleass
The University of Sydney

Yoshihiko Watarai

Inje University Busan Paik Hospital

University of Richmond

ENG

Room 6 (203)

University of Toronto

Kyung Hee University Hospital at Gangdong

Leicester General Hospital033

Day 3 June 15 (Sat)Japanese Red Cross Aichi Medical Center, Nagoya Daini
Hospital

Detailed Program
KOR → ENG Interpretation

11:15-11:30

Case Study

11:30-12:00

Panel Discussion

12:00-13:00

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

Sydney TangThe University of Hong Kong

Industry Symposium 8

ENG→KOR

Bayer Korea

Room 1 (GBR 101-102)

Chair(s)Masaomi Nangaku The University of Tokyo Graduate School of Medicine

12:00-12:05

Opening Remarks

12:05-12:15

A Time to Act: How Early Identification of CKD in T2D Improves
Outcomes

Sung Gyun Kim

12:15-12:25

MRAs in 2024: Still All the Same?

Rajiv Agarwal

12:25-12:40

The Ripple Effects: ​How NS-MRAs’ Unique Mechanisms are Driving
Clinical Benefits

Rajiv Agarwal

12:40-12:55

From Bench to Practice: The Clinical Application of NS-MRAs in theManagement of CKD in T2D

Minghui Zhao

12:55-13:00

Q&A and Closing Remarks

Hallym University Sacred Heart Hospital

Indiana University School of Medicine

Indiana University School of Medicine

Peking University First Hospital

Day 3 June 15 (Sat)

Industry Symposium 9 (Fresenius Medical Care)

Room 2 (GBR 103)

12:00-13:00

Individualized Care for Patients Undergoing Dialysis At-Home and InCenter: The Right Therapy, Right Place, Right Time

Chair(s)Bum Soon Choi The Catholic University of Korea, Eunpyeong St. Mary's Hospital

12:00-12:30

Home Dialysis: Empowering Patients at Home: Why, Who and How?

Yeoungjee Cho

12:30-13:00

The CONVINCE Study: Recognizing the Benefits of High-Volume
Hemodiafiltration for Enhanced Patient Outcomes

Bernard Canaud

12:00-13:00

Industry Symposium 10
Yong-Lim Kim Kyungpook National University Hospital

12:00-13:00

A New Era of Calcimimetics in Asia

12:00-13:00

12:00-13:00

Online HDF vs Super High Flux HD

Room 3 (GBR 104-105)

Tokai University

ENG→KOR

Nipro Dongduk Medical
Yon Su Kim Seoul National University Hospital

Montpellier University

Masafumi Fukagawa

Industry Symposium 11

Chair(s)Princess Alexandra Hospital

ENG→KORKyowa Kirin Korea

Chair(s)ENG→KOR

Hideki Kawanishi
Tsuchiya General Hospital

034

Room 4 (201)Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official ProgramAward Ceremony (Young Investigator Award)

ENG

Room 7 (Auditorium)Award Ceremony (Haiyan Wang Lecture Award)

ENG

Room 7 (Auditorium)

13:30-14:20

Plenary Lecture 3

ENG→KOR

Room 7 (Auditorium)

Chair(s)Hunjoo Ha Ewha Womans University
Masaomi Nangaku The University of Tokyo Graduate School of Medicine

13:30-14:20

Stem Cell-derived Human Kidney Tissue for Drug Development andTissue Engineering

14:20-15:00

Coffee Break and Poster Presentation

14:20-15:00

Best Poster Presentation 2

Chair(s)Tae Hyun Ban The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Young Su Joo Yongin Severance Hospital
Se Won Oh Korea University Anam Hospital

14:20-14:24

Association with Dietary Sugar Intake and Hyperuricemia in KoreanChildren and Adolescents: Korea National Health and Nutrition
Examination Survey

Sang Youn You

14:24-14:28

Efficacy of integrated risk score using omics-based biomarkers for theprediction of acute rejection in kidney transplantation: A randomized
prospective pilot study

Mingyu Kim

14:28-14:32

New Strategies for Improving Kidney dECM Recellularization Efficiency

BOYUN KIM

14:32-14:36

Establishment of a Drug Screening Platform for Polycystic Kidney
Disease using Human Urine Tubuloids

Hye Youn Kim

14:36-14:40

Influence of the method of addition of nitric oxide during hemodialysis
on its antithrombotic effect.

MAYU FUKADA

14:40-14:44

Interaction of the miR-466-699 clusters and Wnt signaling in cellproliferation of the aldosterone-sensitive distal nephron

Hyo-Ju Jang

14:44-14:48

Development of Dialysis Patient Exercise Therapy Support System I-Proposal for the Continuation of Exercise Therapy-

Tokuo UMEDA

13:00-13:30
13:00-13:10
13:00-13:30
13:10-13:20

Melissa Little
Murdoch Children's Research Institute

ENG

Ganghwa-gun Public Health Center

Kyungpook National University Hospitalrokithealthcare

Yonsei University College of Medicine

Kitasato University Graduate School

Kyungpook National University, School of Medicine

Former Kitasato University

Day 3 June 15 (Sat)035

Exhibition Hall

Detailed Program
KOR → ENG Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

15:00-16:30

Home Hemodialysis

Chair(s)Kyung Don Yoo University of Ulsan College of Medicine
Donghyung Lee Beomil Yonsei Clinic & Hemodialysis Center

15:00-15:30

Home Versus Facility Dialysis and Mortality in Australia and New
Zealand

Mark R. Marshall

15:30-16:00

Changes in Insurance and Financial Support for Hemodialysis Patientsin Japan: Focusing on Home Hemodialysis

Ikuto Masakane

16:00-16:30

The Development History of Korean Mobile Hemodialysis Machines

Jintae Lee

15:00-16:30

Day 3 June 15 (Sat)ENG → KOR Interpretation

ENG→KORAPSN-KDIGO Joint Symposium 2

Middlemore Hospital

Yabuki Hospital

Synopex Inc.

ENG→KORADA-KDIGO Consensus Report

Chair(s)Yon Su Kim Seoul National University Hospital
Katherine R. Tuttle University of Washington

15:00-15:20

Management of Diabetes and CKD - Insights from the KDIGO 2022
Diabetes Guideline and ADA Consensus ReportPeter Rossing

15:20-15:40

Referral Time to Nephrology Care

Sungjin Chung

15:40-16:00

Implementation of the 2022 Diabetes Guideline: Progress and Barriers

Juliana Chan

16:00-16:20

Story Not Covered in the Guideline

Seung Seok Han

16:20-16:30

Q&A

15:00-16:30

Room 1 (GBR 102)

Room 2 (GBR 103)

Steno Diabetes Center Copenhagen

The Catholic University of Korea, Yeouido St. Mary's Hospital

The Chinese University of Hong Kong

Seoul National University Hospital

Oral Communications 8

ENG

Nutrition/Green Nephrology

Chair(s)Gang Jee Ko Korea University Guro Hospital
K S Nayak Virinchi Hospitals

15:00-15:07

Alleviating Restless Legs Syndrome (RLS) in Hemodialysis Patients:
Unveiling the Therapeutic Impact of Palm Tocotrienol-Rich Fraction(TRF)

15:07-15:14

The Appropriate Nutritional Re-Education in Hemodialysis Patients:
Analyzed with dietary intake

Jin Su Kim

15:14-15:21

Food Intake, Genetic Risk, and Risk of Incident Chronic Kidney Disease:
A Longitudinal Analysis of the UK Biobank Data

Jeonghwan Lee

15:21-15:28

Association between Healthy Dietary Patterns and Chronic Kidney
Disease: Findings from the Korean National Health and Nutrition
Examination Survey (KNHANES) 2019-2021

036

Room 3 (GBR 104)

Zulfitri Azuan Mat Daud
Universiti Putra Malaysia

The Catholic University of Korea Eunpyeong St. Mary's
Hospital

Seoul National University

Minsang Kim
Seoul National University HospitalDetailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

15:28-15:35

Impacts of a plant-based diet intervention on reducing dietary acidload in CKD3-4: simple messaging is key to success

Kelly Lambert

15:35-15:42

Effect of Ketosteril in Slowing Chronic Kidney Disease Progression in
Patients on Low Protein Diet

Zi Chan

15:42-15:49

Mediterranean lifestyle is associated with a lower risk of chronic kidneydisease: population-based prospective study

Hyo Jeong Kim

15:49-15:56

Fluctuating Risk of Acute Kidney Injury-Related Mortality for Four
Weeks After Exposure to Air Pollution: A Multi-Country Time-Series
Study in 6 Countries

15:56-16:03

The global burden of glomerulonephritis attributable to non-optimum
temperature among adolescents and young adults in 204 countries and Guohua He
The First Affiliated Hospital, Sun Yat-sen University
territories, 1990-2019

16:03-16:10

The Impact of Greenness on Graft Outcomes and Mortality in Kidney
Transplant Recipients: A Longitudinal Study from South Korea

Soie Kwon

16:10-16:17

Optimizing CKRT dose prescription, as the first step for green
nephrology

Taeil Kim

15:00-16:30

Oral Communications 9

University of Wollongong

United Christian Hospital

Gangnam Severance Hospital

Jieun Min
Ewha Womans University Medical Center

Chung-Ang University Hospital

Pusan National University Hospital

ENG

Renal Conservative Care/Geriatrics

Chair(s)Mooyong Park Soonchunhyang University Hospital Bucheon
Reshma Aziz Merchant National University Health System

15:00-15:07

Shared Decision-Making Facilitates Non-Hemodialysis Renal
Replacement Therapy: A Retrospective Study at Seoul National
University Bundang Hospital

15:07-15:14

Associations of Obesity, Sarcopenia, and Sarcopenic Obesity with
Chronic Kidney Disease Development in the Elderly Population

Young Su Joo

15:14-15:21

Comparison of the Safety of Normal Saline and Balanced crystalloid inhydration after kidney biopsy

Yu Tanaka

15:21-15:28

Lean Body Mass as a Predictor of Mortality in Hemodialysis Patients:
A Focus on Age-Related Variations

JI EUN KIM

15:28-15:35

Role of Wearable Technology And Geo-Fencing Device In Managementof Renal Data And Quality of Life In Relation To Chronic Kidney Disease
Patients With Type 2 Diabetes

15:35-15:42

Frailty predicts adverse clinical outcomes in patients with moderate tosevere chronic kidney disease

Tai-Shuan Lai

15:42-15:49

The Clinical Outcome of Chronic Kidney Disease Stage V patients on
Conservative Kidney Management In a tertiary hospital in Cebu City

Claire Sanaani

15:49-15:56

Evaluation of efficacy, safety and treatment patterns of sodium
zirconium cyclosilicate in management of hyperkalemia in China: aninterim analysis (Actualize)

Julee You
Seoul National University Bundang Hospital

Yongin Severance Hospital

kobe university, japan

Inha University Hospital

Vikas Sharma
IDC research center

National Taiwan University Hospital Bei-Hu branch

Chong Hua Hospital

Nan Shen
The First Affiliated Hospital of Dalian Medical University

Day 3 June 15 (Sat)037

Room 3 (GBR 105)

Detailed Program
KOR → ENG Interpretation

Oral Communication & Room 6 (English only)

15:56-16:03

Genotype-Phenotype Correlation and Long Term Outcomes in a
Large Cohort of Patients with Primary Distal Renal Tubular Acidosis
from India

Sayali Thakare

16:03-16:10

Risk factors of under-correction in severe hyponatremia: a post-hoc
analysis of the SALSA trial

Seon Ha Baek

16:10-16:17

Comparison of Creatinine-based Glomerular Filtration Rate Equationsfor Mortality Prediction in Korean Population: a Retrospective Kangbuk
Samsung Health Cohort study

15:00-16:30

Day 3 June 15 (Sat)ENG → KOR Interpretation

Oral Communications 10

Plenary Lecture & Official Program

Seth GS Medical College and KEM Hospital,
Mumbai, India

Dongtan Sacred Heart Hospital

Daseul Huh
Kangbuk Samsung Medical Center

ENG

Pediatrics/Genetics

Chair(s)Jae Il Shin Severance Hospital
Alison Ma Hong Kong Children's Hospital

15:00-15:07

Variants in TSHZ3 Encoding a Regulator of Smooth Muscle
Differentiation in Human Congenital Anomalies of the Kidney And
Urinary Tract

15:07-15:14

EZH2 promotes cyst growth in autosomal dominant polycystic kidneydiseaseCheng Xue

15:14-15:21

Genotype-phenotype analysis in patients with PAX2 pathogenic
variants: beyond renal coloboma syndrome

JI HYUN KIM

15:21-15:28

Integrated bioinformatic analysis showing Lcn2 is a key molecular in
Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD

Ruilian You

15:28-15:35

Long-term clinical outcomes in pediatric patients with primary
nephrogenic diabetes insipidus

Seon Hee Lim

15:35-15:42

Impact of COVID-19 outbreak on the incidence of uveitis and TINU
syndrome in Korean children

Min Ji Park

15:42-15:49

Integrating Machine Learning to Forecast End-Stage Renal Disease
Progression in Pediatric Nephropathic Cystinosis: A Prospective
Multi-Center Study

15:49-15:56

Single-cell transcriptomics reveals distinct pathophysiologic signatureof the primary coenzyme Q10 nephropathy in pediatric SRNS patientPeong Gang Park

15:56-16:03

Interplay of trace elements & cardiovascular status in pediatric chronic
kidney disease patients

Dina Sallam

16:03-16:10

Acquired cystic kidney disease is prevalent among children with kidney
failure: A territory-wide cross-sectional study

Eugene Yu-hin Chan

16:10-16:17

Successful sequential haploidentical maternal haematopoietic stem
cell and kidney transplantation without requirement for long term
immunosuppression

Stephen Marks

16:17-16:24

Exploring patient, family and clinician perspectives about thepsychosocial factors influencing access to kidney transplantation andtransplant outcomes for children

Ji Soo Kim

038

Room 4 (201)

Ruthild Weber
Hannover Medical School, Hannover

Shanghai Changzheng Hospital

Seoul National University Bundang Hospital

peking university first Hospital

Pusan National University Yangsan Hospital

Kyungpook National University HospitalAndi Nursanti Andi Ureng
Andini Persada College of Health Sciences

Ajou University HospitalProf

Hong Kong Children's Hospital

UCL Great Ormond Street Institute of Child Health, London,
UK

Great Ormond Street Hospital for Children NHS Foundation
TrustDetailed Program
KOR → ENG Interpretation

16:24-16:31

15:00-16:30

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Comprehensive Molecular Genetic Approach for Patients with
Nephrocalcinosis and Suspected SLC34A3/SLC34A1 Damage

Oral Communications 11

Plenary Lecture & Official Program

Margarita Sharova
Research Centre for Medical Genetics

ENG

Chronical Kidney Disease 2

Chair(s)Robert J. Walker Otago Medical School University of Otago
Sang Heon Song Pusan National University Hospital

15:00-15:07

Phase II Dose-Selection, Randomised, Controlled Trial of ASi BI
690517 With and Without EMPA in CKD: Subgroup Analysis by T2D
StatusDavid Cherney

15:07-15:14

TYRO3 is a Promising Immune-derived Factor in Diabetic Kidney
DiseaseSuhua Gao

15:14-15:21

Cell states and niches in diabetic kidneys identified by spatial mappingof targeted gene panel at single cell resolution

Su Woong Jung

15:21-15:28

Untargeted urinary metabolomics reveals novel biomarkers for type 2
diabetic kidney disease

Donghwan Yun

15:28-15:35

Integrated Personalized Lifestyle Management Program for Diabetic
Nephropathy Control in Limited Resources Healthcare Facility:
Randomized Controlled Trial

15:35-15:42

Assessment of Chronic Kidney Disease Epidemiology Collaboration(CKD-EPI) Equation in Uzbek Diabetic Patients

Sherzod Abdullaev

15:42-15:49

Insulin resistance linked to increased risk of End-Stage Renal Disease in
non-diabetic and diabetic individuals: findings from a large-scale study

Javad Alizargar

15:49-15:56

Refined Machine Learning Approach for Early Identification of HighRisk Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients:
Simplified Screening Tool Version

15:56-16:03

Neutrophil extracellular traps predict disease condition in complement- Xiaotian Liu
Peking university first Hospital
mediated thrombotic microangiopathy patients

16:03-16:10

Soluble ST2 is an early marker for hypertensive nephrosclerosis
signatured in glomerular mesangial cell

16:10-16:17

Association between Blood Pressure and Chronic Kidney Disease
Progression in Patients with Advanced Chronic Kidney Disease: Findings Cheol Ho Park
Severance Hospitalfrom KNOW-CKD Study

15:00-16:30

Satellite Symposium (ADPKD)

Chair(s)Ken Tsuchiya Tokyo Women's Medical University
Yun Kyu Oh Seoul National University

15:00-15:15

Current Efforts of Japanese Public Research Groups on ADPKD

Department of Medicine, Toronto General Hospital,
Toronto, ON, Canada

Chu Hsien-I Memorial Hospital & Tianjin Institute of
Endocrinology, Tianjin Medical University

Kyung Hee University Hospital at Gangdong

Seoul National University Hospital

Burhan Gunawan
Sumber Waras Hospital, West Jakarta

Republican specialized scientific and practical medical
center of nephrology and kidney transplantation

Day 3 June 15 (Sat)Kashan University

Wanjak Pongsittisak
Navamindradhiraj University

Jeong Min Cho
Seoul National University Hospital

ENG

039

Room 5 (202)

Room 6 (203)

Satoru Muto
Juntendo University Faculty of Medicine

Detailed Program

Day 3 June 15 (Sat)

KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

15:15-15:30

Treatment Strategies of ADPKD

Saori Nishio

15:30-15:45

Experiences of Tolvaptan Usage in Korea

Yaerim Kim

15:45-16:00

Modeling and Drug Discovery for ADPKD Using iPSC-Derived Kidney
Organoid

Kenji Osafune

16:00-16:15

Genetic Study Findings in the Korean Registry

Hayne Park

16:15-16:30

Q&A

16:30-17:00

Coffee Break and Poster Visiting

16:30-17:00

KSN General Assembly

KOR

Room 7 (Auditorium)

17:00-17:30

Award Session

KOR

Room 7 (Auditorium)MC

Jwa-kyung Kim (Hallym University Sacred Heart Hospital)

17:00-17:10

젊은 연구자상 시상 (Young Investigator Award)

17:10-17:20

학술상 시상 (KSN Academic Excellence)

17:20-17:30

공로상 시상 (KSN Lifetime Achievement Award)

17:00-18:30

Hokkaido University Hospital

Keimyung University School of Medicine

Kyoto University Hospital

Hallym University Kangnam Sacred Heart Hospital

Cheol Ho Park
Severance Hospital

Seok Hui Kang
Yeungnam University Hospital

APSN-ISPD Joint Symposium 2

Young-Ki Lee
Hallym University Kangnam Sacred Heart Hospital

ENG→KOR

Improving the Time on Peritoneal Dialysis

Room 1 (GBR 101-102)

Chair(s)Kamal Sud Nepean Hospital
Sunita Bavanandan Hospital Kuala Lumpur

17:00-17:20

Optimizing the PD Prescription for Improved Outcomes

Adrian Liew

17:20-17:40

Training the PD Nurse for a Successful PD Program

Josephine Chow

17:40-18:00

Continuous Quality Improvement in a PD Program

Lily Mushahar

18:00-18:20

Managing Non-Infectious Complications of Peritoneal Dialysis

Rajnish Mehrotra

18:20-18:30

Q&A

040

Mount Elizabeth Novena Hospital

University of New South Wales

Hospital Tuanku Ja'afar

University of Washington School of Medicine

Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

17:00-18:30

Advancing Nephrology Trials:
The KSN Young Investigator Symposium

Chair(s)Muh Geot Wong Concord Repatriation General Hospital
Sung Gyun Kim Hallym University Sacred Heart Hospital

17:00-17:10

Overview of Recent Clinical Trials in Nephrology

Rajiv Agarwal

17:10-17:30

The Single Center Randomized Trial - Can It Still Make a Difference?

Rajiv Agarwal

17:30-17:50

Can Autologous Cell Treatment Preserve Kidney Function and Delay
Progression of Advanced Chronic Kidney Disease?

Borut Cizman

17:50-18:10

Clinical Trial on Nephrology Area & Feasibility Set-up

Sunil Youn

18:10-18:20

Q&A

17:00-18:30

Interventional Nephrology

Chair(s)Seok-Joon Shin The Catholic University of Korea, Incheon St. Mary's Hospital
Vandana Niyyar Emory University School of Medicine

17:00-17:20

How to Conquer Physiological and Clinical Fistula Immaturity

Dirk M Hentschel

17:20-17:40

Is HD Catheter a Necessary Evil?

Do Hyoung Kim

17:40-18:00

Challenges Faced in Setting up PTA Service by Interventional
Nephrologists in a Developing Nation

Vinoth Kasi Rajan

18:00-18:20

Implanting PD Catheter Exit-site Facing an Upward Direction

Masato Ikeda

18:20-18:30

Q&A

Concord Repatriation General Hospital

Indiana University School of Medicine

ProKidney Corp.

Alexion Pharma Korea, L.L.C

ENG→KOR

Room 3 (GBR 104-105)

Harvard Medical School

Hallym University Kangnam Sacred Heart Hospital

Pediatric Nephrology 2

Queen Elizabeth Hospital

The Jikei University, Kashiwa Hospital

ENG→KOR

Uncommon Childhood Kidney Diseases

Chair(s)Koichi Nakanishi University of the Ryukyus Hospital
Kandai Nozu Kobe University Graduate School of Medicine

17:00-17:20

Cystic Kidney Diseases

Franz Schaefer

17:20-17:40

Atypical Haemolytic Ureamic Syndrome in Children

Alison Ma

17:40-18:00

Alport Syndrome

Judith Savige

18:00-18:20

Lupus Nephritis in Children

Seong Heon Kim

Heidelberg University HospitalHong Kong Children's Hospital

The University of Melbourne

Seoul National University Hospital

041

Room 4 (201)

Day 3 June 15 (Sat)17:00-18:30

Room 2 (GBR 103)

ENG→KORDetailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

18:20-18:30

Q&A

17:00-18:30

KORDS Report/Dialysis Center Accreditation

Chair(s)Seon Ho Ahn Wonkwang University Hospital
Yong Kyun Kim The Catholic University of Korea, St. Vincent's Hospital

17:00-17:15

17:15-17:30

Plenary Lecture & Official Program

KOR→ENG우리나라 투석 환자 발병률 및 유병률

Tae Hyun Ban

Incidence and Prevalence of Korean Dialysis Patients

The Catholic University of Korea, Eunpyeong St. Mary's
Hospital

Hye Eun Yoon우리나라 투석 환자의 임상적 특징

The Catholic University of Korea, Incheon St. Mary's
Hospital우리나라 투석 환자의 생존 분석

Tae Hee Kim

Mortality in Patients on Dialysis in South Korea

Inje University Busan Paik Hospital

17:00-18:30

KORDS Report/Dialysis Center Accreditation

KOR→ENG

Chair(s)Young-Ki Lee Hallym University Kangnam Sacred Heart Hospital
Chang Su Boo Choo Medical Center

17:30-17:45

17:45-18:00
18:00-18:15

2024년 인공신장실 인증평가 보고

Myung-Gyu Kim

2024 Hemodialysis Center Certification Evaluation Report

Korea University Anam Hospital복막투석 재택관리 시범사업 보고

Ho Sik Shin

Report on Peritoneal Dialysis At-Home Management Pilot Project

Kosin University Gospel Hospital

So Mi Kim

Green Nephrology

Dankook University Hospital

Day 3 June 15 (Sat)

18:15-18:30

Room 5 (202)042

Room 5 (202)Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

Day 4 June 16 (Sun)08:30-10:00

Dialysis Specialist Physician Course 1

Room 1 (GBR 101-102)

ENG→KOR

Issue in Hemodialysis

Chair(s)Hankyu Lee Lee Hankyu Clinic

08:30-09:00

CKD-MBD Management: About the New Phosphate Binder

Seun Deuk Hwang

09:00-09:30

Strategies for Achieving High Volume HDF

Ajin Cho

08:30-10:00

Dialysis Nurse Course 1

Chair(s)Hyung Duk Kim The Catholic University of Korea, Seoul St. Mary's Hospital

08:30-09:00

혈액투석막의 구조와 성능 및 가장 적합한 투석막의 선택은

09:00-09:30

Current Evidence of Anticoagulation Therapy in Hemodialysis Patient

Inha University Hospital

Hallym University Kangnam Sacred Heart Hospital

Room 2 (GBR 103)

KOR

Jang Han Lee
Bundang Jesaeng General Hospital

Hayne Park
Hallym University Kangnam Sacred Heart Hospital혈액투석을 위한 수질관리 및 투석장비 유지를 위한 소독지침Youkyoung Kim

Quality Management of Dialysis Water and Machine System

BAXTER

08:30-10:30

Education Symposium (Ethics)

KOR→ENG

Chair(s)Seung Ho Park Hub IM Clinic
Sang Youb Han Inje University Ilsan Paik Hospital

08:30-08:50

고령 환자의 투석 유보 권고안

In O Sun고령 환자의 투석 중단 권고안

Seo Rin Kim

Guidelines for Dialysis Withdrawal in Elderly Patients

Pusan National University Yangsan Hospital

09:30-10:00

08:50-09:10

Presbyterian Medical Center해외 권고안 비교 분석

09:10-09:30

09:50-10:10

Comparative Analysis of Overseas Guidelines for Withholding &Withdrawing RRTEun Kyung Choi
Kyung Pook National University School of Medicine권고안에 대한 윤리적 고려사항Eun-Young Lee

Ethical Considerations for Recommendations

Catholic University of Pusan보존콩팥관리

Sung Joon Shin

Conservative Kidney Management

Dongguk University Ilsan Hospital043

Day 4 June 16 (Sun)09:30-09:50

Room 3 (GBR 104-105)

Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

In O Sun
Presbyterian Medical Center

Seo Rin Kim
Pusan National University Yangsan Hospital

Eun Kyung Choi
10:10-10:30

Kyung Pook National University School of Medicine

Panel Discussion

Eun-Young Lee
Catholic University of Pusan

Sung Joon Shin
Dongguk University Ilsan Hospital

Jae-Won Lee
G Sam Medical Center

08:30-10:00

KRCP: The Current and the Future

Chair(s)Tae-Hyun Yoo Severance Hospital

08:30-08:50

Statistical Considerations in KRCP

Hakmook Kang

08:50-09:10

Recent trends in academic journal publishing, including the use ofgenerative artificial intelligence

Sun Huh

09:10-09:30

Expectations for KRCP From Outside Korea

Kent Doi

09:30-09:50

The Role of the ErbB Receptor Family in Progressive Kidney Disease andMetabolic Syndrome

Ming-Zhi Zhang

09:50-10:00

Q&A

Day 4 June 16 (Sun)08:30-10:00

ENG→KOR

Room 4 (201)

Vanderbilt University

Hallym University

The University of Tokyo Graduate School of Medicine

Asian Nephrology Forum

Vanderbilt University

ENG→KOR

Optimal Management of ESKD Patients in Asia

Chair(s)Mai-Szu Wu Taipei Medical University
Yoshiaki Takemoto Osaka Metropolitan University Hospital
Sang-Ho Lee Kyung Hee University Hospital at Gangdong

08:30-08:50

Conservative Kidney Management & Palliative Care: Dialysis Withhold
and Withdrawal

Sung Joon Shin

08:50-09:10

Strategies to Increase Kidney Transplantation

Mai-Szu Wu

09:10-09:30

Patient Selection and Prescription of Hemodiafiltration

Tomo Tadashi

09:30-09:50

PD-first Policy in Hong Kong: Pros and Cons

Philip Kam-Tao Li

09:50-10:00

Q&A

Room 5 (202)Dongguk University Ilsan Hospital

Taipei Medical University

Clinical Engineering Research Center, Oita University

Prince of Wales Hospital044

Detailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

Kidney Transplantation Special Session
09:00-12:00

Structure and Function of Organ Procurement Organization for
Deceased Kidney Transplantation in Asia

Room 6 (203)

ENG

Chair(s)Curie Ahn National Medical Center
Yeong Hoon Kim Inje University Busan Paik Hospital

09:00-09:30

Differences Between OPO Structures and Roles and Their Advantages
and Disadvantages: (US vs Spain vs Australia)

Stefan Tullius

09:30-10:00

Key Foundations for OPO Success I: Ethics, Compliance, Data Integrity,and Healthcare Collaboration

Ghazali Ahmad

10:00-10:30

Key Foundations for OPO Success II: Comprehensive Training for
Coordinators

Dong Van He

10:30-11:00

Coffee Break

11:00-11:30

Key Foundations for OPO Success III: Cultural Awareness and Public
Engagement

Harvard Medical School

National Heart InstituteVietnam National Coordinating Center for Human Organ
Transplantation (VNHOT)

Yingyos Avihingsanon
Chulalongkorn University

Kidney Transplantation Special Session
09:00-12:00

Chair(s)Structure and Function of Organ Procurement Organization for
Deceased Kidney Transplantation in Asia

Room 6 (203)

ENG

Jeremy Chapman Westmead Hospital
In-Sung Moon Korea Organ Donation Agency
Oderdene Lkhaakhuu
First Central Hospital of Mongoli a

11:30-12:00

Panel Discussion: Country Experience Cons and Pros in OPO

Harun Ur Rashid
Kidney Foundation Hospital and Research InstituteBattsetseg Gonchigjav
Regulatory Department of Cell, Tissue and Organ
Transplantation, Center for Health Development

10:00-10:30
10:30-12:00

Coffee BreakRoom 4 (201)

Dialysis Specialist Physician Course 2

ENG→KOR

Vascular Access and Ultrasound in Nephrology

Room 1 (GBR 101-102)

Chair(s)Jung Geon Lee Nam Seoul Clinic

10:30-11:00

Monitoring and Surveillance in Hemodialysis Access

11:00-11:30

Vascular UltrasoundSangeon Gwoo

11:30-12:00

Application of Ultrasound in Nephrology Other than Vascular
Ultrasound

Eun Jung Kim

Hyung Duk Kim

Lifeline Vascular Clinic045

Hallym University Dongtan Sacred Heart Hospital

Day 4 June 16 (Sun)The Catholic University of Korea, Eunpyeong St. Mary's
Hospital

Detailed Program
KOR → ENG Interpretation

10:30-12:00

Dialysis Nurse Course 2

Chair(s)Jin Hee Han Asan Medical Center

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

KOR

Room 2 (GBR 103)투석환자의 가려움증 관리

Bo Young Chung

Pruritus in Dialysis PatientsHallym University Kangnam Sacred Heart Hospital자동복막투석(APD)의 이해와 간호

Mihye Kwak

The Patiend Care of Automated Peritoneal Dialysis (APD)

Asan Medical Center혈액투석 중환자 관리

Hyun Young Lee

Critical Care for Hemodialysis - Unstable V/S Management

Samsung Medical Center

10:30-12:00

APSN-ERA Joint Symposium

ENG→KOR

Chair(s)Xueqing Yu Guangdong Provincial People's Hospital
Ivan Rychlik Charles University

10:30-10:50

ADPKD Treatment and New European Guidelines on Tolvaptan

Vladimir Tesar

10:50-11:10

Genetic- and Kidney Disease-related Asymptomatic Hyperuricemial
Mechanisms and Clinical Implications

Stefanie Steiger

11:10-11:30

Modeling of Genetic Kidney Disease and Development of New
Therapeutics Using Patient Derived Induced Pluripotent Stem Cells

Byung Ha Chung

11:30-11:50

Current Treatment Status of Fabry Nephropathy in Korea

Samel Park

11:50-12:00

Q&A

10:30-12:00

Disaster Response Symposium

Chair(s)Won Min Hwang Konyang University Hospital
Dai Hai Choi Gumi CHA General Hospital

10:30-11:00

Emergency Preparedness and Kidney Disease - Sharing Know-Hows of
ISN RDPWG

Ali Abu-Alfa

11:00-11:30

Dietary Plan for Korean Renal Hemodialysis Patients in a Disaster
Emergency Situation

Yumi Jang

11:30-12:00

Emergency Medical System for Disaster Response in Hospitals (Centered Wookjin Choi
Ulsan University Hospitalon Artificial Kidney Units)

10:30-12:00

APSN-APSDA-ASDIN Joint Symposium: Intervention
Nephrology

Chair(s)Takashi Sato Kaikoukai Vascular Access Treatment Center
Sung Gyun Kim Hallym University Sacred Heart Hospital

10:30-10:50

HD VA Endovascular Thrombectomy, Tips for Beginners

10:30-11:00
11:00-11:30
11:30-12:00

Day 4 June 16 (Sun)

ENG → KOR Interpretation

Room 3 (GBR 104-105)

Charles University

LMU Hospital Munich

The Catholic University of Korea, Seoul St. Mary's Hospital

Soonchunhyang University Cheonan Hospital

ENG→KOR046

Room 4 (201)American University of Beirut

University of Ulsan

ENG→KOR

Room 5 (202)Ki Ryang Nah
Chungnam National University HospitalDetailed Program
KOR → ENG Interpretation

ENG → KOR Interpretation

Oral Communication & Room 6 (English only)

Plenary Lecture & Official Program

10:50-11:10

Ultrasound of Kidneys and Bladder: Clinical Case Scenarios

Vandana Niyyar

11:10-11:30

Native Fistula Should Remain the First Choice of Vascular Access for
Elderlies

Hideki Kawanishi

11:30-11:50

Examination of Vascular Access: Best Practices and Tools

Jernej Pajek

11:50-12:00

Q&A

12:00-12:20

Closing Ceremony

Emory University School of Medicine

Tsuchiya General Hospital

University Medical Center Ljubljana

ENG

Room 2, (GBR 103)

Day 4 June 16 (Sun)047

APCN & KSN 2024 Organizing Committee
Chair, Organizing Committee

Director, Publication Committee

Jung Pyo Lee

Dae Eun Choi

Seoul National University

Chungnam National University

Secretary General

Vice Secretary

Myung-Gyu Kim

Ji-Won Min

Korea University

The Catholic University of Korea

Director, Scientific Program Committee

Vice Secretary

Seung Hyeok Han

Jeonghwan Lee

Yonsei University

Seoul National University

Director, International Liasion Committee

Advisory Board

Jung Tak Park

Won Min Hwang

Yonsei University

Konyang University

Yong-Lim Kim
Director, Publicity Committee

Kyungpook National University

Eun Hui Bae
Yon Su Kim

Chonnam National University

Seoul National University

Treasurer

Hyeong-Cheon Park

Jwa-Kyung Kim

Yonsei University

Hallym University

Chul Woo Yang
The Catholic University of Korea

AuditorSang Heon Song
Pusan National University

Director, Registration Committee
Hoon Suk ParkThe Catholic University of Korea

Director, Sustainable Kidney Care Guidelines Committee
Gang Jee Ko
Korea University

048

Scientific Program Committee
Director

Seung Hyeok Han

Yonsei University

Co-director (APSN)

Lily Mushahar

Hospital Tuanku Ja'afar

Muh Geot Wong

Concord Repatriation General Hospital

Se Joong Kim

Seoul National University

Nattachai Srisawat

Chulalongkorn University

Sun-Hee Park

Kyungpook National University

Wei Chen

Sun Yet Sun University

Kook Hwan Oh

Seoul National University

Eun Young Lee

Soonchunhyang University

Sunita Bavanandan

Hospital Kuala Lumpur

Ho Jun Chin

Seoul National University

Hong Zhang

Peking University First HospitalHeon Yung Gee

Yonsei University

Carol Pollock

North Shore Private Hospital

Byung Ha Chung

Catholic University

Germaine Wong

Westmead Hospital

Hee Gyung Kang

Seoul National University

Alison Ma

Hong Kong Children's Hospital

Jung Tak Park

Yonsei University

Gang Ji Ko

Korea University

K S Nayak

Virinchi Hospitals

Soon Hyo Kwon

Soochunhyang University

Eun Hee Bae

Chonnam National University

Chih-Kang Chiang

National Taiwan University Hospital

Hoon Suk Park

Catholic University

Takashi Sato

Kaikoukai Vascular Access Treatment Center

Acute Kidney Injury
Dialysis
Chronic Kidney Disease

Glomerular disease
Basic Research
Transplantation
Pediatric nephrology
Nutrition

Renal Supportive Care

Intervention Nephrology

International Liaison Committee
Director

Jung Tak Park

Yonsei University

MemberJihyun Yang

Kangbuk Samsung Medical Center

Young Su Joo

Yonsei University

Jee Young Lee

Konkuk University049

Publicity Committee
Director

Eun Hui Bae

Chonnam National University

MemberTae Ryom Oh

Chonnam National University

Kipyo Kim

Inha University

Soie Kwon

Chung-Ang University

Young Su Joo

Yonsei University

Jiwon Min

Catholic University

Hyung Duk Kim

Catholic University

Yu Ho Lee

CHA Bundang Medical Center

Jeong-Hoon Lim

Kyungpook National University

Harin Rhee

Pusan National University

Ajin Cho

Hallym University

Jihyun Yang

Kangbuk Samsung Hospital

050

The Asian Pacific Society of Nephrology Executive
President

Sydney Tang

Honorary Secretary

Hyeong Cheon Park

Treasurer

Cheuk Chun Szeto

President Elect

Xueqing Yu

Immediate Past President

Masaomi Nangaku

Ex-co Members

Robert J. Walker

Lily Mushahar

Muh Geot Wong

Mai-Szu Wu

Motoko Yanagita

Vuddhidej Ophascharoensuk

Yusuke Suzuki

Kamal Sud

Kornchanok Vareesangthip

Chun Soo Lim

Rathika Krishnasamy

Sunny SH Wong

Sunita Bavanandan

Guang-Yan Cai

Jung Pyo Lee

051

The Korean Society of Nephrology Executive
Congress President
Seungyeup Han

Director the Insurance and Legal Affairs
Hyung Jong Kim
Dae Eun Choi
Hankyu Lee

President
Chun Soo Lim

Treasurer
Bum Soon Choi

Congress Vice-President
Hyung Eun Yim
Jung Geon Lee

Director, the Ethical Issues
Seung-Ho Park
Sang-Youb Han

AuditorEun Young Lee

Director, the Public Relation
Sang Heon Song

Secretary General
Sung Gyun Kim

Director, the Dialysis Quality Assurance
Chang Su Boo
Ho Sik Shin
Myung-Gyu Kim

Vice-Secretary General
Jwa-Kyung Kim
Yong Chul Kim
Jin Joo Cha

Director, the Disaster Preparedness and Response
Young-Ki Lee

Director, the Scientific Programs
Seung Hyeok Han

Director, the Social Contribution
Ho Seok Koo

Director, the External Affairs and Cooperation
Jung Pyo Lee
Byung Ha Chung

Director at Large
Hyun-Lee Kim
Sun-Hee Park
Soon Kil Kwon
Beom Jin Lim
Jae Won Yang

Director, the Collaborative Studies
Jin Seok Jeon
Director, the Clinical Practice Guidelines
Sungjin Chung

Editor·in·Chief,
Kidney Research and Clinical PracticeTae-Hyun Yoo

Director, the Training and Education
Dong Ki Kim
Jae Il Shin
Director, the KORDS Registry
Seon Ho Ahn
Yong Kyun Kim

052

Floor Plan
Grand Ballroom, 1F, COEX
Session Room
Session Room 1 (GBR 101+102)
Session Room 2 (GBR 103)
Session Room 3 (GBR 104+105)
Registration Desk
Green Nephrology Booth& Photo Zone
APCN 2025 Promotional
Booth

ASEM Ballroom, 2F, COEX

Session Room
Session Room 4 (201)
Session Room 5 (202)
Session Room 6 (203)
Business Meeting Room
Room 205B
Room 209A
Room 209B
Preview Room
205A
LoungeFaculty Lounge (210)
VIP Lounge (211)
Secretariat office053

Auditorium & Exhibition Hall, 3F, COEX
Session Room
Session Room 7 (Auditorium)
Business Meeting Room
R1
R2
R3
Exhibition (Hall D)
Industrial Exhibition
Coffee Break
Poster Exhibition
Rest area
Exhibitor Spotlight
Scientific Exhibition
Best Poster Presentation
Professional Societies' CornerSeoul Promotional POP-UP Booth054

Congress Information
Overview
Title

Asian Pacific Congress of Nephrology 2024 in conjunction withthe 44th Annual Meeting of the Korean Society of Nephrology (APCN & KSN 2024)

Date

June 13 (Thu) – 16 (Sun), 2024

Venue

COEX, Seoul, Korea

Theme

Promoting Sustainable Kidney Health: The Asia-Pacific and Beyond

Hosted by

The Korean Society of Nephrology (KSN)
The Asian Pacific Society of Nephrology (APSN)

Official Language

EnglishWebsitewww.apcn2024.org

Facility Opening Hours
Registration Desk
Date

Operating Hours

June 13 (Thu)

09:00 – 18:30

June 14 (Fri)

07:30 – 18:30

June 15 (Sat)

06:30 – 18:30

June 16 (Sun)07:30 – 11:40

Location

GBR Lobby (1F)

Preview Lounge
Date

Operating Hours

June 13 (Thu)

09:00 – 18:30

June 14 (Fri)

07:30 – 18:30

June 15 (Sat)

07:30 – 18:30

June 16 (Sun)07:30 – 12:00

Location

Room 205A (2F)-	Speakers are required to visit the Preview Lounge and upload their final presentation file(s) before their session begins toensure that the backgrounds, graphics, and linked images or videos appear properly.
- Presentation materials should be brought on a USB memory stick.
- 	If a presentation includes animation(s), movie clip(s), or sound, please let the staff know in advance at the Preview Room.

055

Exhibition Hall
Date

Operating Hours

June 13 (Thu)

10:00-17:00

June 14 (Fri)

08:00-17:00

June 15 (Sat)08:00-17:00

June 16 (Sun)08:00-10:30

LocationHall D (3F)

Official & Social Programs
Opening Ceremony & Welcome Reception
Date & Time

June 13 (Thu), 18:30~21:00

Venue

GBR 101-103 (1F)

Admission

No ticket or admission fee required, open to all participantsAward Ceremony
Date- June 14 (Fri) : Award Ceremony (Priscilla Kincaid-Smith Award, Kirpal Chugh Award, Nephrology Journal Awards)- June 15 (Sat) : Award Ceremony (Young Investigator Award, Haiyan Wang Lecture Award)

Time

13:00 - 13:30

Venue

Room 7, Auditorium (3F)

Closing Ceremony
Date & Time

June 16 (Sun), 12:00-12:20

Venue

Room 2 (GBR 103)

Refreshments
Meals
Lunch boxes will be served at the Luncheon Symposium
Date & Time

June 13 (Thu), 12:30 -13:30
June 14 (Fri), 12:00 - 13:00
June 15 (Sat), 12:00 - 13:00

Venue

During Industry Symposium
Room 1 (GBR 101-102) (Excluding June 13(Thu))
Room 2 (GBR 103)
Room 3 (GBR 104-105)
Room 4 (Room 201)056

Coffee Break
Revitalize your day with Fresh coffee and light refreshments! Coffee & Refreshments will be served as follows:
Date

Operating Hours

June 13 (Thu)

15:00 - 15:30

June 14 (Fri)10:00 - 10:30
14:20 - 15:00
16:30 - 17:00

June 15 (Sat)10:00 - 10:30
14:20 - 15:00
16:30 - 17:00

June 16 (Sun)10:00 - 10:30

LocationHall D (3F)

Wi-Fi
Free Wi-Fi provided by COEX will be available at the venue.
- Network Name: COEX Free Wi-Fi- No password required

Mobile App

Certificate of Attendance
All participants may download and print the certificate of attendance at My Page on the APCN & KSN 2024 website after the
meeting ends.

057

EventGo Green and Get Rewarded! Bring Your Own Cup for Green Nephrology!
Who can Participate

All registrants who own your cup

RewardT Money (transportation) card

Where you get reward

Registration Desk, Grand Ballroom Lobby 1F, COEX
- Limited supply - available on a first come first serve basis- Only redeemable once per person- Use your T-money on taxi, bus, subway and convenience stores!

Note

Bus

SubwayTaxi

Convenience store(7-Eleven, cu, Emart 24, ministop etc.)

Green Nephrology Booth & Photo Zone
Upload the photo taken at Green Nephrology photo zone on the APCN & KSN 2024 mobile app!

058연수평점 안내 (CME credit for Korean)대한의사협회 연수교육 지침에 따라 실제 세션을 수강하신 시간에 비례하여 평점이 인정됩니다.
구분

6/13(목)6/14(금)6/15(토)6/16(일)대한의사협회

최대 6평점

최대 6평점

최대 6평점

최대 3평점
1) 일반 1점2) 필수 2점+일반 1점

1평점
(2시간 이상)1평점
(2시간 이상)1평점
(2시간 이상)1평점
(2시간 이상)

내과전문의
평생교육
대한내과학회
내과전공의외부학술대회

2평점(학술대회 기간 중 총 3시간 이상 참석 시 총 2점 인정)세션별 평점
구분

세션

일자

평점

비고

대한의사협회
필수평점

Ethics Education

6/16(일)최대 2평점

윤리교육 이수 시 필수 2평점,타 세션 추가 이수 시 최대 일반 1평점 합산 가능윤리교육

08:30-10:30(부분평점 가능)*전체 강의 수강시에 한하여‘윤리교육 이수증’ 발급대한내과학회
분과전문의Hands on Session

6/13(목)최대 3평점별도 사전 등록 필요(등록 마감)

11:00-12:30
13:30-15:00(3시간 미만
부분평점 없음)**내과학회 평생교육, 외부학술대회 평점 중복 불가(인터벤션)*의사협회 일반 평점 중복 인정 가능- 세션에 참석한 시간에 비례하여 이수 가능한 평점이 달라집니다.
- 대한의사협회 평점은 1시간 당 1점이 인정됩니다.
- 1시간 미만 참석 시에는 평점이 인정되지 않습니다.
- 세션 종료 1시간 전부터는 부분평점이 인정되지 않습니다.
- 회의장 입/퇴장 시 반드시 QR코드 인식하여 출결 기록을 해야 평점 인정 가능합니다. (1일 2회 이상)- Break, Industry Symposium 시간은 체류시간에서 제외됩니다.

059

List of Invited Guests
Speakers
Ali Abu-Alfa

Chih-Kang Chiang

American University of Beirut

National Taiwan University Hospital

Rajiv Agarwal

Yeoungjee Cho

Indiana University School of Medicine

Princess Alexandra Hospital

Ghazali Ahmad

Ajin Cho

National Heart Institute

Hallym University Kangnam Sacred Heart Hospital

Jung Nam Ahn

Seunghyeok Choi

Hallym University Sacred Heart Hospital

The Catholic University of Korea Seoul St. Mary's Hospital

Shin Young Ahn

Dongsic Choi

Korea University Guro Hospital

Soonchunhyang University College of Medicine

Stephen Alexander

Wookjin Choi

Children's Hospital at Westmead

Ulsan University Hospital

Katsuhiko Asanuma

Eun Kyung Choi

Chiba University Graduate School of Medicine

Kyung Pook National University School of Medicine

Yingyos Avihingsanon

Josephine Chow

Chulalongkorn University

University of New South Wales

Eunjin Bae

Byung Ha Chung

Gyeongsang National University Changwon Hospital

The Catholic University of Korea Seoul St. Mary's Hospital

Arvind Bagga

Sungjin Chung

All India Institute of Medical Sciences

The Catholic University of Korea, College of Medicine

Tae Hyun Ban

Bo Young Chung

The Catholic University of Korea, Eunpyeong St. Mary's Hospital

Hallym University Kangnam Sacred Heart Hospital

Jonathan Barratt

Borut Cizman

Leicester General Hospital

ProKidney Corp.

Sunita Bavanandan

Vikas Dharnidharka

Hospital Kuala Lumpur

Washington University School of Medicine in St.Louis

Bernard Canaud

Kent Doi

Montpellier University

The University of Tokyo Graduate School of Medicine

Daniel C Cattran

Sharon Ford

University of Toronto

Deputy Director Nephrology, Austin HealthRan-hui Cha

Masafumi Fukagawa

National Medical Center

Tokai University

Juliana Chan

Sandra Kanes Gill

The Chinese University of Hong Kong

University of Pittsburgh

Chia-Ter Chao

Heounjeong Go

National Taiwan University Hosptial

Asan Medical Center

Xin-Ming Chen

Sangeon Gwoo

University of Sydney

Lifeline Vascular Clinic

David Z. I. CherneyDieter Haffner

Toronto General Hospital Research InstituteHannover Medical School060

Young Rok Ham

David R.W. Jayne

Chungnam National University Hospital

Cambridge University Hospitals

Seung Seok Han

Su Woong Jeong

Seoul National University Hospital

Kyung Hee University Hospital at Gangdong

Sang Youb Han

Eun-kyung Jeong

Inje University Ilsan Paik Hospital

Seoul National University College of Medicine

Seung Hyeok Han

Sang-Kyung Jo

Severance Hospital

Korea University Anam Hospital

Dong Van He

Young Su Joo

Vietnam National Coordinating Center for Human Organ Transplantation (VNHOT)

Yongin Severance Hospital

Helen Healy

Ji Yong Jung

University of Queensland

Gachon University Gil Medical Center

Dirk M Hentschel

Kamyar Kalantar-Zadeh

Harvard Medical School

Harbor-UCLA Medical Center

Tomoko Horinouchi

Hee Gyung Kang

Kobe University Graduate School of Medicine

Seoul National University Hospital

Tobias B. Huber

Duk-Hee Kang

University Medical Center Hamburg-Eppendorf

Ewha Womans University Seoul Hospital

Sun HuhHakmook Kang

Hallym University

Vanderbilt University

Ng Kar Hui

Talerngsak Kanjanabuch

National University Hospital

King Chulalongkorn Memorial Hospital

Daw-Yang Hwang

Tilakavati KarupaiahNational Institute of Cancer Research

Taylor's University

Seun Deuk Hwang

Manish Kaushik

Inha University Hospital

Singapore General Hospital

Won Min Hwang

Hideki Kawanishi

Konyang University Hospital

Tsuchiya General Hospital

Young Youl HyunDo Hyoung Kim

Kangbuk Samsung Hospital

Hallym University Kangnam Sacred Heart Hospital

Masato Ikeda

Hyung Duk Kim

The Jikei University, Kashiwa Hospital

The Catholic University of Korea, Eunpyeong St. Mary's Hospital

Alp Ikizler

Eun Jung Kim

Vanderbilt University School of Medicine

Hallym University Dongtan Sacred Heart Hospital

Takahiro Imaizumi

Sejoong Kim

Nagoya University

Seoul National University Bundang Hospital

Reiko Inagi

Yong Chul Kim

The University of Tokyo Graduate School of Medicine

Seoul National University Hospital

Yasuhiko Ito

Jwa-kyung Kim

Aichi Medical University

Hallym University Sacred Heart Hospital

Yasunori Iwata

Dong Ki Kim

Kanazawa University

Seoul National University Hospital

Yumi Jang

Yong-Jin Kim

University of Ulsan

Kyungpook National University Hospital

061

Yunmi Kim

Soon Hyo Kwon

Inje University Busan Paik Hospital

Soonchunhyang University Seoul Hospital

Seong Heon Kim

Tae-Hwan Kwon

Seoul National University Hospital

Kyungpook National University School of Medicine

Sung Gyun Kim

Chun-Fu Lai

Hallym University Sacred Heart Hospital

National Taiwan University Hospital

Yaeni Kim

Kelly Lambert

The Catholic University of Korea, Seoul St. Mary's Hospital

University of Wollongong

Yaerim Kim

Beom Hee Lee

Keimyung University School of Medicine

Asan Medical Center

Hyung Woo Kim

Haekyung Lee

Severance Hospital

Soonchunhyang University Seoul Hospital

Jun Chul Kim

So-Young Lee

Gumi CHA Hospital

CHA University Bundang Medical Center

Gheun-Ho Kim

Sunhwa Lee

Hanyang University Medical Center

Kangwon National University Hospital

Tae Hee Kim

Sang-Ho Lee

Inje University Busan Paik Hospital

Kyung Hee University Hospital at Gangdong

Youkyoung Kim

Young-Ki Lee

BAXTER

Hallym University Kangnam Sacred Heart HospitalHyun Suk Kim

Jang Han Lee

Hallym University Chucheon Sacred Hearth Hospital

Bundang Jesaeng General Hospital

Hyo Jeong Kim

Hyun Young Lee

Gangnam Severance Hospital

Samsung Medical Center

Seo Rin Kim

Jintae Lee

Pusan National University Yangsan Hospital

Synopex Inc.

Myung-Gyu Kim

Hanbi Lee

Korea University Anam Hospital

The Catholic University of Korea, Seoul St. Mary's Hospital

So Mi Kim

Kyungho Lee

Dankook University Hospital

Samsung Medical Center

Gang Jee Ko

Sua Lee

Korea University Guro HospitalDaejeon Eulji Medical Center, Eulji University

Eun Sil Koh

Eun-Young Lee

The Catholic University of Korea, Yeouido St. Mary's Hospital

Catholic University of Pusan

Csaba Kovesdy

Chenlei-Kelly Li

University of Tennessee Health Science Center

St George Hospital

Joseph Chin-Chi Kuo

Philip Kam-Tao Li

China Medical University

Prince of Wales Hospital

Soo Heon Kwak

Adrian Liew

Seoul National University Hospital

Mount Elizabeth Novena Hospital

Mihye Kwak

Jeong-Hoon Lim

Asan Medical Center

Kyungpook National University Chilgok Hospital

Soonkil Kwon

Hongli Lin

Chungbuk National University HospitalFirst Affiliated Hospital of Dalian Medical University

062

Melissa Little

Eun-Jee Oh

Murdoch Children's Research Institute

The Catholic University of Korea Seoul St. Mary's Hospital

Kathleen Liu

Se Won Oh

University of California San Francisco

Korea University Anam Hospital

Jicheng Lv

Jun OhPeking University First Hospital

University Medical Center Hamburg-Eppendorf

Alison Ma

Kenji Osafune

Hong Kong Children's Hospital

Kyoto University Hospital

Stephen Marks

Marlies Ostermann

Great Ormond Street HospitalKing's College HospitalMark R. Marshall

Jernej Pajek

Middlemore Hospital

University Medical Center Ljubljana

Ikuto Masakane

Sun-Hee Park

Yabuki Hospital

Kyungpook National University Hospital

Hugh McCarthy

Hayne Park

University of Sydney

Hallym University Kangnam Sacred Heart Hospital

Nick Medjeral-Thomas

Samel Park

Hammersmith Hospital / Imperial College London

Soonchunhyang University Cheonan Hospital

Rajnish Mehrotra

Sadudee Peerapornratana

University of Washington School of Medicine

Chulalongkorn University

Reshma Aziz Merchant

Henry Pleass

National University Health System

The University of Sydney

Ju-Young Moon

S. Russ Price

Kyung Hee University Hospital at Gangdong

East Carolina University

Lily Mushahar

Vinoth Kasi Rajan

Hospital Tuanku Ja'afar

Queen Elizabeth Hospital

Satoru Muto

Jia Rao

Juntendo University Faculty of Medicine

Children's Hospital of Fudan University

Ki Ryang Nah

Connie Rhee

Chungnam National University Hospital

University of California, Los Angeles

Masaomi Nangaku

Eugene Rhee

The University of Tokyo Graduate School of Medicine

Massachusetts General Hospital

K S Nayak

Ian S D Roberts

Virinchi Hospitals

Oxford University Hospitals NHS Foundation Trust

Saori Nishio

Peter Rossing

Hokkaido University Hospital

Steno Diabetes Center Copenhagen

Vandana Niyyar

Jung Hwa Ryu

Emory University School of Medicine

Ewha Womans University Seoul Hospital

Akihiro Nomura

David J. SalantKanazawa University

Boston University School of Medicine

Camilla Nonterah

Judith Savige

University of Richmond

The University of Melbourne

Kajohnsak Noppakun

Franz Schaefer

Chiang Mai University

Heidelberg University Hospital

063

Shaundeep Sen

I-Wen Wu

Concord Repatriation General Hospital

Shuang Ho Hospital, Taipei Medical University

Sanjeev Sethi

Yun Xia

Mayo Clinic

Nanyang Technology University

Sung Joon Shin

Motoko Yanagita

Dongguk University Ilsan Hospital

Kyoto University

Jae Il Shin

Jae Won Yang

Severance Hospital

Yonsei University Wonju Severance Christian Hospital

Ho Sik Shin

Jaeseok Yang

Kosin University Gospel Hospital

Severance Hospital

Kelly D Smith

Zhiming Ye

University of Washington

Guangdong Provincial People's Hospital

Nattachai Srisawat

Kyung Don Yoo

Chulalongkorn University

University of Ulsan College of Medicine

Stefanie Steiger

Hye Eun YoonLMU Hospital Munich

The Catholic University of Korea, Incheon St. Mary's Hospital

Sang Heon Suh

Sunil Youn

Chonnam National University Hospital

Alexion Pharma Korea, L.L.C

In O Sun

Ming-Zhi Zhang

Presbyterian Medical Center

Vanderbilt University

Yusuke Suzuki

Hong Zhang

Juntendo University Faculty of Medicine

Peking University First Hospital

Tomo Tadashi

Minghui Zhao

Clinical Engineering Research Center, Oita University

Peking University First Hospital

Sydney Tang

Cai-Mei Zheng

The University of Hong Kong

Taipei Medical University Shuang-Ho Hospital

Vladimir Tesar

Guoping Zheng

Charles University

University of Sydney

Stefan Tullius
Harvard Medical School

Katherine R. Tuttle
University of Washington

Robert J. Walker
Otago Medical School University of Otago

Suxia Wang
Peking University First Hospital

Angela Yee-Moon Wang
Duke-NUS Medical School

Yoshihiko Watarai
Japanese Red Cross Aichi Medical Center, Nagoya Daini Hospital

Vin-Cent Wu
National Taiwan University Hospital

Mai-Szu Wu
Taipei Medical University064

ChairSeon Ho Ahn

Hunjoo Ha

Wonkwang University Hospital

Ewha Womans University

Curie Ahn

Dieter Haffner

National Medical Center

Hannover Medical School

Eun Hui Bae

Seung Seok Han

Chonnam National University Hospital

Seoul National University Hospital

Chung Hee Baek

Sang Youb Han

Asan Medical Center

Inje University Ilsan Paik Hospital

Tae Hyun Ban

Seung Hyeok Han

The Catholic University of Korea, Eunpyeong St. Mary's Hospital

Severance Hospital

Sunita Bavanandan

Jin Hee Han

Hospital Kuala Lumpur

Asan Medical Center

Chang Su Boo

Seungyeup Han

Choo Medical Center

Keimyung University Dongsan Hospital

Guang-Yan Cai

Won Min Hwang

Chinese People’s Liberation Army (PLA) General Hospital

Konyang University Hospital

Eugene Yu-Hin Chan

Reiko Inagi

Hong Kong Children's Hospital

The University of Tokyo Graduate School of Medicine

Jeremy Chapman

Jin Seok Jeon

Westmead Hospital

Soonchunhyang University Seoul Hospital

Chih-Kang Chiang

Young Su Joo

National Taiwan University Hospital

Yongin Severance Hospital

Ho Jun Chin

Kwon Wook Joo

Seoul National University Bundang Hospital

Seoul National University Hospital

Bum Soon Choi

Chan-Young Jung

The Catholic University of Korea, Eunpyeong St. Mary's Hospital

Asan Medical Center

Dai Hai Choi

Kamyar Kalantar-Zadeh

Gumi CHA General Hospital

Harbor-UCLA Medical Center

Kyungho Choi

Hee Gyung Kang

Seoul National University

Seoul National University Hospital

Hoon Young Choi

Duk-Hee Kang

Gangnam Severance Hospital

Ewha Womans University Seoul Hospital

Byung Ha Chung

Manish Kaushik

The Catholic University of Korea Seoul St. Mary's Hospital

Singapore General Hospital

Sungjin Chung

Hideki Kawanishi

The Catholic University of Korea, College of Medicine

Tsuchiya General Hospital

Khurtsbayar Damdinsuren

Hyung Duk Kim

The First Central Hospital

The Catholic University of Korea, Eunpyeong St. Mary's HospitalHeon Yung Gee

Sejoong Kim

Yonsei University College of Medicine

Seoul National University Bundang Hospital

Hyo Wook Gil

Sung Gyun Kim

Soonchunhyang University Cheonan Hospital

Hallym University Sacred Heart Hospital

065

Yaerim Kim

Jung Eun Lee

Keimyung University School of Medicine

Yongin Severance Hospital

Hyung Woo Kim

Adrian Liew

Severance Hospital

Mount Elizabeth Novena HospitalJi Hong Kim

Beom Jin Lim

Gangnam Severance Hospital

Gangnam Severance Hospital

Yon Su Kim

Chun Soo Lim

Seoul National University Hospital

SMG-SNU Boramae Medical Center

Chan-Duck Kim

Jicheng Lv

Kyungpook National University Hospital

Peking University First Hospital

Gheun-Ho Kim

Alison Ma

Hanyang University Medical Center

Hong Kong Children's Hospital

Yang Wook Kim

Reshma Aziz MerchantInje University Haeundae Paik Hospital

National University Health System

Yong Kyun Kim

In-Sung Moon

The Catholic University of Korea, St. Vincent's Hospital

Korea Organ Donation Agency

Soo Wan Kim

Lily Mushahar

Chonnam National University Hospital

Hospital Tuanku Ja'afar

Yeong Hoon Kim

Ki Ryang Nah

Inje University Busan Paik Hospital

Chungnam National University Hospital

Yong-Lim Kim

Koichi Nakanishi

Kyungpook National University Hospital

University of the Ryukyus Hospital

Gang Jee Ko

Masaomi Nangaku

Korea University Guro Hospital

The University of Tokyo Graduate School of Medicine

Soonkil Kwon

K S Nayak

Chungbuk National University Hospital

Virinchi Hospitals

Soon Hyo Kwon

Jack Ng

Soonchunhyang University Seoul Hospital

The Chinese University of Hong Kong

Sunhwa Lee

Vandana Niyyar

Kangwon National University Hospital

Emory University School of Medicine

Eun Young Lee

Kandai Nozu

Soonchunhyang University Cheonan Hospital

Kobe University Graduate School of Medicine

Sang-Ho Lee

Se Won Oh

Kyung Hee University Hospital at Gangdong

Korea University Anam Hospital

Jong Soo Lee

Kook-Hwan Oh

Ulsan University Hospital

Seoul National University Hospital

Young-Ki Lee

Yun Kyu Oh

Hallym University Kangnam Sacred Heart Hospital

SMG-SNU Boramae Medical Center

Hankyu Lee

Vuddhidej Ophascharoensuk

Lee Hankyu Clinic

Chiang Mai University Thailand

Jung Geon Lee

Marlies Ostermann

Nam Seoul Clinic

King's College Hospital

Donghyung Lee

Hoon Suk Park

Beomil Yonsei Clinic & Hemodialysis Center

The Catholic University of Korea, Seoul St. Mary's Hospital066

Jong Hoon Park

Kornchanok Vareesangthip

Sookmyung Women's University

Siriraj Hospital, Mahidol University

Hyeong Cheon Park

Robert J. Walker

Gangnam Severance Hospital

Otago Medical School University of Otago

Seung Ho Park

Suxia Wang

Hub IM Clinic

Peking University First Hospital

Mooyong Park

Muh Geot Wong

Soonchunhyang University Hospital Bucheon

Concord Repatriation General Hospital

Henry Pleass

Germaine Wong

The University of Sydney

Westmead Hospital

Carol Pollock

Vin-Cent Wu

North Shore Private Hospital

National Taiwan University Hospital

S. Russ Price

Mai-Szu Wu

East Carolina University

Taipei Medical University

Ivan Rychlik

Motoko Yanagita

Charles University

Kyoto University

Takashi Sato

Chul Woo Yang

Kaikoukai Vascular Access Treatment Center

The Catholic University of Korea, Seoul St. Mary's Hospital

Eun Young Seong

Jihyun Yang

Pusan National University Hospital

Kangbuk Samsung Hospital

Seok-Joon Shin

Desmond Yat Hin Yap

The Catholic University of Korea, Incheon St. Mary's Hospital

Queen Mary Hospital

Ho Sik Shin

Kyung Don Yoo

Kosin University Gospel Hospital

University of Ulsan College of Medicine

Aditi Sinha

Tae-Hyun Yoo

All India Institute of Medical Sciences

Severance Hospital

Sang Heon SongHye Eun Yoon

Pusan National University Hospital

The Catholic University of Korea, Incheon St. Mary's Hospital

Nattachai Srisawat

Jong Woo Yoon

Chulalongkorn University

Hallym University Chucheon Sacred Hearth Hospital

Kamal Sud

Xueqing Yu

Nepean Hospital

Guangdong Provincial People's Hospital

Yusuke Suzuki

Minghui Zhao

Juntendo University Faculty of Medicine

Peking University First Hospital

Cheuk Chun Szeto
The Chinese University of Hong Kong

Yoshiaki Takemoto
Osaka Metropolitan University Hospital

Sydney TangThe University of Hong Kong

Ken Tsuchiya
Tokyo Women's Medical University

Katherine R. Tuttle
University of Washington067

PanelEun Kyung Choi

Jae-Won Lee

Kyung Pook National University School of Medicine

G Sam Medical Center

Seo Rin Kim

Sung Joon Shin

Pusan National University Yangsan Hospital

Dongguk University Ilsan Hospital

Eun-Young Lee

In O Sun

Catholic University of Pusan

Presbyterian Medical Center

Instructor
Yong Seon Choi

Eun Jung Kim

Bundang Jesaeng General Hospital

Hallym University Dongtan Sacred Heart Hospital

Gwangho Choi

Jin Ho Lee

Hallym University Chucheon Sacred Heart Hospital

Leesin Hemodialysis and Intervention Clinic

Sangeon Gwoo

Jeonghwan Lee

Lifeline Vascular Clinic

SMG-SNU Boramae Medical Center

Chang Min Heo

Dong Hee Lee

Inje University Haeundae Paik Hospital

Hallym University Sacred Heart Hospital

Narae Joo

Hyung Seok Lee

Hanmaeum Hospital

Hallym University Sacred Heart Hospital

Do Hyoung Kim

Hoon Suk Park

Hallym University Kangnam Sacred Heart Hospital

The Catholic University of Korea, Seoul St. Mary's Hospital

Hyung Duk Kim

Hae Ryong Yun

The Catholic University of Korea, Eunpyeong St. Mary's Hospital

Yongin Severance Hospital

In Soo Kim
Hallym University Sacred Heart Hospital

068

Best Poster Presentation List
Best Poster Presentation 1 (June 14 (Fri), 14:20 – 15:00)
ENG
Presentation
Time

Exhibition Hall

Poster Board
No.

Topic

Title

P-787

Diabetic
Kidney Disease+ Metabolic
Abnormalityrelated Kidney
DiseaseInhibition of PCSK9 attenuates renal lipotoxicity byactivating the AMPK-PGC-1a-FoxO3a signaling indiabetic kidney disease

14:20-14:26

P-553

Hypertensive
Kidney Disease +Vascular Biology
in CKD

Synergistic Effects of Folate and Riboflavin on
Vascular Calcification Amelioration in Uremic Rats

14:26-14:32

P-181

Non-dialysis CKD

Association of Uremic Toxins with
Immunosenescence in Patients with Chronic
Kidney Disease

Ting-Yun Lin

P-757

Interventional
Nephrology

Comparison between the Frequency ofInterventional Procedures for Flow-related
Dysfunction in Tapered Grafts and Straight Grafts:
Analysis Based on the Korean National Health
Insurance Database from 2011 to 2018

Jin Ha Jang

14:38-14:44

P-523

Green
Nephrology

Reducing Water Usage, Carbon Emissions, andWaste Generation in Dialysis Units: A Closed-Loop
Water Recycling Approach for Sustainable Renal
Care

14:44-14:50

P-539

Renal Nutrition

AI-Driven Precision Nutrition for Chronic Kidney
Disease Management Through Machine Learning
Prediction of Phosphorus Bioavailability

14:20 - 14:24

14:32-14:38

069

Presenting Author

Yu Ah Hong
The Catholic University of Korea
Daejeon St. Mary's Hospital

Shin Young Ahn
Korea University Guro Hospital

Taipei Tzu Chi Hospital

Hallym University Sacred Heart Hospital

Sahnaz Vivinda PutriInternational University Semen
Indonesia

Rifaldy Fajar
Karlstad University

Best Poster Presentation List
Best Poster Presentation 2 (June 15 (Sat), 14:20 – 15:00)
ENG
PresentationTime

14:20 - 14:24

Exhibition Hall

Poster Board
No.

Topic

P-268

Pediatric
Nephrology +Inherited Kidney
DiseaseAssociation with Dietary Sugar Intake andHyperuricemia in Korean Children and Adolescents: Sang Youn You
Ganghwa-gun Public Health Center
Korea National Health and Nutrition Examination
SurveyTitle

Presenting Author

14:20-14:26

P-458

Transplantation

Efficacy of integrated risk score using omics-based
biomarkers for the prediction of acute rejection in
kidney transplantation: A randomized prospective
pilot study

14:26-14:32

P-327

Glomerular andTubulointerstitial
Disorders

New Strategies for Improving Kidney dECM
Recellularization Efficiency

14:32-14:38

P-097

Basic Research

Establishment of a Drug Screening Platform for
Polycystic Kidney Disease using Human Urine
Tubuloids

14:38-14:44

P-575

Dialysis

Influence of the method of addition of nitric oxideduring hemodialysis on its antithrombotic effect.

MAYU FUKADA

14:44-14:50

P-893

Fluid, Electrolyte
and Acid-base
DisorderInteraction of the miR-466-699 clusters and Wnt
signaling in cell proliferation of the aldosteronesensitive distal nephron

Hyo-Ju Jang

P-868

Renal
Conservative
Care + Geriatric
Nephrology +Sarcopenia

Development of Dialysis Patient Exercise Therapy
Support System I -Proposal for the Continuation of
Exercise Therapy-

14:50-14:56

070

Mingyu Kim
Kyungpook National University
Hospital

BOYUN KIM
rokithealthcare

Hye Youn Kim
Yonsei University College of Medicine

Kitasato University Graduate School

Kyungpook National University, Schoolof Medicine

Tokuo UMEDA
Former Kitasato University

Poster Exhibition
Acute Kidney Injury
Board No.

Title

Presenting Author

P-002

Application of Macrophage Cell Membrane Encapsulated Poly(Ferulic Acid)
Nanoparticle Drug Delivery System in Acute Kidney Injury

P-003

Caveolin-1 Protects Against Acute Kidney Injury via Regulating Endoplasmic Zhangzhe Peng
Xiangya Hospital, Central South University
Reticulum Stress induced Ferroptosis

P-004

Efficacy and safety of remimazolam besylate -based sedation for intensive
care unit patients with acute kidney injury: a prospective study

Lilin Li

P-005

Development of new method for continuous kidney replacement therapy
weaning: a pilot study

Yohan Park

P-006

The Function And Regulatory Mechanism of NOX4 in Rhabdomyolysisinduced Acute Kidney Injury

Zhuyun Zhang

P-007

The Effect of Nafamostat Mesilate on Regulatory T cell population in
Patients with Acute Kidney Injury receiving continuous renal replacement
therapy

P-008

Plasma humanin level in AKI and CKD patients

P-009

N6-methyladenosine-modified circNfix attenuates sepsis-induced acutekidney injury by facilitating the ubiquitination of YTHDF2 and increasing
DAPK2 mRNA stability

P-010

Dietary supplementation with Bacillus Superoxide dismutase protects
against kidney ischemia reperfusion injury in mice.

P-011

Pharmacovigilance analysis of acute kidney injury associated with
Kazushi Uneda
proteasome inhibitors in the Japanese Adverse Drug Event Report Database Aizu Medical Center, Fukushima Medical University

P-013

Interpretable Machine Learning Approach for Mortality Risk Assessment in
ICU Patients with Heart Failure Complicated by Acute Kidney Injury

Xinyao Luo

P-014

Rapid Complement Inhibition with the C5 Inhibitor Crovalimab: Timing
Analysis Using Animal Model and Composer Trial Data

Xiaochun Zheng

P-015

Toll-like receptor 4 mediates histone-induced endothelial dysfunction inseptic acute kidney injury.

Yang Tinghang

P-016

Difference in Occurrence of Bevacizumab-Induced Nephrotoxicity Among
Cancer Types

Sei-Hong Min

P-017

Therapeutic Effects of CRRT in Patients with Severe Acidosis Using Deep
Learning-Based Causal Inference on MIMIC-III data

Min Woo Kang

P-018

Clinical impact of Wnt5a expression on persistence of acute kidney injury in Jungho Shin
Chung-Ang University Hospitalpatients with urosepsis

Yuanpeng Nie
The Seventh Affiliated Hospital, Sun Yat-sen
University

Yanbian University Hospital

Konyang University HospitalWest China Hospital, Sichuan University

Byung Hwa Park
Kosin University Gospel HospitalWenjing Cai
Guangdong Provincial People's Hospital (Guangdong
Academy of Medical Sciences), Southern Medical
University

071

Peng Wang
Guangdong Medical University

Jihyun Yang
Kangbuk Samsung Medical CenterWest China Hospital, Sichuan University

Shanghai Roche Pharmaceuticals Limited, Shanghai

Department of Nephrology, West China Hospital,
Sichuan University, Chengdu 610041, China.

Seoul National University Bundang Hospital

Seoul National University HospitalPoster Exhibition
Sungmi Kim

P-019

Clinical Significance of Urine Output at Continuous Renal Replacement
Therapy Discontinuation on 1-year Mortality and Renal Outcome in
Critically Ill Patients with Acute Kidney Injury

P-020

Stress hyperglycemia and subsequent cardiovascular or new-onset
diabetes after acute kidney injury requiring continuous renal replacement
therapy

Junseok Jeon

P-021

Machine Learning-Based Prediction of Contrast-Induced Nephropathy in
Cardiac Catheterization Patients: A Prospective Cohort Study

Andi Nursanti Andi Ureng

P-022

tRF-Ala-CGC-023 Aggravates Renal Tubular Cell injury by Inhibiting MFN2
Expression and Promoting Mitochondrial Damage in Mouse AKI model

Xian Xie

P-023

Emerging Trends and Focus of Toll-like Receptor and Kidney Disease: a 20year Bibliometric Analysis

Xinyao Luo

P-024

Association between Preoperative Proton Pump Inhibitor Use andPostoperative Acute Kidney Injury in Patients Undergoing Major Surgery

P-025

Two Phase III Trials Evaluating Crovalimab in Patients with Atypical
Haemolytic Uraemic Syndrome (aHUS): COMMUTE-a and COMMUTE-p

Ming-Hui Zhao

P-026

Gender-specific obesity paradox in critically ill patients with severe acutekidney injury

Hyo Jin Jung

P-027

Global risk of acute kidney injury and tubulointerstitial nephritis following
anticancer drug administration, 1967-2023: long-term pharmacovigilance
analysisP-028

The role of Ginsenoside Rg3 in Ischemia Reperfusion renal Injury Mice via
AMPK and autophagy.

Dae Eun Choi

P-029

Clinical manifestations of acute interstitial nephritis (AIN) according to
infiltrating cells

Sungyeon Kim

P-030

Risk evaluation of acute kidney injury associated with active vitamin D3
drugs: a pharmacovigilance study using the Japanese Adverse Drug Event
Report Database

P-031

Multi-omics analysis revealed extracellular vesicle-mediated crosstalk
between endotheliocyte and macrophage in ischemic acute kidney injury

Wenjuan Wang

P-032

Copper oxide antioxidant nanoparticles alleviate cellular toxicity caused bycolistin

Yun Seok Choi

P-033

Variant analysis Impacts on Nephrotoxicity induced Platinum Compoundby Molecular Simulation and Network Interaction

Putrya Hawa

P-034

Renal Manifestations in cancer patients treated with Immune Checkpoint
Inhibitors

Yu-Been Seo

P-035

Prediction of Contrast-associated Acute Kidney Injury With Machinelearning in Patients Undergoing Contrast-enhanced Computed
Tomography at Emergency Room

Kyungho Lee

072

Division of Nephrology, Department of Internal
Medicine, Eunpyeong St. Marys Hospital, College ofMedicine, The Catholic University of Korea, Seoul,
Republic of Korea

Samsung Medical Center, Sungkyunkwan University
School of Medicine

Andini Persada College of Health Sciences

The Third Xiangya Hospital, Central South University

West China Hospital, Sichuan University

Qing-Qing Zhou
Peking University First Hospital

Peking University First Hospital, Beijing

Kyungpook National University HospitalHyun Kyu Kim
Kyung Hee University Medical Center

Chungnam National University Hospital

Korea University Anam Hospital

Yuki Kawai
Teikyo University Graduate SchoolFirst Medical Center of Chinese PLA General Hospital

College of Medicine, Konyang University

Republic of Indonesia Defense University

Korea University Anam Hospital

Samsung Medical Center, Sungkyunkwan University
School of Medicine

Poster Exhibition
P-036

The cumulative detrimental effect of intradialytic hypotension on kidney
recovery in patients with acute kidney injury receiving intermittent
hemodialysis

P-037

Biphasic Protective Effects of Macrophage Migration Inhibitory Factor in
Ischemia/Reperfusion-Induced Acute Kidney Injury

Yiwei Du

P-038

Identification of Hub Genes and Biomarkers Associated with Oxidative
Stress of Acute Kidney Injury Via Machine Learning Algorithm

Yiwei Du

P-039

Non-Albumin Proteinuria (NAP): An Accessible, Affordable, and Easy-to-Use
Biomarker for Predicting Acute Kidney Injury in Acute heart failure (NAP-HF
study)

P-040

Establishment of machine learning-based risk prediction model for acutekidney injury after acute myocardial infarction

Beijing Anzhen Hospital, Capital Medical University

P-041

The Association of Early Net Ultrafiltration Rate and 90-Day Mortality inPatients Receiving Continuous Renal Replacement Therapy

Department of Nephrology, West China Hospital of
Sichuan University

P-042

Silver nanoparticles of resveratrol attenuates renal damage in acute kidney
injury induced by glycerol via apoptosis and anti-inflammatory effectSam Higginbottom University of Agriculture
Technology & Sciences

P-043

Prediction of RRT Restart after Cessation of CRRT: A Multicenter Study

P-044

Blood Perfusion with Polymyxin B Immobilized Columns in Patients with
COVID-19 Requiring Oxygen Therapy: A Multicenter Prospective Cohort
Study

P-045

A Study on the Effect of Acute Kidney Injury Prediction Artificial Intelligence Giae Yun
Seoul National University Bundang Hospital
Model on Medical Decision Making: A Preliminary Study

P-046

The Role of Kidney Denervation in Preventing Interstitial Fibrosis Following
Kidney Ischemia and Reperfusion Injury

P-047

Prediction Model of Acute Kidney injury in Patients with Acute Pesticide
Poisoning

P-048

Prediction of acute kidney injury in trauma patients using extreme gradient Yongjin Yi
Dankook University Hospital
boosting (XGBoost) model

P-049

A Prospective Cohort Study of Community Acquired Acute Kidney Injury

P-050

Effect of Low-sodium Diet in Patients with Heart Failure with Worsening
Renal Function During Hospitalization

Minhyung Kim

P-051

The Potency of Ascorbic Acid to Prevent Contrast-Induced Nephropathy in
Diabetic Foot Patient Undergoing Digital Subtraction Angiography

Gabriela Claudia

073

Joon Hee Yoon
Inha University Hospital

Tangdu Hospital, Air Force Military Medical University;
Peking univerisity First Hospital

Tangdu Hospital, Air Force Military Medical University;
Peking univerisity First Hospital

Solos Jaturapisanukul
Nephrology and Renal Replacement Therapy division,
Department of Internal Medicine, Faculty of Medicine
Vajira Hospital, Navamindradhiraj University, Bangkok,
Thailand.

Nan YePeiyun Li

Ekta Yadav

Jiwon MinThe Catholic University of Korea Bucheon St. Mary's
Hospital

Daisuke Katagiri
National Center for Global Health and Medicine

Daeun Moon
Jeju National University College of Medicine

Nam-Jun Cho
Soon Chun Hyang University Cheonan Hospital

Jaskiran Kaur
Postgraduate Institute of Medical Education andResearch

Samsung Medical Center, Sungkyunkwan University
School of Medicine

Sebelas Maret University

Poster Exhibition
P-052

Relationship Between Agricultural Vulnerability Exposure To Pesticides
And Occurrence Of Kidney dysfunction Incidence In Indian Farmers And
Vegetable Seller In Meerut District, India

P-053

A Risk Score for Predicting Contrast-Enhanced Computed TomographyAssociated Acute Kidney Injury (Pre-CT AKI score)

Pattharawin Pattharanitima

P-054

Utility of Cystatin C as a Predictor for Postoperative Acute Kidney Injury in
Non-Cardiac Surgeries

Hongtae Kim

P-055

Statin Use and In-hospital Outcomes among Hospitalized Patients withKidney Dysfunction

P-056

Prognostic Analysis of Patients with Septic Acute Kidney Injury afterContinuous Renal Replacement Therapy Using OXiris Filter

P-057

Diagnostic Patterns Associated with Intensive Care UnitAcquired Acute
Kidney Injury: A Comprehensive Analysis and Phenome-Wide Association
Study

Pei Chun Fan

P-058

Post hoc Analysis of the VENUS Trial: Serum Sodium-Potassium Ratio as a
Predictor of Mortality in Severe Acute Kidney Injury Patients UndergoingContinuous Renal Replacement Therapy

Yun Jung Oh

P-059

Experience of pediatric continuous kidney replacement therapy from atertiary care centre

P-060

PREDICTION OF MAJOR ADVERSE KIDNEY EVENTS IN ICU PATIENTS WITHUSE OF RENAL ANGINA INDEX : PROSPECTIVE STUDY FROM A DEVELOPING
COUNTRY

P-061

Renal Pathological Characteristics and Long-term Prognosis of Lupus
Nephritis Patients Presenting with Acute Kidney Injury

P-062

The Incidence, Associative Factors, and Outcomes of Acute Kidney Injury inIntensive Care Units in Malaysia

P-063

Clinical Profile Of AKI In Patients With Malignancy-A Single Center
Experience

Mahesh Kota

P-064

Dietary supplementation with Bacillus Superoxide dismutase protects
against contrast-induced acute kidney injury in mice

Young Eun Choi

P-065

Relationship between high serum calcium phosphate levels and acutekidney injury during hospitalization

Ussanee Boonsrirat

P-066

SOFA score at the time of CRRT initiation predicts the mortality of patientswith acute kidney injury

Donghui Shin

P-067

Comparison of Conventional and High-Dose Continuous Kidney
Replacement Therapy in Critically Ill Patients with Septic Acute Kidney
Injury074

Ankush Kumar
SHAKUNTLA Hospital AND RESEARCH CENTER,

Thammasat University

Chung-Ang University Hospital

Linger Tang
Peking University First Hospital

Siqi HeThe First Affiliated Hospital of Zhengzhou University,
Henan Province

Linkou Chang Gung Memorial Hospital

H Plus Yangji Hospital

Sudarsan K
Assistant Professor

Mohamed Anas
KMC Manipal

Jing Mao
Department of General Hospital of Ningxia Medical
University

Kuan Yee Lim
Nephrology Unit, Department of Medicine, Facultyof Medicine Universiti Kebangsaan Malaysia, Hospital
Canselor Tuanku Muhriz

CONSULTANT CRITICAL CARE NEPHROLOGIST

Korea University Anam Hospital

Prince of Songkla University

Wonju Severance Christian Hospital

Jeehyun Heo
Asan Medical CenterPoster Exhibition
P-068

External Validation of the Simple Postoperative AKI Risk (SPARK-AKI)Classification System in Predicting Post-Operative Acute Kidney Injury
Among Filipino Adult Patients Undergoing Non-Cardiac Surgery in a
Tertiary Hospital

P-069

Comparison of eGFR Cystatin C and eGFR Creatinine in Acute Kidney Injury

P-070

Real-time monitoring of hemodynamic stability in septic shock patients
undergoing continuous renal replacement therapy: propensity scorematched comparison between oXiris and polysulfone membranes(HISTORIX trial)

P-071

Prevalence and Risk Factors of Acute Kidney Injury among Filipino Adults

Cherry Ann Durante

P-072

Comparison of circuit patency and exchange rates between the originaland generic versions of nafamostat mesylate in critically ill adults receiving
continuous renal replacement therapy

Ye Na Kim

P-073

Non-traumatic Rhabdomyolysis As A Rare Complication From Lutetium177PSMA-617 In A 81 Year-old Male With Prostate Adenocarcinoma Stage
IV

Ziggy Ryan Amores

P-074

Steroidal Mineralocorticoid Receptor Antagonist Plus Angiotensin
Converting Enzyme-Inhibitor (ACEi) or Angiotensin Receptor Blocker(ARB) Versus Mono-Therapy ACE-i/ARB in Heart Failure Patients: Impact onHyperkalemia and Acute Kidney Injury

P-075

Outcomes of sustained low-efficiency dialysis and continuous renal
replacement therapy in ICU patients with acute kidney injury: A single
center retrospective cohort study

P-076

Cardiac surgery associated acute kidney injury, incidence, and predictors.
Prospective observational single center study

P-077

The Effect of Hemoperfusion on the Clinical Outcome of Severe and Critical
COVID-19 patients admitted at the University of Santo Tomas Hospital: An
Analytical Cohort Study

P-078

Clinical Profile & Outcomes Of AKI Cases At A Tertiary Care Centre In,
Hyderabad, Telangana, India

Mahesh Kota

P-079

Urine Microscopy as Predictor of Renal Replacement Therapy in Patientswith Acute Kidney Injury

Mary Ann Espina

P-080

An Interesting Case of Colovesical Fistula Complicated by Severe
Emphysematous Cystitis

Hye Jun Lee

P-081

HYPERLACTATION SYNDROME AND CAUSE STUDY OF ELEVATED PROLACTIN Zolzaya Gantumur
Mongolian Nephrology Association
LEVELS IN ACUTE KIDNEY FAILURE CHILDREN IN MONGOLIA

P-082

Study of Novel Biomarkers in early prediction of Snake Bite induced Acute
Kidney Injury: A Systematic Review

Vincci Monique Salud
Philippine General Hospital

Sherzod Abdullaev

075

Republican specialized scientific and practical
medical center of nephrology and kidneytransplantation

Seong Geun Kim
Inje University Sanggye Paik Hospital

Emilio Aguinaldo College

Kosin University Gospel Hospital

St. Luke's Medical Center Global City

Eduward Thendiono
Bunda Hospital Gorontalo

Miguel Manuel Mattus
Philippine Society of Nephrology

Nilufar Jabayeva
National Research Cardiac Surgery Center

Cherryl Anne Umlas
University of Santo Tomas Hospital

MBBS,MD,IDCCM,DNB(NEPHROLOGY),CONSULTANTNEPHROLOGIST

Chong Hua Hospital

Wonkwang University School of Medicine & Hospital

Priti Solanky
GMERS Medical College, ValsadPoster Exhibition
P-083

Renal Infarction Caused by Spontaneous Renal Artery Dissection after
Playing Golf

P-084

Rhabdomyolysis induced acute kidney injury cause by statin in patient with Dongwon Kim
Eulji University Hospital
alcoholic liver cirrhosis : a case report

P-085

A case of severe acute kidney injury in a patient with lupus nephritis

P-086

Severe acute kidney injury associated with transformation of chronic
myelomonocytic leukemia to acute myeloid leukemia: A case report

P-087

Acute tubular necrosis with unusually prolonged and marked polyuria: apediatric case reportJi Hyun Kim

P-088

Mefenamic Acid Induced 'Classic Triad' Acute Interstitial Nephritis

Tessa Oktaramdani

P-089

Efficacy of hemodialysis and plasma exchange for ceftriaxone-induced
encephalopathy in an elderly patient with acute kidney injury due torapidly progressive glomerulonephritis: A case report

Shohei Nagayama

P-090

Acute Kidney Injury Post Renal in Elderly

P-091

Supportive Hemodialysis in Severe Malaria Falciparum with Acute Kidney
InjuryDenny Moniaga

P-092

Warfarin-related Nephropathy in Two Patients with Mechanical Valves

Guoqin Wang

P-093

Korean multicenter study of data repository derived from patients withacute kidney injury requiring continuous kidney replacement therapy toovercome transition to acute kidney disease

Jung Nam An

P-094

To Study The Role of Artificial Intelligence in Early Prediction of Acute
Kidney Injury in Pediatric Patients: Systematic review

Seung Hee Jeong
Presbyterian Medical Center

Ju Hwan Oh
Presbyterian Medical Center

Seong-Wook Lee
Kyungpook National University Hospital

Seoul National University Bundang Hospital

Ciptomangunkusumo National Hospital

Saiseikai Yokohamashi Nanbu Hospital

Dedy Kusnadi
medical faculty, hasanuddin University, Makassar,
South Sulawesi Indonesia

University of Indonesia

Beijing Anzhen Hospital, Capital Medical University

Hallym University Sacred Heart Hospital

Nilesh Chavda
GMERS Medical College Valsad

Basic Research
Board No.

Title

Presenting Author

P-097

Establishment of a Drug Screening Platform for Polycystic Kidney Diseaseusing Human Urine Tubuloids

Hye Youn Kim
Yonsei University College of Medicine

P-098

The generation of renal cell carcinoma - kidney assembloids: A preclinicalplatform for anticancer drug screening and biomarker assessment in tumor Sun Ah Nam
School of Medicine, The Catholic University of Korea
microenvironment

P-099

Glutamyl-prolyl-tRNA-synthetase 1 induces fibroblast activation topromote kidney fibrosis

P-100

Regulation of Bacterial Load in Leptospira-Infected Macrophages throughIL-10: Significance for Leptospirosis Kidney Diseases

076

Seung Seob Son
Soonchunhyang University College of Medicine

Li-Fang Chou
Chang Gung Memorial HospitalPoster Exhibition
P-101

TMEM30A downregulation initiate podocyte injury through reducing
glycolysis in focal segmental glomerulosclerosis

P-102

Renoprotective Effects of Empagliflozin in Obesity-Related Glomerulopathy Lei Lei
The seventh affiliated Hospital of Sun Yat-sen
Mice through Regulation the Gut-Kidney Axis
University

P-103

Unveiling the molecular signatures of macrophages in AKI-to-CKD

Kyu Hong Kim

P-104

Studying Organoid Phenotypes of CoQ10-deficient Glomerulopathy

Seyoung Yu

P-105

3D-printed Omentum Patch Transplantation Mitigates Fibrosis in Acute
Kidney Injury to Chronic Kidney Disease Transition

Wencheng Jin

P-106

Alterations in Cell Cycle and MAP-kinase Pathway Contribute to theTransition from SMFs-associated Acute Renal Tubular Injury to Fibrosis:
Field Direction Matters

P-107

Ileum Delivery of Budesonide by 3D Micro-structure Design for theTreatment of IgA Nephropathy

P-108

Ezetimibe Mitigates Exacerbated Tubulointerstitial Fibrosis Resulting from
P62 Knockout in a UUO Model: Insights from Spatial Transcriptomics andHistology

P-109

Neither SGLT-2 Specific Inhibitor nor SGLT-1 Specific Inhibitor, only
Dual SGLT-2/1 Inhibitor can Reduce Glucose Absorption and Improve
Ultrafiltration during Peritoneal Dialysis in Rats

P-110

Sequence determination of light chains causing cast nephropathy by denovo sequencing

P-111

Single-cell transcriptome atlas in C57BL/6 mice encodes morphologicalphenotypes in the aging kidneys

P-112

Characteristics of a novel rat model of autosomal recessive polycystic
kidney disease with salt-sensitive hypertension

P-113

Establishment of a rapidly progressing ADPKD model and verification of
the effect of an AMPK activator (HL156A)

Hyunsuk Kim

P-114

Comprehensive Characterization of MSCs-derived Extracellular Vesicles
Using Different Culture Media: FBS versus HPL

Yue Zhang

P-115

Protective Effects of Hibiscus Sabdariffa (Roselle) Against Hydrogen
Peroxide-Induced Oxidative Stress in Zebrafish Kidney

Henkie Isahwan Ahmad Mulyadi Lai

P-116

Delivery of A4GALT targeting siRNA-lipid nanoparticle rescues fabry disease Yoo-Jin Shin
The College of Medicine, The Catholic University ofphenotypes in hiPSC derived endothelial cell and podocyte models
Korea

P-117

AST-120 Ameliorates Cognitive and Emotional Dysfunction in a 5/6
Nephrectomy Chronic Kidney Disease Model

Dong Jin Lee

P-118

Microtubule-associated protein tau causes CKD

Seong Woo Lee

Yanpei Hou
Sichuan Provincial People's Hospital

Seoul National University

Yonsei University College of Medicine

Seoul National University

Ran-Hui Cha
National Medical Center

Xianghao Zuo
Triastek, Inc.

Jisup Kim
Gachon University Gil Medical Center

Junpeng You
The First Affiliated Hospital of Zhengzhou University

Xin Wang
Peking University

Shanzhi Yang
Guangdong Provincial Peoples Hospital

Aya Yoshimura
Fujita Health University

Chuncheon Sacred Heart HospitalSoutheast university

University College MAIWP International

Soonchunhyang University Cheonan Hospital

Soonchunhyang University college of Medicine

077

Poster Exhibition
P-119

Tonsil-derived Mesenchymal Stem Cells ameliorate Peritoneal Fibrosis by
Inhibiting Oxidative Stress

Dal-Ah Kim

P-120

Collectin-11 promotes cell proliferation and regulates cell functions in renal
fibroblasts via engaging EGFR and TGFRII

Wanbing Chen

P-121

The effect of PGC-1 on the interaction between HIF-1 and PKM2 to preserve Jee Young Lee
Konkuk University Medical Centermitochondrial metabolism in diabetic kidney diseaseP-122

IGF-2 triggers epithelial-mesenchymal transition in mesothelial cells andcontributes to the pathogenesis of dialysis-related peritoneal fibrosis.

P-123

Urine-Derived Stem Cell attenuated renal fibrosis in ischemia-reperfusion
renal injury mice.

P-124

Effects of Nutritional Ketosis Induced by Ketogenic Diet on Kidney Function Sol Been Park
Seoul Women's University
and Metabolism in a Mouse Model of Diabetic Kidney Disease

Ewha Womans University Medical Center

The Second Affiliated Hospital, School of Medicine,
Xi'an Jiaotong University

Siqi Zheng
Guangdong Provincial Peoples Hospital (Guangdong
Academy of Medical Sciences), Southern Medical
University, Guangzhou, China

Hyerim Park
Chungnam National University

Tatiana Kursova
Clinical resident, Department of Hereditary and
Acquired Kidney Diseases named after Professor M.S.
Ignatova Research Clinical Institute of Pediatrics andPediatric Surgery named after A.I. Academician Yu.E.
Veltishchev

P-125

The role of mast cells in the formation of tubulointerstitial fibrosis as aresult of chronic kidney injury

P-126

Renal Fibrosis: Understanding the Function and Mechanisms of TMEM52B

P-127

Astragalus mongholicus Bunge and Panax notoginseng formula (A&P)
Improves Renal Fibrosis in UUO Mice via Inhibiting the Long Non-coding
RNA A330074K22Rik and Downregulating Ferroptosis Signaling

P-128

Low dose colchicine inhibits the NLRP3 inflammasome activation to protect Ga Young Heo
Yonsei University College of Medicine
kidney fibrosis

P-129

Improvement of brain function after hemodialysis in ESKD patients

P-130

Dysregulated autophagy conrtibute to podocyte injury in PodocyteSpecific Yes-Associated Protein Deletion mice

Division of Nephrology, Guangdong Provincial
People's Hospital (Guangdong Academy of Medical
Sciences), Southern Medical University, Guangzhou,
510080, China

P-131

Intercellular Communication Network of CellChat Uncovers Mechanisms ofKidney Fibrosis Based on Single-Cell RNA Sequencing

Lei Lei

P-132

Novel Autotaxin inhibitor LCB17 ameliorates folic acid-induced kidney
fibrosis

Na Kyung Hoon

P-133

Proteomic Profiling of Transglutaminase 2 Inhibition in Human Kidney
Tubular Epithelial Cells

Hong-Beom Park

P-134

Tissue Clearing: A Novel Tool for Visualization of Collagen Deposition in
Injured Kidney

Yoosun Joo

Rui Xue
The First Affiliated Hospital of Shenzhen University,
Shenzhen Second People's Hospital

Yue HuangSouthwest Medical University

Euljo Jeong
Inje University Haeundae Paik Hospital

Jiaying Li

078

The seventh affiliated Hospital of Sun Yat-sen
University

Soonchunhyang University College of Medicine

Seoul National University College of Medicine

Kyung Hee University Hospital at Gangdong

Poster Exhibition
Jeonghwan Lee

P-135

The Role of Kidney Multiciliated Cells in Glomerular Disease Outcomes

P-136

Empagliflozin attenuates epithelial to mesenchymal transition throughsenescence in a peritoneal dialysis model

Yunmee Lho

P-137

FGF-23 Gene Expression and DNA Polymorphism in Anemia AcrossDifferent Stages of Chronic Kidney Disease

Henkie Isahwan Ahmad Mulyadi Lai

P-138

Placental Growth Factor Overexpression Modulates Metabolic Pathways
and Ketone Body Levels in Mice under Varying Dietary Conditions

Yaeni Kim

P-139

Glucagon-like peptide-1 receptor agonist improves kidney structure andfunction in chronic kidney disease

Hee Seul Jeong

P-140

Knockout of PTP4A1 ameliorate renal fibrosis induced by unilateral ureteralobstruction in mice.

Hyerim ParkP-141

TREM2 Macrophage Regulates the Process of AKI-CKD Transition by
Suppressing Inflammation via a PI3K/Akt Signaling Pathway.

Yating Zhang

P-142

Overview of Kidney Disease Diagnosis in Hemodialysis Patients andHemodialysis Procedures in Indonesia on 2014-2020

Derizal Derizal

P-143

Breaking Ground in CKD Therapy: Harnessing Resveratrol Derivatives to
Combat Renal Fibrosis via Transforming Growth Factor Beta 1 Receptor
Inhibition

Rian Ka Praja

P-144

The role of montelukast in hypertensive nephropathy

Eun Jin Bae

P-145

Autophagy caused by oxidative stress promotes TGF-1-induced epithelialto-mesenchymal transition in human peritoneal mesothelial cells

Se-hyun Oh

P-146

Protective Effect of Vericiguat, soluble guanylate cyclase (sGC) stimulator,
in Attenuating Renal Aging

In Soo Kim

P-147

STAT3 blockade ameliorates LPS-induced acute kidney injury throughmacrophage-driven inflammation

Seongmin Lee

P-148

Prevalence and Antibiotic Susceptibility Pattern of Uropathogens in
Outpatients at The Third Central Hospital, Mongolia

Sarangerel Garamjav

P-149

Knowledge Mapping of CRISPRCas9 in Nephrology: A Bibliometric Analysis

Wenlong Qiu

P-150

Robot-Assisted Kidney Imaging: Transforming Kidney Ultrasound Practices

P-151

Inhibiting STAT3 promotes G1 arrest downregulation in magnetic field
induced injury on cilia by enhancing calcium intake

Seong Joon ParkP-152

The Association Between Lifestyle-Related Risk Factors and Renal
Progression

Po-Ya Chang

079

Seoul National University Boramae Medical Center

Yeungnam University Medical Center

University College MAIWP International

The Catholic University of Korea Seoul St. Mary's
Hospital

Soonchunhyang University College of Medicine

Chungnam National University

Sun Yat-sen Memorial Hospital, Guangzhou

IP Trisakti

Faculty of Medicine, Universitas Palangka Raya

Gyeongsang National University Changwon Hospital

Kyungpook National University Hospital

Hallym University Sacred Heart Hospital

Seoul National University College of Medicine

The Third Central Hospital

General Hospital of Ningxia Medical University

Muhammad Umair Ahmad Khan
University of Engineering and Technology Narowal
CampusSeoul National University College of Medicine

National Taipei University of Nursing and Health
SciencePoster Exhibition
P-153

Alleviation of Chronic Kidney Disease by Combinational Approach of
Resveratrol and Cinnamic Acid in Rodents by Regulating Gut Microbiota
and Inflammation

Ekta Yadav

P-154

NOX2 Inhibition as a Therapeutic Strategy for AKI-to-CKD Transition:
Efficacy in Fibrosis and Cell Cycle Arrest

Jeonghwan Lee

P-155

YAP Activation Mediates Myofibroblast Transformation and Senescenceduring Repeated Treatment with Cisplatin in Kidney Fibroblasts

Jiabin Yu

P-156

Choroid plexus enlargement in patients with end-stage renal disease:
implications for glymphatic system dysfunction

Jiyae Yi

P-157

Protective roles of proximal tubular Sirt6 in resiquimod-induced murine
lupus nephritis model

Kyung Pyo Kang

P-158

Impact of Ring Finger Protein 20 and Its Downstream Regulation on Renal
Tubular Injury in a Unilateral Nephrectomy Mouse Model Fed a High-Fat
Diet

P-159

AMPK activation ameliorates angiotensin II-induced downregulation of
podocyte ZO-1

P-160

Exosome derived myomiRNA in hemodialysis patients: search for noninvasive sarcopenia biomarker

P-161

Multilayer network analysis in patients with end-stage renal disease:integrating insights into structural and functional layers

P-162

Production and Cytotoxic effects of Chemotherapeutic Pigment Prodigiosin Girish Pendharkar
Sadguru Gadage Maharaj College, Karad.
on HL60 and K562 tumor cell lines.

P-163

Alterations in frequency and function exhausted memory B cells in lupus
nephritis

Litong Zhu

P-164

Synergistic Nephroprotective Effects of Terminalia chebula and Annona
muricata in Mitigating Renal Toxicity in Zebrafish

Rushduddin Al Jufri Bin Roosli

P-165

Maternal Exposure to Fine Particulate Matter Impairs Renal VascularHomeostasis in Adult Male Rat Offspring: Impact of Maternal Vitamin D
Supplementation

P-166

Inhibition of STAT3 mitigates fibrosis development in AKI-to-CKD byenhancing anti-oxidative responses

Ji Won Lee

P-167

Acetylase Sirtuin 6 Expression in Kidneys

Huiwen Ren

P-168

Polystyrene Microplastic-Induced Extracellular Vesicles Cause Endoplasmic
Reticulum Stress and Reactive Oxygen Species Production in the Kidneys

Hui-Wen Chiu

P-169

Risk Factors for Complicated Urinary Tract Infection and their Association
with Bacterial Pathogens

Julie Anne Wang

P-170

Particulate Matter Exacerbates Kidney Damage by Increasing the CSF2,
Inflammasomes, and Senescence

Yu-Hsuan Lee

Sam Higginbottom University of Agriculture
Technology & Sciences

Seoul National University Boramae Medical Center

Jeju National University

Inje University Haeundae Paik Hospital

Jeonbuk National University Hospital

You-Jin Kim
Kyungpook National University Hospital

Tae-Sun Ha
Chungbuk National University Hospital

Janghee Cho
Gangnam Severance Hospital

Yoo Jin Lee
Inje University Haeundae Paik Hospital

The University of Hong Kong

UNIVERSITY COLLEGE MAIWP INTERNATIONAL

Hyung Eun Yim
Korea University Ansan Hospital

Seoul National Unversity

Dalian Medical University

080

Taipei Medical University

San Juan de Dios Educational Foundation Inc.
Hospital

China Medical University

Poster Exhibition
Pin-Han Hsia

P-171

Improve the education effectiveness of shared-decision making for dialysis

P-172

Omega-3 fatty acid mitigates mitochondrial dysfunction and modifies renal Yu In Jeong
Bethesda Gospel Hospital
myostatin expression in adenine-induced uremic rats

P-173

The Role of RIPK3 in Mitochondrial Dysfunction of Diabetic Podocytes

Jeong Suk Kang

P-174

An Economic Insight from the Relationship between Hypertension andChronic Kidney Disease: When the Middle Classes are More at Risk

Riska Dwi Astuti

P-175

Alteration of Uromodulin expression by Uric Acid Stimulation in Primary
Culture of Renal Thick Ascending Limb Cells

P-176

Suitable albumin concentration of perfusate in a rat kidney in situ perfusion Kozue Kobayashi
School of Allied Health Science Kitasato University
model

P-177

Human leucocyte antigens association with anti-SARS-CoV-2 spike protein
humoral response in renal allograft recipient.

Sonam Gautam

P-178

Antinephritic Potential of Eicosapentaenoic Acid In High Fat-Diet/AlloxanInduced Diabetes In Male Rats

Sumit Rajput

P-179

Imatinib Use and Risk of Chronic Kidney Disease in Chronic Myeloid
Leukemia Patients: A Meta-Analysis Using Real-World Data

Md Sarfaraj Hussain

P-180

A Screening Method of a Material Inducing Klotho Transcripitional
Activation

Sheng Cui

National Taiwan University Hospital, Taipei, Taiwan

Soonchunhyang University Cheonan Hospital

Universitas Islam Indonesia

Chor Ho Jo
Ewha Womans University Medical Center

Sanjay Gandhi Post Graduate Institute of Medical
SciencesB V Deemed University

Lord Buddha, Koshi Pharmacy College, Baijnathpur,
Saharsa

The College of Medicine, The Catholic University of
Korea, Seoul, Republic of Korea

Non-dialysis CKDBoard No.

P-181

Title

Presenting Author

Association of Uremic Toxins with Immunosenescence in Patients with
Chronic Kidney Disease

Ting-Yun Lin

P-182

Exploring the Genetic Interrelationships among Major Morbidities: A
Comprehensive Study

Yaerim Kim

P-183

Comparing the Impact on Renal Outcomes of Acid Suppression Therapies:
Potassium Competitive Acid Blocker vs. Proton Pump Inhibitor

Minyoung Jang

P-184

Reduced renal function is associated with faster loss of bone mineraldensity in patients with non-dialysis CKD

P-185

Qiuyu Xie
Binding ability of recombinant uromodulin fragments to complement
Renal Division, Peking University First Hospital,factor H and its regulation mechanism on complement alternative pathway Beijing, China

P-186

Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in CKD G3G4 Patients with Atrial Fibrillation: A Nationwide Cohort Study of South
Korean Adults

081

Taipei Tzu Chi Hospital

Keimyung University Dongsan Medical Center

Samsung Medical Center, Sungkyunkwan University
School of Medicine

Dong Hoon Kang
Yonsei University College of Medicine

Hyung Woo Kim
Severance HospitalPoster Exhibition
P-187

The Impact of Treating Metabolic Acidosis in CKD: Consideration of timevarying confounding among treatment, renal function, and acidosis
through G-formulaP-188

Omgea-3 Polyunsaturated Fatty Acids attunuates Contrast-Induced BloodBrain-Barrier Injury in Uremic Mice

P-189

Characteristics of obstructive sleep apnea and metabolic parameters inindividuals with albuminuria in Korea: A nationwide population-based
study

P-190

Integrating Masked Auto Encoder for Enhanced Chronic Kidney Disease
Detection in Electrocardiogram

P-191

The Molecular Basis and Potential Drug Prediction for The Co-occurrence of Siqin Yi
Xiangya Hospital Central South University and Central
Chronic Kidney Disease and Tuberculosis
South University Xiangya School Of Medical

P-192

Association between Progression of Coronary Artery Calcification andDevelopment of Kidney Failure with Replacement Therapy: Findings from
KNOW-CKD Study

P-193

Association Between Early Smoking and Cardio-cerebrovascular Diseases in Sehyun Jung
Gyeongsang National University Hospital
Chronic Kidney Disease: A Nationwide Population-Based Study

P-194

Mortality Prediction of Plasma Presepsin in Patients with Urinary Tract
Infection

P-195

Pharmacotherapy of Endothelin Receptor Antagonists for patients with
Chronic Kidney Disease: A Component Network Meta-analysis and Systemic Qinbo Yang
West China Hospital, Sichuan University
Review

P-196

Association of eGFR With Asthma Incidence: A Population-Based Study in
the US Using NHANES Data.

P-197

Effect of Dapagliflozin on Markers of Kidney Damage in CKD

Republican specialized scientific and practical
medical center of nephrology and kidneytransplantation

P-198

Association between the number of parity and the prevalence of chronic
kidney disease

Heechan Moon

P-199

Evaluating the association between hypertension and cerebral whitematter alterations in patients with chronic kidney disease

Yi-Ting Lin

P-200

Association between weekend catch-up sleep and chronic kidney disease:
Analysis from the NHANES 2017-2020

Seung Hyun Han

P-201

Prognostic value of triglyceride glucose (TyG) index in population withchronic kidney disease

Jin Sug Kim

P-202

Converting Urine Protein-to-Creatinine Ratio to Urine Albumin-toCreatinine Ratio: Evaluating the Diagnostic Accuracy of Simple versus
Complex Formulas in Albuminuria Detection

Joseph Kuo

Soie Kwon
Chung-Ang University Hospital

Jin Ah Shin
Chungnam National University

Yeojin Yu
Seoul National University Hospital

Jung Nam An
Hallym University Sacred Heart Hospital

Cheol Ho Park
Severance HospitalJi Won Lee
Konyang University Hospital

Sorawis Ngaohirunpat
Mahidol University

Sherzod Abdullaev

082

Presbyterian Medical Centre

Kaohsiung Medical University Hospital

Seoul National University Hospital

Kyung Hee University Medical Center

China Medical University Hospital and China Medical
University

Poster Exhibition
P-203

Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) in Healthy
Chinese Volunteers Treated with SC0062, a Highly Selective Endothelin-A(ETA) Receptor Antagonist

P-204

Antiproteinuric Effect of Febuxostat in Patients with Advanced Chronic
Kidney Disease and Asymptomatic Hyperuricemia

Izaya Nakaya

P-205

Prediction of risk of chronic kidney disease using multi-ethnicity andmultiple polygenic risk score in Korean population

Yunmi Ji

P-206

Markers of Body Composition and Arterial Stiffness in Chronic Kidney
Disease: from the KNOW-CKD StudyJu Young Lee

P-207

Acquired metabolic risk factors, genetic risk score and risk of incident
chronic kidney disease

Ga Young Heo

P-208

Integrated genomics and metabolomics to identify cause-specificbiomarkers for chronic kidney disease in Korean population

Min Woo Kang

P-209

Polygenic scores for hypertension and low-density lipoprotein cholesterol
and risk of incident chronic kidney disease

Dong Hoon Kang

P-210

Alterations in Innate Lymphoid Cells-related Cytokines with Chronic Kidney
Disease progression

Sehyun Jung

P-211

Circulating Osteoprotegerin as a Cardiac Biomarker for Left Ventricular
Diastolic Dysfunction in Patients with Pre-Dialysis Chronic Kidney Disease:
The KNOW-CKD Study

P-212

Real world outcomes of bisphosphonate for osteoporosis in chronic kidneydisease stage 5

P-213

Changes of body fluids volume and nutritional status in anemic CKD
patients depending on hemoglobin improvement from recombinanthuman erythropoietin administration

P-214

Hypertension, Chronic Kidney Disease, Mental Health: A Large Crosssectional Study

Riska Dwi Astuti

P-215

Alterations of urinary proteomic profile in patients with chronic kidneydisease of uncertain aetiology in Sri Lanka

Yueyue Zhu

P-216

Association of Accelerometer-measured Physical Activity with Incident
CKD: A UK Biobank Study

Byounghwi Ko

P-217

Associations of MRI-derived kidney volume, kidney function, bodycomposition, and physical performance in ~38,000 UK Biobank participants: Jeong Min Cho
Seoul National University Hospital
A population-based observational study

P-218

Smoking Start in Adolescence and Chronic Kidney Disease: A National
Cohort Analysis

Seong Geun Kim

P-219

Prevalence of Chronic Kidney Disease-associated Pruritus (CKD-aP) in NonDialysis Dependent Chronic Kidney Disease (NDD-CKD) Patients.

Harry Liaw

083

Yong-Jiang Hei
Biocity Biopharmaceutics Co.Ltd, Wuxi, China

Iwate Prefectural Central Hospital

College of Natural Sciences, Seoul National University,
Seoul, Republic of Korea

Kangbuk Samsung Medical Center

Severance Hospital

Seoul National University Hospital

Yonsei University College of Medicine

Gyeongsang National University Hospital

Sang Heon Suh
Chonnam National University Hospital

SeonMin Kim
Soonchunhyang University Bucheon HospitalJi Teak Kim
Wonju Severance Christian Hospital

Universitas Islam Indonesia

Laboratory of Electron Microscopy, PathologicalCenter, Peking University First Hospital. Beijing

Severance Hospital

Inje University Sanggye Paik Hospital

Nephrology, Dialysis & Transplantation Associates at
The Kidney Institute, Houston, Texas

Poster Exhibition
P-220

Cf-PWV but not cr-PWV or cd-PWV is associated with cardiovascularmortality in patients with chronic kidney disease

P-221

Long Term Use of Proton Pump Inhibitors is Associated with Rapid
Progression of Chronic Kidney Disease ; A Nationwide Korean Study Basedon HIRA OMOP-CDM Database

P-222

Investigating Alkaline Phosphatase Variability As A Key Predictor of
All-Cause Mortality in Chronic Kidney Disease Patients: Multi-Nation
Retrospective Cohort Study

P-223

Cost-effectiveness of Population-based Screening for Chronic Kidney
Disease in China

Fengyu Wen

P-224

Association of plasma beta-2-microglobulin with risk of cardiovasculardisease in patients with chronic kidney disease

Khaliun Boldbaatar

P-225

Impact of Real-world Off-label dose of Apixaban on long-term clinicaloutcomes in Patients with Atrial Fibrillation and Chronic Kidney Disease

Song Yi Kil

P-226

Relationship between renal dysfunction, non-obstructive ACS and inhospital prognosis: findings from the Improving Care for Cardiovascular
Disease in China - Acute Coronary Syndrome (CCC-ACS) project

P-227

Association of Insulin-like Growth Factor-1 with Cardiovascular Outcomes in Byounghwi Ko
Severance Hospital
Individuals with or without Chronic Kidney Disease: the UK Biobank Study

P-228

Predictors of Kidney Outcome in AL Amyloidosis: Hematologic and Kidney
Responses

P-229

Comparative mortality outcomes in chronic kidney disease: a cross-national Ping-Hsun Wu
Kaohsiung Medical University Hospital
analysis of electronic health records from Korea and Taiwan

P-230

Improvement in unhealthy behaviors among patients with chronic kidneydisease receiving integrated care was associated with slower progression of Teerawat Thanachayanont
Bhumirajanagarindra Kidney Institute
CKD.

P-231

The effect of gemigliptin treatment on immune parameters including
regulatory T cells in patients with type 2 diabetes and moderate to very
severe chronic renal impairment

P-232

Comparative analysis of the impact of febuxostat and allopurinol on
glomerular filtration rate and hyperuricemia in chronic kidney disease
patients

P-233

Influenza Vaccination Status and Factors Influencing Vaccination in Korean
Chronic Kidney Disease Patients: A National Cohort Study

P-234

Inverse association between serum chloride levels and the risk of atrial
fibrillation in chronic kidney disease patients

Yangang Gan

P-235

The usefulness of cystatin C in measuring renal function in patients withcirrhosis

So Mi Kim

Yan Wang
Peking University People's Hospital

Harin Rhee
Pusan National University Hospital

Yaerim Kim
Keimyung University Dongsan Medical Center

Peking University Health Science Center

Kidney center, The First Central Hospital of Mongolia

Kosin University Gospel Hospital

Nan YeBeijing Anzhen Hospital, Capital Medical University

Sungmi Kim

084

Division of Nephrology, Department of Internal
Medicine, Eunpyeong St. Marys Hospital, College ofMedicine, The Catholic University of Korea, Seoul,
Republic of Korea

Ye Na Kim
Kosin University Gospel Hospital

Mohan V Bhojaraja
Department of Nephrology, Kasturba Medical
College, Manipal, Manipal Academy of Higher
Education, Manipal, Karnataka, India

Hyunjeong Cho
Chungbuk National University Hospital

Sun yat-sen memorial Hospital

Dankook University HospitalPoster Exhibition
P-236

The Association of Urinary Phosphate Excretion and Osteoporosis inPatients with Chronic Kidney Disease : Result from KNOW-CKD

Yunmi Kim

P-237

Age-specific estimated glomerular filtration rate for Mortality Prediction in
Korean Population: a Retrospective Kangbuk Samsung Health Cohort study

Jihyun Yang

P-238

Long-term Trends of Blood Pressure and Blood Glucose in Patients with
Chronic Kidney Disease in South Korea, 1998-2021

Dae Kyu Kim

P-239

Kidney outcomes associated with adherence to recommendation fromEvidence-based Clinical Practice Guidelines for CKD in real-world clinicalpractice: A nationwide, cross-sectional cohort study using the Japan CKD
Database Ex

P-240

Association between Plasma Fibroblast Growth Factor 21 levels andIncident Chronic Kidney Disease

Hee Byung Koh

P-241

Hemorrhagic Complications in Stage 4 Chronic Kidney Disease with Atrial
Fibrillation during Anticoagulant Therapy

Ranokhon Igamberdieva

P-242

Rapid Detection and Surveillance of Chronic Kidney Disease: Protein-Bound Yi-Chou Hou
Cardinal-Tien Hospital
Uremic Toxin ELISA Kit

P-243

Effect of Smoking on Kidney Function Status in Patients With AcuteCoronary Syndrome

Khadijah Khairunnisa Hasyim

P-244

Prevalence and Risk Factors of Initial Estimated Glomerular Filtration Rate
Decline in Patients Receiving SGLT2 Inhibitors: A Real-World Clinical Study

Dong Hee Lee

P-245

A Pilot Randomized Trial of Cholecalciferol Supplementation in CKD

P-246

Role of Desidustat in Anemic CKD- Eastern India Experience

Rohit Rungta

P-247

The Effect of AST-120 on regulatory T cell population in Patients with
Chronic Kidney Disease

Byung Hwa Park

P-248

SSESSMENT IN THE QUALITY OF LIFE OF HEMODIALYSIS PATIENTS IN
VICENTE SOTTO MEMORIAL MEDICAL CENTER RENAL CENTER: A CROSSSECTIONAL STUDY IN THE ONGOING COVID19 PANDEMIC DURING MARCH
2023

P-249

Association between long-term exposure to PM2.5 and MACE onset inpeople with chronic kidney disease

P-250

Risk of Chronic Kidney Disease in Orthostatic Hypotension: A Communitybased Cohort Study

P-251

Revolutionizing CKD Management: Synbiotic Supplementation as a
Breakthrough in Curbing Hyperphosphatemia and Hyperparathyroidism

Inje University Busan Paik Hospital

Kangbuk Samsung Medical Center

Kyung Hee University Medical Center

Hirokazu Okada
Saitama Medical University

Catholic Kwandong University International St. Mary's
Hospital

Tashkent pediatric medical institute

Medical Faculty, Hasanuddin University Makassar,
South Sulawesi, Indonesia

Hallym University Sacred Heart Hospital

Kajal Kamboj
Student

MEDICA SUPERSPECIALITY Hospital

Kosin University Gospel HospitalFranzis Mari Lawas
Vicente Sotto Memorial Medical Center

Miju Kim
Pusan national university

Jonghoon Seok
Korea University College of Medicine

Weerapat Anegkamol

085

Metabolic Disease in Gastrointestinal and Urinary
System research Unit, Department of Biochemistry,
Faculty of Medicine, Chulalongkorn University,
Bangkok, Thailand

Poster Exhibition
P-252

Influence of Different Erythropoiesis-Stimulating Agents on Mortality andRenal Disease Progression among Non-Dialysis Chronic Kidney Disease
Patients

Ji Hye Kim

P-253

Assessing the Benefits and Risks of Anticoagulant Therapy in Patients With
Renal Anemia in Atrial Fibrillation and Chronic Kidney Disease Stages IIIb-V

Ranokhon Igamberdieva

P-254

Dose anemia is associated with ESKD progression and mortality? : Study
from multinational cohort

Soie Kwon

P-255

Trends in Real-World Lipid Lowering Therapy Use among Adult Patientswith Chronic Kidney Disease: 5-year Single Center Experience in thePhilippines

Vincent Anthony Tang

P-256

The association between low serum cholinesterase and renal function
decline in patients

P-257

Real World Outcomes of Direct Oral Anticoagulant in Chronic Kidney
Disease Stage 5

Yoonwon Choi

P-258

The efficacy of chronic kidney disease patient education program

Keonhwa Kim

P-259

A Management Approach To Patient With Rare Spina Bifida And Its Renal
Complication: A Case Report

Lydia Tan

P-260

Analysis of The Influence of Food Habits, Smoking, Diabetics andSocioeconomic Factors on Kidney Patients in Indonesia

Derizal Derizal

P-261

Impact and Outreach of Kidney Health Videos on YouTube: A Content
AnalysisHsin-Yi Lai

P-262

The Increased Incidence and Risk of Developing Sensorineural Hearing Loss
Atika Sri Raharjani
on Chronic Kidney Disease from Multiple Nationwide Health Screening
Sebelas Maret University
Records : A Systematic Review and Meta-Analysis

P-263

Evaluating the Safety and effectivenesS in adult KorEaN patients treatedwith Tolvaptan for management of autosomal domInAnt poLycystic kidneydisease (ESSENTIAL): final report

P-264

Effect of genotype on renal outcome among the patients with inherited
cystic kidney disease

Hayne Cho Park

P-265

Association of LDL cholesterol levels with the risk of cardiovascularoutcome according to stages of chronic kidney disease

Nam Ju Heo

P-266

Renal Failure Due To Renal Amyloidosis: A Case Report

Abdul Rahman

P-267

Risk Factors and Clinical Prediction Models for Osteoporosis in Predialysis
Chronic Kidney Disease Patients

Fanna Liu086

Incheon St. Mary's Hospital, The Catholic University of
Korea

Tashkent pediatric medical institute

Chung-Ang University Hospital

University of the Philippines - Philippine General
Hospital

Chenyu Lei
Guangdong Provincial People's Hospital (Guangdong
Academy of Medical Sciences), Southern Medical
University

Soonchunhyang University Bucheon Hospital

Kangbuk Samsung Medical Center

Sebelas Maret State University and Dr. Moewardi
Hospital, Surakarta, Central Java, Indonesia

IP Trisakti

Department of Internal Medicine, National Taiwan
University Hospital

Hayne Cho Park
Kangnam Sacred Heart Hospital

Kangnam Sacred Heart Hospital

Healthcare Research Institute, Gangnam Healthcare
Center, Seoul National University Hospital

Cipto Mangunkusumo Goverment Hospital

The First Affiliated Hospital of Jinan

Poster Exhibition
Pediatric Nephrology + Inherited Kidney Disease
Board No.

P-268

Title

Presenting Author

Association with Dietary Sugar Intake and Hyperuricemia in KoreanChildren and Adolescents: Korea National Health and Nutrition Examination Sang Youn You
Ganghwa-gun Public Health Center
SurveyP-269

Identification of Novel Pathogenic Genes and Variants in IFT-A Complex
Related Genes in Children with Nephronophthisis

Ye Fang

P-270

Calcium-mediated Calpain elevation induces tubulointerstitial fibrosis in
Nephronophthisis

Dantong Li

P-271

Clinical Outcomes in Patients Switching from Agalsidase beta to Migalastat: Bongsoo Park
Inje University Haeundae Paik Hospitala Fabry Registry Analysis

P-272

Medication Prescribing Practices and Appropriateness in Pediatric Chronic
Kidney Disease

P-273

Deficiency of Shroom3 Delays Kidney Development Process and Increases
Susceptibility to Injury

P-274

Diagnostic Yield of Kidney Disease Gene Panel Testing During Kidney
Transplant Evaluation

Han Bi Lee

P-275

Rapid Detection and Prevalence of the AGT Deletion/Insertion Mutation
underlying Autosomal Recessive Renal Tubular Dysgenesis in Taiwan

Min-Hua Tseng

Schema For Resolution Of Genetic Variants Of Uncertain Significance In
Patients With Suspected Genetic Glomerulopathies: DRAGON (Deciphering
Diversities: Renal Asian Genetics Network)

Chee Teck Koh

P-276

P-277

Hyperkalemia and Pseudohyperkalemia in Pediatric Patients with
Hematologic Malignancies: A Single Center experience

Yung-Chieh Huang

P-278

Dermatological manifestations of chronic kidney disease (CDK) in pediatrics Dina Sallam

P-279

NEUROPSYCHIATRIC SLE (NPSLE) IN CHILDREN AND ADOLESCENTS WITH
LUPUS NEPHRITIS

Hong Kong Children's Hospital

P-280

Carotid Intima-Media Thickness, Fibroblast Growth Factor 23, and Mineral
Bone Disorder in Children with Chronic Kidney Disease

Faculty of Medicine Universitas Indonesia - Cipto
Mangunkusumo Hospital, Jakarta, Indonesia

P-281

Efficacy and safety of Dapagliflozin in children with kidney disease: a realworld data

Naye Choi

P-282

Evaluating the role of serum phosporus in predicting acute kidney injury inpediatric cardiac surgery patients.

Aashal Bhavesh Shah

P-283

Trends and socioeconomic inequality of CAKUT burden among children
and adolescents in 204 countries, 1990-2019

Guohua He

Children's Hospital of Fudan University

Guangdong Provincial People's Hospital

Eujin Park
Korea University Guro Hospital

Li-Nan Xu
Department of Nephrology, Children's Hospital
affiliated with Fudan University, Shanghai 200200,
China

The Catholic University of Korea Seoul St. Mary's
Hospital

Chang Gung Memorial Hospital

Khoo Teck Puat-National University Childrens
Medical Institute, National University Health System,
Singapore

Taichung Veterans General Hospital

Prof

087

Eugene Yu-Hin Chan
Chika Carnation TandriSeoul National University Hospital

Guwahati Medical College

The First Affiliated Hospital, Sun Yat-sen University

Poster Exhibition
P-284

Prevalence Of Sleep Disordered Breathing In Children With Chronic Kidney
Disease A Single Center Cross Sectional Study

P-285

Outcomes of Peritoneal Dialysis Using Stiff Catheters in Children with Acute Madhileti Sravani
Jawaharlal Institute of Post Graduate and Medical
Kidney Injury: A Retrospective Review
Education Research (JIPMER), Pondicherry, India

P-286

The Mechanism of lage3 Gene Deficiencies Inducing Developmental Delay
in C. elegans.

P-287

Treatment outcomes of childhood onset IgA nephropathy and IgA vasculitis Jiwon Jung
Asan Medical Centerfrom a single tertiary center

P-288

Two Weeks VS Four Weeks Use of Atorvastatin to Reduce Hyperlipidemia inChildren with Refractory Nephrotic Syndrome: Which One is Better?

P-289

The Long-Term Effectiveness Of Tolvaptan For Treatment Of ADPKD

P-290

The Long-Term Effectiveness Of Tolvaptan For Treatment Of ADPKD

P-291

Rare inherited kidney diseases in the Republic of Korea

Jiwon Lee

P-292

Extrarenal clinical features are reported for most genes implicated in
genetic kidney disease

Judy Savige

P-293

Polycystic Kidney Disease of infants: too large to grow together

Seokyoung Chung

P-294

Early detection of Arterio-Venous Fistula (AVF) complications

Dina Sallam

P-295

The Association of HLA Alleles with IgA Nephropathy in a Taiwanese
Population

Yung-Chieh Huang

P-296

Exploring the Significance of Japanese 3-Year-Old Urine screening in
Diagnosing Alport Syndrome Patients

Hideaki Kitakado

P-297

Therapeutic Plasma Exchange in Pediatric Patients: A Single-Center
Retrospective Study

Reza Fahlevi

P-298

A Rare Cause of Fanconi Syndrome With Recurrent AKI: Renal Tubular
Dysgenesis-A Case Report

George-Claudiu Costea

P-299

Strategic Insights: Early Diagnoses, Genetic Pathways, and Personalized
Medicine in Pediatric CKD - Children's New Clinic Perspective

Ketevan Kvatadze

P-300

Immunoadsorption (IA) with Glycosorb column in ABO- incompatible living Alison Lap-Tak Ma
Hong Kong Children's Hospitaldonor kidney transplantation: First paediatric case in Hong Kong

P-301

Urinary Tract Infection Diagnostic Challenges in Pediatric Patients using
Automated Urine Analyzer Sysmex UX-2000 to find the best cut-off forLeukocyturia and Bacteriuria

Naresh Kumar Shanmugam
Christian medical college, Vellore, India

Hua ShiChildren's Hospital of Fudan University

Astrid Kristina Kardani
Dr. Saiful Anwar General Hospital, Faculty of Medicine,
Universitas Brawijaya, Malang

Juliana Tze-Wah Kao
Taipei Medical University-Shuang Ho Hospital, Ministryof Health and Welfare, New Taipei City, Taiwan

Juliana Tze-Wah Kao

088

Taipei Medical University-Shuang Ho Hospital,
Ministry of Health and Welfare, New Taipei City,
TaiwanKorea Disease Control and Prevention Agency

The University of Melbourne

Seoul National University Hospital

Prof

Taichung Veterans General Hospital

Department of Pediatrics, Kobe University Graduate
School of Medicine

Cipto Mangunkusumo Hospital

Fundeni Clinical InstituteChildren New Clinic

Muhamad Ramdani Ibnu Taufik
Sebelas Maret University

Poster Exhibition
P-302

Audit of pediatric kidney biopsies from a tertiary care center

Sudarsan K

P-303

A Journey of Empowerment - the KIDS' Dream Choir

Tsz Wai Ho

P-304

Enuresis- Is it really that Simple?

Nayan Chaudhari

P-305

Clinical Profile of Post-Kidney Transplantation Hypertension in Children

P-306

Congenital anomalies of kidney and urinary tract below 12 years

P-307

It takes two to tango

P-308

Atypical Immune Dysregulation, Polyendocrinopathy, Enteropathy X-Linked
George-Claudiu Costea(IPEX) Syndrome - Should We Consider Kidney Involvement As A Major
Fundeni Clinical InstituteHallmark? A Clinical Case Presentation

P-309

SCHIMKE immuno - osseous dysplasia: the first clinical case report in
Kazakhstan.

Rakhat Rysbek

P-310

Unusual Renal Presentation of an Autoimmune Disease

Dina Sallam

P-312

Genetic Sequencing Unlocks Alport Spectrum-COL4A3: Tailored Insights
and Evolving Frontiers in Clinical Decision-Making

Ekaterine Gaprindashvili

P-313

The Mechanism Underlying Galloway-Mowat Syndrome Caused by LAGE3
Deficiencies

Hua ShiP-314

Nephrocalcinosis, tubular proteinuria and progressive kidney failure inpatient with KIF11 mutation

Min Ji Park

P-315

Gitelman-like Syndrome Manifested by Dysarthria and Dystonia in Early
Childhood: A Case Report

Hyunseung Noh

P-316

Unilateral polycystic kidney with PKHD1 gene mutation

Soon-Kil Kwon

P-317

The first confirmed case of cystinosis in children in the Republic of
Kazakhstan.

Rakhat Rysbek

P-318

Autosomal Dominant Polycystic Kidney Disease in Children

Se Jin Park

P-319

Thrombotic microangiopathy in a child with coenzyme q10 deficiency
associated glomerulopathy

P-320

Fabry disease with genetic variants of unknown significance andconcomitant immunoglobulin A nephropathy in a single center in China:case series and review

P-321

Hemolytic Uremic Syndrome- Not really an end of a rainbow in the interiors Nayan Chaudhari
Senior resident, PDMMC Hospital, Amravatiof India

Assistant Professor

Hong Kong Children's Hospital

Senior resident, PDMMC Hospital, Amravati

Budyarini Prima Sari
Faculty of Medicine, Universitas Indonesia, Jakarta,
Indonesia

Nokto M Konyak
Vardhman mahavir medical College and safdarjung
Hospital, Delhi, India

Dina Sallam
Prof

089

Corporate fund: University Medical Center

Prof

Children New Clinic

Children's Hospital of Fudan University

Kyungpook National University Hospital

Samsung Medical Center

Chungbuk National University Hospital

Corporate fund: University Medical Center

Eulji University Hospital

Kyle Ying-kit Lin
Hong Kong Children's Hospital

Huan Zhou
Division of Nephrology, Department of Medicine,West China Hospital, Sichuan University, Chengdu,
Sichuan, China.

Poster Exhibition
P-322

Liddles Syndrome: A Case Report of a Rare Monogenic Form ofHypertension

S Kiran Kumar Navalba

P-323

Successful Treatment with Methylprednisolone Pulse and Hemodialysis in
12-Year-Old Boy with Atypical Haemolytic Uremic Syndrome (aHUS) andStage 3 Acute Kidney Injury

Astrid Kristina Kardani

P-324

Analyzing the Role of Urine-to-Plasma Urea Ratio as Predictive Biomarker inNajma Nusaibah
Autosomal Dominant Polycystic Kidney Disease Progression: A Systematic
Dr. Moewardi Hospital, Central Java
Review

P-325

Alport Syndrome: A Case Report

P-326

A Case of MPGN with TMA in HCV-Negative Adolescent.

Narayana Hrudalaya, Bangalore, India

Dr. Saiful Anwar General Hospital, Faculty of Medicine,
Universitas Brawijaya, Malang

Abigayle Therese Guiritan
St. Luke's Medical Center Quezon City

Nodira Murtalibova
National Children Medical Center, Central Asian
University

Glomerular and Tubulointerstitial Disorders
Board No.

P-327

Title

Presenting Author

New Strategies for Improving Kidney dECM Recellularization Efficiency

Boyun Kim

P-328

An Exploratory Trial of an Investigational RNA Therapeutic, IONIS-FB-LRx,
for Treatment of IgA Nephropathy: New Interim Results

Jason Choo

P-329

Potential therapeutic targets for Membranous Nephropathy: Muti-omics
Mendelian randomization and colocalization analysis

P-330

Proteomic Analysis of Laser-Captured Tubules Reveals Shared Molecular
Mechanisms of Renal Tubular Damage in Immune-Related Chronic Kidney
Diseases

Mengyun Xiao

P-331

Efficacy and safety of telitacicept in IgA nephropathy: a real-world study

Lingqiu Dong

P-332

Analysis of the Clinical Value of the ABCB1 and PAI-1 Gene Polymorphisms
in Predicting Glucocorticoid-Induced Adverse Reactions in Nephrotic
Syndrome Patients.

Shuaigang Sun

P-333

Aliskiren: A Promising Intervention for Reducing Complement Deposition
in Postpartum Atypical Hemolytic Uremic Syndrome

P-334

Impairment of ACSS2 aggravates renal fibrosis and cell senescence during
aging

P-335

Study on the Mechanism of Cysteinylation of Complement Protein C4A in
Lupus Nephritis

P-336

Rituximab add-on therapy for individuals with refractory lupus nephritis
not responded to other drugs therapy

090

rokithealthcare

Singapore General Hospital

Zhihang Su
Department of Nephrology, the First AffiliatedHospital of Shenzhen University

The First Affiliated Hospital of Jinan University

West china Hospital of Sichuan University

The First Affiliated Hospital of Zhengzhou University

Chuqiao Wang
Peking university first Hospital

Ting Xiang
West China Hospital of Sichuan University

Zhengyong Li
Department of TCM-Integrated Department ofNephrology, the First Affiliated Hospital of Zhengzhou
University

Jatinkumar Dhanani
GMERS Medical College, Navsari

Poster Exhibition
P-337

Complement C5a and C5a Receptor 1 Mediates Glomerular Damage inPrimary Focal Segmental Glomerulosclerosis

Xiaojie Gong

P-338

Gene-Gene Interaction of Susceptibility Genes for IgA Nephropathy in the
Chinese Han Population

Dianchun Shi

P-339

Medical costs in peri-diagnosis period of various biopsy-confirmed kidneydiseases in South Korea

Young Sun Shin

P-340

The risk factors for the relapse and aggravation of the patients with primary Yue Shu
Renal Division, Peking University First Hospital
membranous nephropathy after COVID-19 infection

P-341

IMAGINATION: A Global Phase 3 Trial of RO7434656, an Antisense
Oligonucleotide Inhibitor of Complement Factor B, in IgA Nephropathy

P-342

Safety, Tolerability, and Pharmacodynamics of ARO-C3, a Subcutaneously
Administered Investigational RNA-interference Therapeutic Targeting
Complement C3 in Adult Healthy Volunteers: Interim Findings from the
AROC3-1001 Study

P-343

Single-cell sequencing analysis of paired PBMC and BMMC samples fromAL patients

P-344

Kidney Outcomes in Children with Primary Focal Segmental
Glomerulosclerosis from a Low Middle Income Country

P-345

Molecular pathology patterns in podocytopathy: a pilot study

Darya Narygina

P-346

Kidney prognosis in patients with gross hematuria following COVID-19
vaccination

Dal Sik Shin

P-347

The prognosis of primary membranous nephropathy treated withcalcineurin inhibitors vs. cyclophosphamide: a multi-center retrospective
study

Weiting He

P-348

The Role of von Willebrand Factor in the Pathogenesis of C3
Glomerulopathy

Zixin Hua

P-349

Application of Kunxian Capsule in Idiopathic Membranous Nephropathy

Jia Lv

P-350

CFD as a Novel Serum Biomarker of Lupus Nephritis and Renal Pathology
Activity

P-351

External Validation of an Updated International IgA Nephropathy Risk
Prediction Tool in Chinese Population

Xinru Du

P-352

A Retrospective Study on the Maternal, Fetal and Renal Outcomes of Viable
Pregnancies Complicated by Renal Diseases

Joseph Johny

P-353

Humoral Response to COVID Vaccine and Infection is Intact During
Sibeprenlimab Treatment of IgAN: Data From the ENVISION Trial

Adrian Liew

091

Peking University First Hospital

Guangdong Provincial Peoples Hospital, Guangdong
Academy of Medical Sciences, Guangzhou, China

Seoul National University Hospital

Jonathan Barratt
University of Leicester

Nick Cross
New Zealand Clinical Research

Weiting He
Guangdong Provincial Peoples Hospital, Guangzhou,
China.

Bobbity Deepthi
Jawaharlal Institute of Postgraduate Medical
Education and Research (JIPMER)Peter the Great St.Petersburg Polytechnic University

Soon Chun Hyang University Cheonan Hospital

Guangdong Provincial Peoples Hospital, Guangzhou,
China.

Peking University First Hospital

The Second Hospital of Jilin University

Zhengyong Li
Department of TCM-Integrated Department ofNephrology, the First Affiliated Hospital of Zhengzhou
University

The Second Hospital of Jilin University,China

Christian Medical College Vellore, Tamil Nadu India

Mount Elizabeth Novena HospitalPoster Exhibition
P-354

Early application of treatment to patients with IgA nephropathy who were
supposed to have steroid regimen predicts good renal outcome

P-355

Clinical decision aid in cardiovascular risk evaluation and optimization:
Health Initiatives in Immune-Mediated Kidney Disease: Empowering
Physicians and Patients (HIKE)

P-356

The clinicopathologic prognostic factors to estimate ESRD in patients withFSGS from national wide cohort of renal biopsy

So Young Jang

P-357

Enhanced expression of AXL correlates with PLA2R in membranous
nephropathy

Shanzhi Yang

P-358

Diffusional magnetic resonance imaging for the evaluation of
immunoglobulin A nephropathy by DTI and IVIM DWI

P-359

Moderate-severe intrarenal arteriosclerosis may influence the cardiac-renal
prognosis of IgAN patients

Weiyi Guo

P-360

Histopathological Pattern and Renal Outcomes of Patients with Kidney
Biopsy at A Tertiary Care Center in Indonesia

Ni Made Hustrini

P-361

Multi-system alterations in the mesangium of IgA nephropathy miceusing single-nucleus RNA-seq and single-nucleus assay for transposaseaccessible chromatin

P-362

Clinical Scenario Of Childhood Nephrotic Syndrome Associated With
Common Infections And Major Complications

Praveen Kumar Naik Hasavath

P-363

Multi-omics Studies Unveil the Relationship between Systemic Microbiota
and Metabolites with IgA Nephropathy

Fengtao Cai

P-364

Efficacy of prolonged release tacrolimus, administered once daily, inmaintaining remission of calcineurin inhibitor dependent steroid sensitive
nephrotic syndrome in children

P-365

Podocyte Infolding Glomerulopathy As The First Renal Manifestation In
Systemic Lupus Erythematosus

P-366

Change of podocyte-glomerular basement membrane interaction in
nephrotic syndrome

P-367

SARS-COV-2 deposition enhances renal complement activation andaggravates kidney injury in MN after COVID-19

Guo-qin Wang

P-368Intervening Effects of Gut Microbiota and Metabolites on Obesity-Related
Glomerulopathy Based on Metabolomics, 16S rRNA Sequencing, andMetorigin Analyses

Kai-Wen Cai

P-369

Therapeutic Plasmapheresis in Severe Lupus Nephritis with Acute Kidney
Injury: A Case Series.

P-370

Hydroxychloroquine concentration in Indian patients with lupus nephritis

092

So Young Jang
Seoul National University Bundang Hospital

Lydia Wei Wei Lim
Singapore General Hospital

Seoul National University Bundang Hospital

Guangdong Provincial Peoples Hospital

Huan Zhou
Division of Nephrology, Department of Medicine,West China Hospital, Sichuan University, Chengdu,
Sichuan, China.

Beijing Anzhen Hospital, Capital Medical University

Universitas Indonesia

Soo-Young Yoon
Kyung Hee University Medical Center

Government Medical College, Jalaun

Guangdong Provincial Peoples Hospital, Guangdong
Academy of Medical Sciences

Srinivasavaradan Govindarajan
All India Institute of Medical Sciences, New Delhi

Pei Xuan Ang
Singapore General Hospital

Jaeseok Kim
Wonju Severance Christian Hospital

Beijing Anzhen Hospital, Capital Medical University

The Seventh Affiliated Hospital of Sun Yat-sen
University

Durga Arinandini Arimuthu
Hospital Sultan Idris Shah Serdang

Arunkumar Subbiah
AIIMS, New Delhi

Poster Exhibition
P-371

Shunt Nephritis

Dina Sallam

P-372

The Anti-nonglycan MPO-ANCA was Associated with Prognosis in
Crescentic Lupus Nephritis

Zixin Hua

P-373

Network Pharmacology and in Vitro Experimental Verification Reveal
the Mechanism of Hederagenin in Suppressing Podocyte Injury in Focal
Segmental Glomerular Sclerosis

Hu Qiongdan

P-374

Lithium-associated Kidney Failure: Predictors and Outcomes

Emily Qian

P-375

SGLT2 Inhibitors Alleviated Podocyte Damage in Lupus Nephritis by
Decreasing Inflammation and Enhancing Autophagy

Xinyu Zhao

P-376

Cardiovascular Risk Evaluation in Lupus Nephritis and ANCA-associatedVasculitis

Tung Lin Lee

P-377

Cardiometabolic Risk Evaluation among Lupus Nephritis and ANCAassociated Vasculitis patients in the first year of treatment

Lydia Wei Wei Lim

P-378

Interobserver Agreement Analysis Among Renal Pathologists In
Classification Of Lupus Nephritis Using Digital Pathology Image Dataset:
After Third Evaluation

Wei Wang

P-379

Clinicopathological characteristics and predictors of renal outcomes indiffuse crescentic glomerulonephritis : a retrospective single-center study
from Western China study

P-380

Urinary Metabolomics Identifies Novel Metabolites for Distinguishing
Membranous Nephropathy And Its Subtype

Ji Hye Kim

P-381

Complement System is Overactivated in Patients with IgA Nephropathy
after COVID-19

Weiyi Guo

P-382

Clinicopathological spectrum of patients with renal lesions associated withlymphoma from a single Chinese center

P-383

Clinical features and outcomes of primary glomerulonephritis in Taiwan

Anfu Lee

P-384

Clinical features and outcomes of Immunoglobulin G4-related kidneydisease and Immunoglobulin G4-related retroperitoneal fibrosis in Korea

Sua Lee

P-385

Assessing the Risk of Poor Renal Outcomes in Taiwanese IgA Nephropathy
Patients Using the International IgAN Prediction Tool: a single center
retrospective study

P-386

Glomerular galactose-deficient IgA1(KM55) positive may be associated with Weiyi Guo
Beijing Anzhen Hospital, Capital Medical University
poor prognosis in DKD patients

P-387

Relapse During and After Regular Single-Dose Rituximab Treatment in
Adult Patients with Steroid-Dependent Nephrotic Syndrome

Prof

093

Peking University First Hospital

The Affiliated Traditional Chinese Medicine Hospitalof Southwest Medical University

Royal Prince Alfred Hospital, Sydney

the First Affiliated Hospital of Zhengzhou University

Singapore General Hospital

Singapore General HospitalSung-Eun Choi
CHA Bundang Medical Center

Renal Department and Nephrology Institute, Sichuan
Provincial Peoples Hospital, School of Medicine,
University of Electronic Science and Technology of
China

Chungbuk National University Hospital

Beijing Anzhen Hospital, Capital Medical University

Xiaojuan Zhu
Laboratory of Electron Microscopy, PathologicalCenter, Peking University First Hospital. Beijing

National cheng kung university Hospital

Eulji University Hospital

Chia-Tien Hsu
Taichung Veterans General Hospital, Taichung

Eiichiro Saito
Iwate prefectural central HospitalPoster Exhibition
P-388

The Impact of military enlistment on the Prognosis of young patients withIgA nephropathy

Seunghye Lee

P-389

Construction and validation of a predictive model for malignant tumor inpatients with membranous nephropathy

Shuaigang Sun

P-390

The Predictive Value of Free Thyroxine Combined with Tubular Atrophy/
Interstitial Fibrosis for Poor Prognosis in Patients with IgA Nephropathy

Bixia Yang

P-391

Clinical Characteristics and Outcomes of Children and Adolescents with
Lupus Nephritis

Bobbity Deepthi

P-392

Identification of two novel phenotypes in membranous lupus nephritis
patients

Wang Zhipeng

P-393

LOW DOSE PREDNISOLONE PLUS TACROLIMUS THERAPY IS MORE EFFECTIVE Akhilesh Jaiswal
Sanjay Gandhi Post Graduate Institute of Medical
IN PLA2R-VE MEMBRANOUS GLOMERULONEPHRITIS PATIENTS
Sciences

P-394

Clinical Feature and Histopathological Patterns of Lupus Nephritis at
Moewardi Hospital, Indonesia

Inas Khoirun Nisa

P-395

The impact of anemia on the prognosis of IgA nephropathy

Jieun Yoo

P-396

An Observational Study of Treatment on IgA Nephropathy with Telitacicept
and Immunosuppressive Regimens in a Single Center

P-397

Predictors of Long-Term Outcomes in Lupus Nephritis Amongst Asian
Indians

Divya Bajpai

P-398

A report of Dr. Vidya N Acharya Glomerular Registry from of one of thelargest tertiary care hospitals in Western India

Tulsi Modi

P-399

Effect of Telitacicept In Elderly Patients With Active Systemic Lupus
Erythematosus

P-400

Abnormal renal presentation of a common autoimmunity disease

Dina Sallam

P-401

Relationship Of Crescents With Clinico-histological Parameters In Lupus
Nephritis

Uttayan Chakrabarti

P-402

Infection Risk Stratification and Antimicrobial Prophylaxis in Patients with
Glomerulonephritis Treated with Rituximab

Hui Ing Fiona Yeo

P-403

Think Renal, Think Wise

P-404

Renal biopsy & Pathology together at OPD level without admission

P-405

Clinical and Pathological Features of Patients with Recurrent Antiglomerular Basement Membrane Disease

Gyeongsang National University Hospital

The First Affiliated Hospital of Zhengzhou University

The Third Affiliated Hospital of Soochow University

Jawaharlal Institute of Postgraduate Medical
Education and Research (JIPMER)

Sun Yat-sen University First Affiliated HospitalInternal Medicine Department, Sebelas Maret
University, Indonesia

Kyungpook National University Hospital

Xuehong Lu
Department of Nephrology, The Second Hospital of
Jilin University, 218 Ziqiang Street, ChangchunJilin,
130041, China.

Seth G.S.M.C. and K.E.M. Hospital, Mumbai

SETH GSMC AND KEM Hospital

Niu DanDepartment of Nephrology, College of Medicine,
Nephrotic Hospital, First Affiliated Hospital, Xian
Jiaotong University

Prof

All India Institute of Medical Sciences Jodhpur

Singapore General Hospital

Dina Sallam
Prof

094

Sung Min Jung
Dr.Cho's Kidney Center

Yaru Liu
The First Affiliated Hospital Of Zhengzhou University,
Zhengzhou University

Poster Exhibition
P-406

Successful Pregnancy In IgA Nephropathy Patient After Treatment With
Telitacicept: Case Report

P-407

Co-existing Systemic Lupus Erythematosus with Lupus Nephritis and Sickle
Cell Trait in a Patient with Urinary Tract Infection: A Case Report of Rare
Combination

Sanjeev Kharel

P-408

A 23-year-old man with Kidney sarcoidosis

Khaliun Boldbaatar

P-409

A Rare Renal Manifestation of Lymphoplasmacytic Lymphoma: Cast
Nephropathy

Yu Jin Shin

P-410

Optic Neuritis as an Atypical Initial Symptom of Microscopic Polyangiitis: A
Case Report

Jang Hee Park

P-411

DIFFERENT CLINICAL ASPECTS OF LUPUS NEPHRITIS IN YOUNG ADULT
MALES : A CASE SERIES IN dr. SARDJITO YOGYAKARTA

Ratna Damayanti

P-413

Thin Basement Membrane Nephropathy as a Cause of Kidney Injury in a
Young Hypertensive Patient

Katrina Pattaguan

P-414

Post-thymectomy Membranous Nephropathy in a Patient with Myasthenia
Gravis: A Case Report

Marie Joyce Jorge

P-415

Fulminant Guillain-Barre' Syndrome And Lupus Nephritis As The Presenting Fatima Hannah Romero
Features In Childhood-Onset Systemic Lupus Erythematosus: A Case Report University of Santo Tomas Hospital

P-416

IgG4 related tubulointerstitial nephritis in a renal failure patient withhypereosinophilia: A case report

Yanghyeon Kim

P-417

Nephrotic Syndrome ec Focal Segmental Glomerulosclerosis in Elderly
Patients

Novandra Abdillah

P-418

Complete Response in a Patient with New-Onset Lupus Nephritis Class
Following COVID-19 Vaccination

Won Hee Cho

P-419

Clinical efficacy of Telitacicept in the treatment of kidney disease in 2 casesof primary Sjogren's syndrome

P-420

Unusual Tubular Necrosis in a patient with Renal Eosinophilic
Granulomatosis with Polyangiitis (EGPA): A Case Report

Zhu Wenjuan

P-421

A Lupus Nephritis Patient with Negative ANA and anti-dsDNA

University of Indonesia/Dr. Cipto Mangunkusumo
Hospital

P-422

A rare case of young women with hypokalemia nephropathy associatedwith diabetes melitus and coexisted minimal changes disease

Edi Setiawan

P-423

Focal Segmental Glomerulosclerosis Primary Manifestation Of SteroidResistant Nephrotic Syndrome

Chairil Makky

P-424

DISEASE OF MINIMAL CHANGES: MANIFESTATIONS OF RELAPSINGNEPHROTIC SYNDROME

Eva Julita

Xinru DuThe Second Hospital of Jilin University,China

Tribhuvan University Teaching Hospital, Kathmandu,
Nepal

Kidney center, The First Central Hospital of Mongolia

095

Chonbuk National University Hospital

Chungbuk National University Hospital

Sardjito Hospital, Gadjah Mada University

Veterans Memorial Medical Center

East Avenue Medical Center

BongSeng Memorial Hospital

Mohammad Hoesin General Hospital / Medical
Faculty, Sriwijaya University Palembang

SAHMYOOK MEDICAL CENTER

Feng Xu
The Second Hospital of Jilin University

The University of Hong Kong - Shenzhen Hospital

Darryl Virgiawan Tanod

Ciptomangunkusumo goverment Hospital, central of
Jakarta

Universitas Sriwijaya

Universitas Sriwijaya

Poster ExhibitionP-425

Difficulties In Managing Diffuse Alveolar Haemorrhage In Systemic Lupus
Erythematosus

P-426

A Rare Case of an Asian Woman with Systemic Light Chain Amyloidosis with Hazel Ann Gianelli Cu
St Luke's Medical Center
Multiple Myeloma

P-427

Telitacicept for the treatment of IgA nephropathy in postpartum patients
presenting with nephrotic syndrome: A case report

Fan Jia

P-428

Clinical Observation of Tacrolimus Treatment for Systemic Lupus
Erythematosus Nephritis Combined with Liver Damage

Wang Xuehui

P-429

Rituximab in Treating Collapsing Focal Segmental Glomerulosclerosis(cFSGS) in a 13-year-old presenting with Acute Kidney Injury (AKI) andVenous Sinus Thrombosis: A Case Report

P-430

Atypical Hemolytic Uremic Syndrome Occurring During Anti-GBM
Glomerulonephritis Treatment

P-431

A 40-year-old female who was managed as a case of rapidly progressive
glomerulonephritis (RPGN) from antithyroid drug-induced ANCAassociated vasculitis (AAV)

P-432

A Rare Case of a 74 year-old Filipina with Sjogren's Syndrome presenting
with Tubulointerstitial Nephritis on Kidney Biopsy

Wilmark Gular

P-433

Henoch-Schonlein Nephritis in an Adult Woman Presenting as ANCANegative Pauci-Immune Crescentic Glomerulonephritis

Diane Tabucanon

P-434-308 G/A polymorphism in the TNF-alpha gene is associated withsusceptibility to nephrotic syndrome in children: a systematic review andmeta-analysis

Neil David Cayanan

P-435

Safety and Efficacy of Belimumab in Patients with Lupus Nephritis: A
Systematic Review and Meta-Analysis

P-436

Analysis of clinicopathological characteristics of membranous nephropathy Guoqin Wang
Beijing Anzhen Hospital, Capital Medical University
with concomitant malignancy and literature review

P-437

The association between complement in the system or kidney andcomplement gene polymorphisms with severity and clinical outcomes in
ANCA-associated vasculitis: a scoping review

P-438

Clinical determinants for optimal treatment for emphysematous
pyelonephritis

P-439

Effect of Statins on IgA Nephropathy

A-440

A Case of Renal Injury Caused by Renal Artery Aneurysm in the Right Single
Kidney: Improvement Following Embolization

Yusuf Abu Shamsi
Hospital Canselor Tuanku Muhriz

china

Heilongjiang Province Great Northern Wilderness
Group General Hospital

Christopher Sim Sze Bing
Hospital Teluk Intan

Hyejin Jeon
Gyeongsang National University HospitalLouise Ruth Paras
Ospital ng Maynila Medical Center

St Luke's Medical Center Global City

Perpetual Succour Hospital

College of Allied Medical Professions, Angeles
University Foundation

Tohari Tohari
Medical Faculty of Univesitas Brawijaya

Yi-Ting Ong
Singapore General Hospital

Dong Eon Kim
Pusan National University Hospital, Pusan

Arthur HC Tang
Queen Mary Hospital, The Univesity of Hong Kong,
Hong Kong

096

Kiyoung Choi
Suwan happiness geriatric hospitalPoster Exhibition
Transplantation
Board No.

P-457

Title

Presenting Author

Efficacy of integrated risk score using omics-based biomarkers for theprediction of acute rejection in kidney transplantation: A randomized
prospective pilot study

Mingyu Kim
Kyungpook National University Hospital

P-458

Circulating T-cell and Cytokines Profiles in Renal Transplant Recipientswith Inflammatory Interstitial Fibrosis and Tubular Atrophy and Chronic
Antibody Mediated Rejection

P-459

The outcome and risk factor of refractory T cell mediated rejection(TCMR) on renal allograft transplantation based on the Korean organ
Transplantation registry (KOTRY)

P-460

Triglyceride-Glucose Index And Risk Of Cardiovascular Events, Renal
Allograft Loss, And New Onset Diabetes After Transplantation In Renal
Transplant Recipients

Jeong-Yeun Lee

P-461

Pre- and Post- Transplant BK Virus-Specific ELISPOT Assay for Predicting theoutcome of BK virus infection in Kidney Transplant Recipients

Na Do-Hyun

P-462

Enhancing Pediatric Kidney Transplant Rejection Detection By Integrating
The Absolute Copy Number Per Ml Of Donor-derived Cellfree Dna To The
Donor Percentage Fraction.

P-463

Cardioprotective effect of SGLT2 inhibitor in diabetic kidney transplant
recipients

Oh Youn Sik

P-464

Comparable Graft Survival of Re-transplantation in Elderly Kidney
Recipients in Regard to Rejection

Han Bi Lee

P-465

Predicting the Impact of PM2.5 Exposure on Kidney Transplant Recipients:
A Machine Learning Approach to Assessing Clinical Outcomes

P-466

ABCC2-24C>T Gene Polymorphism and Its Effects on Graft Survival Among
Kidney Transplant Recipients

P-467

Hypertension Remission After Kidney Transplantation is Associated With
Lower Graft Failure and Mortality Rates

P-468

Effects of Body Mass Index on Kidney Transplant Outcomes in Korea: A
Nationwide Cohort Study

Eun-Young Cho

P-469

Cardiovascular outcomes of kidney transplantation in elderly patients: A
nationwide cohort study from South Korea

Sang Hun Eum

P-470

Comparison of Long Term Outcomes among the Treated and UntreatedHepatitis C positive Kidney Transplant Recipients

Sana Shadab

P-471

Longitudinal Kinetics Of Donor-derived Cell-free DNA In Pediatric Kidney
Transplantation: Absolute Copy Number Per Ml Vs. Percentage

Vikas Dharnidharka

097

Brijesh Yadav
SANJAY GANDHI POSTGRADUATE INSTITUTE OF
MEDICAL SCIENCES, LUCKNOW

Eun-Jeong Kwon
Seoul National University Bundang Hospital

College of Medicine, Kyung Hee University Hospital,
Kyung Hee University

The Catholic University of Korea Seoul St. Mary's
Hospital

Vikas Dharnidharka
Washington University School of Medicine in Stlouis

Kyungpook National University Hospital

The Catholic University of Korea Seoul St. Mary's
HospitalSeung Hyun Han
Seoul National University Hospital

Chiau Ling Choong
Center of Quality Medicine Management, Faculty of
Pharmacy, Universiti Kebangsaan Malaysia

Kyungho Lee
Samsung Medical Center, Sungkyunkwan University
School of Medicine

Kyungpook National University Hospital

Incheon St. Mary's Hospital, The Catholic University of
Korea

Assistant Professor, Department Of Nephrology, MLN
Medical College, Allahabad, Uttar Pradesh, India

Washington University School of Medicine in StlouisPoster Exhibition
P-472

Clinical outcomes of repeat kidney transplantation according to repeat HLA Seunghyeok Choi
The Catholic University of Korea Seoul St. Mary's
mismatch and Class II molecular mismatch
Hospital

P-473

Long-term infectious disease and risk factors in Korean kidney transplantpatients: Results from the KoreaN Cohort Study for Outcome in Patients
With Kidney Transplantation (KNOW-KT) Study

P-474

Predicting postdonation kidney function in living kidney donors using
machine learning techniques

Junseok Jeon

P-475

Increased Risk of Genitourinary Cancer in Kidney Transplant Recipients: A
Large-Scale National Cohort Study and Its Clinical Implications

Tae Hyun Ban

P-476

Impact of Probiotic Supplementation on Kidney Transplantation Outcomes

P-477

Residual renal volume as a long-term independent predictive factor ofdeveloping Chronic Kidney Disease after donor nephrectomy

Thanakhom Hoontrakul

P-478

The Survival Following Kidney Transplantation According To Ethnicity
Among Kidney Transplant RecipientsSong Yi Kil

P-479

Use of SGLT-2 Inhibitors in post renal transplant proteinuria

Abhilash Chandra

P-480

Efficacy and Safety of Dapagliflozin in Diabetic Kidney Transplant
Recipients

P-481

Denosumab recovers aortic arch calcification in kidney transplant recipients Woo-yeong Park

P-482

Commercial Kidney Transplantation: Hazards and Outcomes

P-483

Effect of intraoperative continuous renal replacement therapy on livertransplant recipient outcomesTai Yeon Koo

P-484

Risk of Sensitization based on Panel Reactive Antibody Level on Blood
Transfusion and Pregnancy in Kidney Transplant Candidate

In Joon Hwang

P-485

Clinical Outcomes of Asymptomatic Microscopic Hematuria in Living
Kidney Donors: A Korean Cohort Study

Bon Jin Koo

P-486

HLA-incompatible Kidney Transplantation Showed Similar Outcomes
Compared To HLA-compatible Kidney Transplantation After An Early
Rejection

P-487

The outcomes of mycophenolate mofetil-related gastrointestinal mucosal
injury in kidney transplant recipients

P-488

Lymphocyte And Capillary Densities in Renal Allografts are Affected by
Dietary Salt Intake

Jung Hwa Ryu
Ewha Womans University Medical Center

Samsung Medical Center, Sungkyunkwan University
School of Medicine

The Catholic University of Korea Eunpyeong St. Mary's
Hospital

Yookyung Jang
Korea University Anam Hospital

Faculty of Medicine, Thammasat University

Kosin University Gospel Hospital

Dr RMLIMS

Sherzod Abdullaev
Republican specialized scientific and practical
medical center of nephrology and kidneytransplantation

Keimyung University Dongsan Medical Center

098

Fahad Mohammed Al Jabir
King Faisal Specialist Hospital And Research Center

Korea University Anam Hospital

The Catholic University of Korea Eunpyeong St. Mary's
Hospital

Pusan National University Yangsan Hospital

Yoon Ju Kim
Kyungpook National University Hospital

Abdullah Ansari
Sanjay Gandhi Post Graduate Institute of Medical
Sciences

Kyungho Lee
Samsung Medical Center, Cell and Gene Therapy
Institute, Sungkyunkwan University School of
MedicinePoster Exhibition
P-489

Joint association of Early Steroid Withdrawal and mTORi usage with kidneytransplant outcomes

P-490

Recurrent and De Novo Focal Segmental Glomerulosclerosis After
Kidney Transplantation: A Comparison of Clinical Features and Transplant
Outcomes

Do Kyun Kim

P-491

The Brunei National Kidney Transplant Program - A 10 Year Analysis

Nur Hanisah Haji Johan

P-492

Understanding post-transplant anemia in kidney transplant recipients:
insights from a Vietnamese cohort

P-493

Clinical Outcomes in Transplanted Kidneys: The Analysis of Biopsy Timing
and Indication Biopsy Results

Seung Yun Chae

P-494

Alterations of Bioelectrical Impedance Analysis-derived Variables in the
Early Period of Kidney Transplantation

Jihyun Yeom

P-495

Human Leukocyte Antigen Polymorphism in North Indian Population

P-496

Early hospital readmission after kidney transplantation

P-497

Urinary tract Infection is risk factors off graft outcomes in kidneytransplanted patient in Mongolia

Bayasgalan Munkhdalai

P-498

Covid-19 infection outcomes of the kidney transplant recipients in
Mongolia

Khishgee Tseren

P-499

Prognostic role of the hematocrit level in patients with kidneytransplantation.

Byung Min Ye

P-500

Expanding deceased donor kidney transplantation in Mongolia

Lkhaakhuu Oderdene

P-501

The use of immunoadsorption (IA) with Glycosorb column in ABOincompatible living donor kidney transplantation: First paediatric case in
Hong Kong

Alison Lap-Tak Ma

P-502

OPO Structure and Function in Asia

P-503

Recovery of Transplant Kidney Function in a Male Recipient with Pre-renal
Acute Kidney Injury

P-504

Effective Treatment Of UTIs : A Targeted Approach Of Antibiotics As Future
Perspective

P-505

A CASE REPORT OF EARLY SEVERE PNEUMONIA FOLLOWING LIVING DONORKIDNEY TRANSPLANTATION

Ratna Damayanti

P-506

The first experience of transplantation of the bladder en bloc with thekidney and ureters in an animal experiment

Gani Kuttymuratov

Lee-Moay Lim
Kaohsiung Medical University Hospital

Pusan National University Yangsan Hospital

Jerudong Park Medical Centre

Nguyen Thu Ha
108 Military Central Hospital

The Catholic University of Korea Seoul St. Mary's
Hospital

Chonbuk National University Hospital

Brijesh Yadav
SANJAY GANDHI POSTGRADUATE INSTITUTE OF
MEDICAL SCIENCES, LUCKNOWHye Jin Chong
Sunchon National University

First center Hospital of MongoliaFirst center Hospital of Mongolia

Pusan National University Yangsan Hospital

Nephrology doctor in organ transplantation center

Hong Kong Children's Hospital

Harun Rashid
Kidney Foundation Hospital and ResearchInstitute,Dhaka-1216,Bangladesh

099

Hee Yeoun Kim
BongSeng Memorial Hospital

Hinal R
jaslok Hospital

Sardjito Hospital, Gadjah Mada University

University Medical Center, Corporate Fund

Poster Exhibition
P-507

CNI toxicity and severe ABMR in kidney transplantation

Byung Hwa Park

P-508

Eventful yet Successful Renal Transplantation in a case of TNF Receptor
Associated Periodic Syndrome

Aviral Kashyap

P-509

Squamous Cell Carcinoma In Post Kidney Transplant Patient In Dr. Sardjito
General Hospital Yogyakarta Indonesia

P-510

The Impact of Metabolic Syndrome and Vascular Calcifications of Iliac
Arteries in Transplant Kidney Patients: A Case Report

P-511

Mycobacterial Coinfection in Kidney Transplant Recipients : A Case Reportin DR. Sardjito General Hospital, Indonesia

P-512

Management of Orthostatic Hypotension in Post-Kidney Transplant Patient:a Case Report

Fellow of Nephrology and Hypertension, Department
of Internal Medicine, Faculty of Medicine, Public
Health and Nursing, Gadjah Mada University, Dr.
Sarjito Hospital, Yogyakarta

P-513

Recurrence of Calcinosis Cutis in a Female Post Near-Total
Parathyroidectomy and Kidney Transplant: A Case Report

Marvin Ace Tindoy

P-514

Beyond Routine: Disseminated Strongyloidiasis After Renal Transplant

Yeoh Hung Yew

P-515

Anemia due to Myelodysplastic Syndrome Induced by Azathioprine andAllopurinol in Kidney Transplant Patient: A Case Report

Aryan Yohanes Djojo

P-516

Uncommon presentation of adenovirus nephropathy after renaltransplantation - a single centre experience

Phang Yinn Rhu

P-517

A review of strength-based strategies used by transplant patients' lives

Camilla Nonterah

P-518

Renin-angiotensin System Inhibitors Reduce Mortality and Allograft LossAmong Renal Transplant Recipients

Yu-Hsiang Chou

P-519

Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney TransplantPatients: A Systematic Review and Meta-Analysis

P-520

A meta-analysis and systematic review were conducted to determine thetherapeutic efficacy of Cordyceps sinensis as an additional therapy forkidney transplant patients.

Kosin University Gospel Hospitalmahatma gandhi medical college

Budi Satria
Fellow of Nephrology and Hypertension, Department
of Internal Medicine, Faculty of Medicine, Public
Health and Nursing, Gadjah Mada University, Dr.
Sarjito Hospital, Yogyakarta, Indonesia

Zaenab Muslikhah
1Fellow student of Nephrology and Hypertension
Division, Department of Internal Medicine, Facultyof Medicine, Public Health and Nursing Universitas
Gadjah Mada / Dr. Sardjito General Hospital,
Yogyakarta, Indonesia

Sri Lestari
Fellow of the Nephrology and Hypertension Division,
Department of Internal Medicine, Faculty of Public
Health Medicine and Nursing UGM, Dr. Sardjito
Hospital, Yogyakarta.

Hery Agung Samsu Alam

100

Makati Medical Center

Hospital Kuala Lumpur

Fatmawati Central General Hospital

Subspecialty trainee in nephrology

University of RichmondNational Taiwan University

Jayson Villavicencio
Philippine General Hospital

Md Sarfaraj Hussain
Lord Buddha, Koshi Pharmacy College, Baijnathpur,
SaharsaPoster Exhibition
Green Nephrology
Board No.

Title

Presenting Author

P-522

Reducing Water Usage, Carbon Emissions, and Waste Generation in Dialysis
Units: A Closed-Loop Water Recycling Approach for Sustainable Renal Care

Sahnaz Vivinda PutriInternational University Semen Indonesia

P-523

Optimizing Dialysate Temperature Control Through Predictive Machine
Learning for Improved Patient Comfort and Resource Efficiency in Green
Nephrology

P-524

Long-term Exposure to Low Perceived Temperature in Winter Increases the
Risk of Death in CKD patients

P-525

Environmental Chemical Exposure Trends in CKD Patients: A Study During
Recent Global Health Changes

P-526

The Modification Effect of Ambient Temperatures on the Associations
between PM2.5 Components and Hospitalizations for Chronic Kidney
Disease: a Nationwide Space-time-stratified Case-crossover Study in China

Wanzhou Wang

P-527

The Impact of Urinary Phthalate Metabolites on Kidney Function: A
Longitudinal Analysis among CKD Patients

Yaerim Kim

P-528

Perceived Temperature Variability and Its Impact on Mortality Risk in
Chronic Kidney Disease Patients: A Retrospective Cohort Study in Seoul

Ara KoP-529

The Influence of Long-Term Exposure to Nitrogen Dioxide on Cardiovascular
Boram Weon
Event Risks in CKD Patients using Machine Learning-based Ultra-HighSeoul National University Boramae Medical Center
Resolution Air Pollution Forecasts

P-530

Exposure of PM2.5 and its constituents are associated with chronic kidneydiseaseTai-Shuan Lai

P-531

Chronic kidney disease and the indoor and ambient PM2.5 ratio

Semin Cho

P-532

Urinary volatile organic compounds and kidney function

Semin Cho

P-533

A noninvasive Diagnostic model for IgA nephropathy in Chinese population Jie Hou

P-534

Correlation Between Air Pollutant Concentration and Renal Function
Impairment

P-535

Emission Of Greenhouse Gases; Way To Reduce Carbon Footprint In Dialysis
Units.

P-536

Environmentally sustainable renal care- A qualitative scoping review

Priti Solanky

P-537

Turning Dialysis Waste Into Treasure: A Sustainable Upcycling Model
Empowering Communities and Achieving Plastic Neutrality

Ravichandran Palani

Rifaldy Fajar
Karlstad University

Ara KoSeoul National University Hospital

Jeonghwan Lee
Seoul National University Boramae Medical Center

National Institute of Health Data Science at Peking
University

Keimyung University Dongsan Medical Center

Seoul National University Hospital

National Taiwan University Hospital

Chung-Ang University Gwangmyeong Hospital

Chung-Ang University Gwangmyeong Hospitalthe first Hospital of jilin university

101

Seungyoon Lee
Korea University College of Medicine

Umamaheswari PakkirisamyCollege of Nursing, Government Medical College
Jalaun

GMERS Medical College, Valsad

Saveetha Medical College

Poster Exhibition
Renal Nutrition
Board No.

Title

Presenting Author

P-538

AI-Driven Precision Nutrition for Chronic Kidney Disease Management
Through Machine Learning Prediction of Phosphorus Bioavailability

Rifaldy Fajar

P-539

Abdominal Subcutaneous Fat Area can Predict 2-Year Survival in Patientswith End- stage Renal Disease Initiating Hemodialysis

Yoon Kyung Chang

P-540

Nutritional Changes Among Maintenance Hemodialysis Patients During
Ramadan: An Integrative Analysis of Dietary Patterns Using Posteriori andHybrid Methods

P-541

Inflammation and Oxidative Stress: Correlation with Protein Energy Wasting Zainab Habeeb
Sanjay Gandhi post graduate institute of medical
in Pre-Dialysis Chronic Kidney Disease Patients (Stage 2 To 5).
sciences, Lucknow

P-542

Safety and Impact of the Mediterranean Diet in Patients with Chronic
Kidney Disease: A Pilot Randomized Crossover Trial

Jung Eun Lee

P-543

Feasibility of Using a Web Application for Dietary Phosphate Control
Compared with 24-hour Food Takes Notes by Patients Undergoing Regular
Hemodialysis: A Quasi-Experimental Study Design.

Yuwadee Pattanamontree

P-544

Assessment of Nutritional Status in Non-dialysis-dependent Chronic Kidney
Minsang Kim
Disease Patients Using Handgrip Strength: Results from the KNOW-CKD
Seoul National University Hospital
study

P-545

Insulin resistance linked to increased risk of End-Stage Renal Disease in
non-diabetic and diabetic individuals: findings from a large-scale study

Javad Alizargar

P-546

Phase Angle: A Promising Biomarker for Sarcopenia Detection in Malaysian
Peritoneal Dialysis Patients

Zulfitri Azuan Mat Daud

P-547

Dietary Manganese Intake and Risk of Chronic Kidney Disease: Insights from Cheol Ho Park
Severance Hospital
the UK Biobank Study
Shurui Wang

P-548

Association between Dietary Acid Load and Chronic Kidney Disease in the
Chinese Population: A Comprehensive Analysis of the China Health andNutrition Survey (2009)

P-549

A Comparative Analysis of the Global Leadership Initiative on Malnutrition
and Subjective Global Assessment for Diagnosing Malnutrition among
Predialysis and Dialysis Inpatients

Lulu Octaviani

P-550

Associations between Plant-Based Diet, Plant Protein, and Kidney Functionin Patients with Autosomal Dominant Polycystic Kidney Disease

Sumin Heo

P-551

Assessment of Protein Energy Wasting in Children with Chronic Kidney
Disease Stage 2-5: A Cross-Sectional Study

Bobbity Deepthi

102

Karlstad University

The Catholic University of Korea Daejeon St. Mary's
Hospital

Zulfitri Azuan Mat Daud
Universiti Putra Malaysia

Yongin Severance Hospital

Division of Clinical Nutrition, Department of Internal
Medicine, Phramongkutklao Hospital, Bangkok

Kashan University

Universiti Putra Malaysia

Department of Nephrology, State Key Laboratory ofComplex Severe and Rare Diseases, Peking Union
Medical College Hospital, Chinese Academy ofMedical Science and Peking Union Medical College

Dr. Cipto Mangunkusumo National Central General
Hospital

Seoul Women's University

Jawaharlal Institute of Postgraduate Medical
Education and Research (JIPMER)

Poster Exhibition
Hypertensive Kidney Disease + Vascular Biology in CKDBoard No.

P-552

Title

Presenting Author

Synergistic Effects of Folate and Riboflavin on Vascular Calcification
Amelioration in Uremic Rats

Shin Young Ahn

P-553

Lipocalin-2 promotes cardiovascular calcification in chronic kidney disease
by upregulating NCOA4-mediated ferritinophagy and ferroptosis throughSTAT3 signaling activation

Yujia Wang

P-554

Renal tubule-derived EVs carrying complement 3 aggravate CKD vascular
calcification by downregulating autophagy in vascular smooth muscle cells

Yuxia Zhang

P-555

A Nonsteroidal Mineralocorticoid Receptor Antagonist Ameliorates Vascular Seo Rin Kim
Pusan National University Yangsan Hospital
Calcification in Chronic Kidney Disease

P-556

Associations of Elevated Brachial-Ankle Pulse Wave Velocity and Short-Term Ye Eun Ko
Severance Hospital
Blood Pressure Variability with Incident Chronic Kidney Disease

P-558

Hyperuricemia induces hypertension and kidney injury via endoplasmic
reticulum stress

P-559

Periventricular microangiopathy and uremic toxins in CKD stage 3-5d
patients with mild cognitive disorder

P-560

The Impacts of calorie restriction diet on blood glucose regulator treatment Pardeep Kumar
SHAKUNTLA Hospital AND RESEARCH CENTER
for chronic kidney disease patients with post-gastric bypass

P-561

Interaction of Phosphate and Uremic Substances on Vascular Calcification

Masahide Mizobuchi

P-562

Systolic blood pressure modifies the relationship between coronary artery
calcification and adverse kidney outcome: results from KNOW-CKD

Young Su Joo

P-563

Antihypertensive and Renal Effects of Drug Switching to Sacubitril/
Valsartan, an Angiotensin Receptor-Neprilysin Inhibitor, in TreatedHypertensive Patients: Evaluation in Daily Clinical PracticeP-564

Clinical Efficacy and Safety of Spironolactone as an Add-on Therapy for
Blood Pressure in Hypertensive Patients

P-565

Polyarteritis Nodosa Presenting as Renal Artery Stenosis in a Filipino Female Stephanie Joyce Liao
Chong Hua Hospital
Patient: A Case Report

P-566

Resistant Hypertension ec Renovascular Hypertension ec Fibromuscular
Dysplasia in CKD Patients ec Chronic Glomerulonephritis G5Ax On CAPD

103

Korea University Guro Hospital

Institute of Nephrology, Zhong Da Hospital, Southeast
University, School of Medicine, Nanjing, China

Southeast University

Chor Ho Jo
Ewha Womans University Medical Center

Yen-Chung Lin
Taipei Medical University Hospital

Showa University Scool of Medicine

Yongin Severance Hospital

Takeshi Horio
Ishikiriseiki HospitalBancha Satirapoj
Phramongkutklao Hospital

Novandra Abdillah
Mohammad Hoesin General Hospital / Medical
Faculty, Sriwijaya University Palembang

Poster Exhibition
Dialysis
Board No.

Title

Presenting Author

P-574

Influence of the method of addition of nitric oxide during hemodialysis on
its antithrombotic effectMayu Fukada

P-575

The Effect of Dialysis Modality on Annual Mortality: a Prospective Cohort
Study

Yae Hyun Kim

P-576

The trends in epidemiologic characteristics and clinical patterns of vascularaccess of incident hemodialysis patients: Nationwide cohort study (20062019) in Korea

P-577

SARS-CoV-2 vaccine effectiveness and clinical outcomes in patients
undergoing hemodialysis in South Korea

P-578

The Potential of Serum Growth Differentiation Factor-15 as a Screening
Marker in Hemodialysis Patients with Cognitive Impairment.

Hae Ri Kim

P-579

The association between body mass index and mortality in elderly patientswith hemodialysis

Dong-Kyu Lee

P-580

Developing an AI-powered prescription algorithm for maintenancehemodialysis patients

Gwangeon Sim

P-581

Association of Physiological Reserve Assessed by Cardiopulmonary
Exercise Testing and Physical Frailty with All-cause Mortality in Patients on
Hemodialysis: a Multi-center Prospective Cohort Study

P-582

Monitoring Heart Rate Variability Using Blood Flow Sounds in the Blood
Circuit

Shunichiro Urabe

P-583

Low Quality of Life is Associated with Higher Mortality in Elderly
Hemodialysis Patients

Yoosun Joo

P-584

Mortality in Patients receiving Renal Replacement Therapy in South Korea

P-585

A novel approach to monitoring for fluid status of maintenancehemodialysis patients using Remote Dielectric Sensing Technology

P-586

Effects of remote cloud platform follow-up combined with traditional clinic
follow up on volume control and cardiovascular disease in homeperitoneal Yuwei Bai
General Hospital of Ningxia Medical University
dialysis patients

P-587

A Prognostic Model (BLEND35) with Internal Validation for Treatment
Failure in Patients with Peritoneal Dialysis-Associated Peritonitis

P-588

Galectin-3 as a Predictor of Heart Failure in Hemodialysis Patients withPreserved Ejection Fraction

P-589

Medication Burden and Adverse Cardiovascular Events and Death inPatients Undergoing Maintenance Hemodialysis: A Nationwide Cohort
Study

104

Kitasato University Graduate School

Seoul National University Hospital

Kyoung Sook Park
National Health Insurance Service Ilsan Hospital

Ajin Cho
Hangang Sacred Heart Hospital

Chungna National University Sejong Hospital

Kyungpook National University Hospital

Chuncheon Sacred Heart Hospital

Naoto Usui
Juntendo University

Juntendo University

Kyung Hee University Hospital at Gangdong

Beongwoo Kim
Inje University Busan Paik Hospital

Nan ZhuShanghai general Hospital, Shanghai Jiaotong
University, School of Medicine

Qichen Liang
Peking University People's HospitalJi Hwan Kim
Hallym University Sacred Heart Hospital

Cheol Ho Park
Severance HospitalPoster Exhibition
Jialing Rao

P-590

Prognostic Role Of Neutrophil-to-lymphocyte Radio In Dialysis Patients
With Parathyroidectomy

P-591

Association of Low Fat Mass with Increased Risk of Osteoporosis andOsteosarcopenia in Patients Undergoing Peritoneal Dialysis

Jin Ha Jang

P-592

Effect of Intraperinoneal Immunoglobulin G in Patients with Refractory or
Relapsing peritonitis

Yang Wook Kim

P-593

Risk factors for the mortality among Hemodialysis patients with COVID-19
infection: a multicenter study from Yeolin medical foundation, 28
hemodialysis centers.

P-594

The Effect of a Scenario-based Cognitive Behavioral Therapy Mobile App
oln End-stage Kidney Disease Patients on Dialysis

Dong-Seop Kim

P-595

Association of proteinuria with cardiac structure and diastolic dysfunction
in incident hemodialysis patients

Takhyeon Kweon

P-596

Presence of Bacterial DNA Fragments and Their Molecular Size after Heat
Disinfection

Minoru Nakamura

P-597

Addressing the Decline in Peritoneal Dialysis Prevalence: The 2023
Initiatives of the Peritoneal Dialysis Reimbursement Program in Taiwan

Yen-Hsuan Tai

P-598

Analysis of the relationship between permanent catheter patency and the Moo Jun Kim
nutrient score in patients over 75 years requiring renal replacement therapy Chungnam National University Sejong Hospital

P-599

Effects of administration and intensity of statin on mortality in patients
undergoing hemodialysis

Seok Hui Kang

P-600

Trends and Practices in Early versus Late Initiation of Renal Replacement
Therapy in South Korea and Taiwan

Soie Kwon

P-601

Risk Factors And Characterization Of Falls In Hemodialysis Patients: A Multicenter Study

Huifen Han

P-602

Machine learning approach to predict dialysis initiation in CKD stage 3-5
patients: a multi-center study

Chia-Te Liao

P-603

Evaluating the Pleth Variability Index as an Objective Indicator of Dry
Weight Setting

Makoto Saito

P-604

Blood transfusion is a major determinant of all-cause mortality in ESKD
patients : Machine learning analysis of National Health Insurance Claims
data

P-605

Comparison of clinical outcomes based on dialysis modality and icodextrin
usage in patients on peritoneal dialysis

Jun Young Do

P-606

Diagnostic Performance of Biological Scores for Hepatic Steatosis andAdvanced Liver Fibrosis among Hemodialysis Patients

Wei Kei Wong

P-607

Unveiling Risk Factors: A Prognostic Model of Frequent Peritonitis in
Peritoneal Dialysis Patients

Yun-Yun Zhang

105

Division of Nephrology, Department of medicine,Third Affiliated Hospital of Sun Yat-Sen University,
Guangzhou, Guangdong, China.

Hallym University Sacred Heart Hospital

Inje University Haeundae Paik Hospital

Moon Jeong Seo
Yeolin Medical Foundation

Soon Chun Hyang University Cheonan Hospital

Kangdong Sacred Heart Hospital

Hokkaido University of Science

Taipei Veterans General Hospital, Taipei

Yeungnam University Medical Center

Chung-Ang University Hospital

The Third Affiliated Hospital of Sun Yat sen University

Taipei Medical University Shuang Ho Hospital

Gunma Paz University

Myung-Gyu Kim
Korea University Anam Hospital

Yeungnam University Medical Center

University of Malaya

Department of Nephrology, Institute of Nephrology,
West China Hospital of Sichuan University, China

Poster Exhibition
P-608

The Current Trend of Chronic Kidney Disease-Mineral Bone Disorder
Management in Korean Patients on Maintenance Hemodialysis: The
Movement of Past 10 Years

Donghyuk Kang

P-609

Poor Skin Conditions are Vulnerable to Catheter-related Infections in
Peritoneal Dialysis Patients

Jeong Geon Lee

P-610

ASSOCIATION OF ARTERIOVENOUS FLOW AND VOLUME STATUS BY MULTIFREQUENCY IMPEDANCE ANALYSIS

Hyung Jong Kim

P-611

Insights into Caregiver Well-being in Chronic Dialysis - Assessing Burden
and Depression : A Cross-Sectional Study

Lydia Kamaruzaman

P-612

Pre- and Post-Hemodialysis Differences in Heart Failure Diagnosis by
Current Heart Failure Guidelines in Patients With End-Stage Kidney Disease

Song Yi Kil

P-613

Feasibility of Expanded Hemodialysis for Extremely Older Patients in South
Korea

Seongmin Kang

P-614

Effects of shared decision-making on the prognosis of peritoneal dialysis
patients

Song Yi Kil

P-615

Comparison of Patient Survival in Hemodialysis versus Immediate-Start
Peritoneal Dialysis: A Propensity-Matched Study

Hyunjin Cho

P-616

The Triglyceride and Glucose (TyG) Index as a Predictor of Adverse
Cardiovascular Events in Hemodialysis Patients

Dae Kyu Kim

P-617

Retrospective study of peritoneal dialysis-related peritonitis requiring
emergency laparotomy during 18 years in a single center

Masashi Mizuno

P-618

Transient increment of dialysis initiations after massive natural disaster
caused by hypertensive renal disease.

P-619

The effect of emergency equipment preparation on patient survival inhemodialysis facilities: A Korean nationwide cohort study

Do Hyoung Kim

P-620

Dual-clamp method increases the actual blood flow rate in single-needle
hemodialysis

Kojiro Suzuki

P-621

Association between Warfarin Use and Clinical Outcomes in Hemodialysis
Patients with Atrial Fibrillation

Kyu Hyang Cho

P-622

PD Peritonitis - A 10 year Australian Analysis Of Outcomes

Jarrad Hopkins

P-623

The feasibility and clinical effects of moderate-to-high intensity exercise
program for people on hemodialysis

Se Hee Jung

P-624

Efficacy and safety evaluation of sackubactril/valsartan in the treatment of
hemodialysis patients with heart failure

Ying Lei

P-625

Construction of alarm fatigue risk prediction model of APD machine innight for peritoneal dialysis patients

Cheng Qiong

P-626

Evaluating 2-Hour versus 4-Hour Intradialytic Blood Cultures In Diagnosing
Catheter-Related Bloodstream Infection

Lydia Kamaruzaman

106

The Catholic University of Korea Bucheon St. Mary's
Hospital

Soon Chun Hyang University Cheonan Hospital

CHA Bundang Medical Center

Faculty Of Medicine, Universiti Kebangsaan Malaysia

Kosin University Gospel Hospital

Ulsan University Hospital

Kosin University Gospel Hospital

Konkuk University Medical Center

Kyung Hee University Medical Center

Nagoya University Graduate School of Medicine

Michiaki Abe
Tohoku University Hospital

Kangnam Sacred Heart Hospital

Matsumoto City Hospital

Yeungnam University Medical Center

The University of Adelaide, Adelaide, South Australia

Seoul National University Boramae Medical Center

Peoples Hospital of Huadu District Guangzhou China.

17708381521

Faculty Of Medicine, Universiti Kebangsaan Malaysia

Poster Exhibition
P-627

EFFECTS OF RANKL ON LOWER DEPRESSIVE SYMPTOMS IN HEMODIALYSISPATIENTS

Dong-Young Lee

P-628

Efficacy Of Sacubitril/valsartan In Hemodialysis Patients With Heart Failure:
A Single Center Experience

Da Eun Park

P-629

Break-in Period 24 Hours as an Option for Urgent-start Peritoneal Dialysis inPatients With Diabetes

Wenpeng Cui

P-630

Effect of medical and nursing interventions on caregivers motivation tocontinue home hemodialysis support

Saori Kuroda

P-631

Effect of Leucine-enriched Amino Acid Supplementation and Exercise inPatients on Maintenance Hemodialysis

P-632

Clinical Usefulness of Monitoring Using the Physical Findings Ordinal Scale
for Vascular Access

Katsuya Tokuda

P-634

Bedside Lung Ultrasound for the Assessment of Volume Status in Chronic
Kidney Disease Patients on Hemodialysis

Asheesh Malhotra

P-635

Shared decision-making intervention regarding dialysis modality inpatients with CKD stage 5

Byung Hwa Park

P-636

Compatibility of Hemodialysis Adequacy Kt/V Calculation of Daugirdas
Formula and Kt/V Hemodialysis Machine in Chronic Kidney Disease Patients Tohari Tohari
Medical Faculty of Univesitas Brawijaya
Who Underwent Hemodialysis at Saiful Anwar Hospital, Malang, Indonesia.

P-637

Catheter Tip thrombus: A Rare But Serious Complication

Mendell Ray Sinda

P-638

Decreased NK cell-mediated cytotoxicity is associated withhypoalbuminemia in hemodialysis patients

Yen-Ling Chiu

P-639

Clinical value of measuring central blood pressure in hemodialysis patients

Seok-hyung Kim

P-640

Unraveling Treatment Decisions: Factors Influencing the Selection of
Hemodialysis over Peritoneal Dialysis (PD) among Newly Initiated EndStage Renal Disease (ESRD) Patients in a PD Preferred National Strategy in
Singapore

P-641

Effect of the Use of Polyflux H for Malnutrition in Hemodialysis Patients

Erika Koyama

P-642

Longitudinal Study on the Trajectory of Frailty Development andInfluencing Factors in Patients Undergoing Peritoneal Dialysis

Shengnan Wei

P-643

Tacrolimus treatment of pure red cell aplasia due to anti-erythropoietin
antibodies induced by COVID-19 in hemodialysis patient: A case report

Guangdong Cardiovascular Institute Guangdong,
Provincial People's Hospital Provincial People's
Hospital,Guangdong Academy of Medical
Guangdong Academy of Medical SciencesSciences

P-644

Human Development and Accessibility for Hemodialysis: An Analysis ofDistrict Level on Java Island

Dagun Raisah Laksmi Pratiwi

VHS Medical Center

Yeungnam University Medical Center

The Second Hospital of Jilin University

Shizuoka kyoritsu clinic

Eujin Lee
Chungnam National University Hospital

Hara Sanshin Hospital

Christian Medical College and Hospital, Ludhiana,
Punjab

Kosin University Gospel Hospital

Perpetual Succour Hospital

Far Eastern Memorial Hospital

Chuncheon Sacred Heart Hospital

Xin Xin Teo
Singapore General Hospital

Medical Corporation H.N.Medic

The second Hospital Affiliated of the PLA Military
Medical University

Yongyu Feng

107

Faculty of Medicine, Public Health, and Nursing,
Universitas Gadjah Mada

Poster Exhibition
Shengnan Wei

P-645

Longitudinal Study on Post-traumatic Growth in Peritoneal Dialysis Patients

P-646

Exploring the Influencing Factors and Risk Prediction of Sleep Quality in
Maintenance Hemodialysis Patients

Dong Wan

P-647

Evaluation of Polyvinylpyrrolidone Elution from Polysulfone Dialyzer in an
Experimental Circulation Simulating Hemodialysis Therapy

Masahiro Miyata

P-648

Assessing the Impacts of Haemodialysis on Red Blood Cells Morphology
and Mast Cell Activation

Rushduddin Al Jufri Bin Roosli

P-649

Validation of the Visayan Translation of the End Stage Renal Disease Adherence Questionnaire (VESRD-AQ)

Julienne Marie Canoy

P-650

Analysis Of Risk Factors And Outcome In Peritoneal Dialysis Patients With
Early-Onset Peritonitis: A Single Center Retrospective Analysis

Pamela Elaine Mangabat

P-651

HOME HEMODIALYSIS OPTION IN INDIA: LUXURY OR MAINSTREAM?

Shreshta Tripathi

P-652

Dialysis Dose and Removal Efficiency of Post-Dilution Online HDF at a
Reduced Dialysate Flow Rate

Teruhiko Miyamoto

P-653

Application of the MDT Integrated Care Model Led by Specialist Nurses inPatients Undergoing Peritoneal Dialysis

Shengnan Wei

P-654

Negative Impact of Fear of COVID-19 on Kidney Disease Quality of Life and
Its Subscales among Hemodialysis Patients as Modified by Health Literacy:
A Multi-Hospital Survey

Tran Tuan Tu

P-655

Risk Factors of Peritoneal Dialysis Associated Peritonitis Caused by GramNegative Bacteria: A Single-Center Retrospective Study Over 16 Years

Qichen Liang

P-656

Prospective self-crossover study of simplified citric acid and conventional
heparin anticoagulant hemodialysis

Wei Wang

P-657

Efforts to reduce medical errors associated with weight data in patients
undergoing hemodialysis in the artificial kidney unit

Sanghyuk Kwak

P-658

Risk factors for mortality within 6 mo in patients with diabetes undergoingurgent-start peritoneal dialysis: A multicenter retrospective cohort study

Wenpeng Cui

P-659

Serum Magnesium Level and Blood Pressure in Hemodialysis Patients

Department of Nephrology, Beijing Tsinghua
Changgung Hospital, School of Clinical Medicine,
Tsinghua University

P-660

Risk factors of severe abnormal hemogram in patients undergoing chronic
hemodialysis

Wei Wang

P-661

Clinical implications of frailty in peritoneal dialysis patients

Yi-Ting Chen

P-662

Circulating microRNAs enriched in hemodialysis patients using medium
cut-off dialyzers

Samel ParkThe second Hospital Affiliated of the PLA Military
Medical University

China-Japan Friendship Hospital

Faculty of Fukuoka Medical Technology, Teikyo
University

UNIVERSITY COLLEGE MAIWP INTERNATIONAL

Perpetual Succour Hospital

National Kidney and Transplant Institute

Nephrology

Chuo Naika Clinic

The second Hospital Affiliated of the PLA Military
Medical University

THAINGUYEN UNIVERSITY OF MEDICINE AND
PHARMACY

Peking University People's Hospital

Beijing Tsinghua Changgung Hospital

Kwak Clinic

The Second Hospital of Jilin University

Shihming Tsai108

National Taiwan University Hospital

National Taiwan University Hospital

Soon Chun Hyang University Cheonan HospitalPoster Exhibition
P-663

The Effect of Home-Based Tele-exercise on Sarcopenia and Physical
Function in Peritoneal Dialysis Patients: A Randomized Controlled Trial

Mohammad Ali Tabibi

P-664

The Association Of Serum Cystatin C, Beta-Trace Protein And Beta2Microglubin Levels With All-Cause Mortality In Peritoneal Dialysis Patients

Li FanP-665

Influence of thyroid function on the dose of erythropoietin used in patients
undergoing maintenance hemodialysis

P-666

The association of glycemic control with patient survival and techniquesurvival in incident diabetic peritoneal dialysis patients

P-667

Short-term effect of roxadustat combined with erythropoiesis stimulating
agent (ESA) treatment for anemia in patients undergoing hemodialysis
with ESA hyporesponsiveness

P-668

Higher N-terminal Pro-brain Natriuretic Peptide Level Is a Risk Factor forTechnique Failure in Patients with Peritoneal Dialysis-related Peritonitis

Niya Ma

P-669

Prevalence of Depression and Anxiety among Hemodialysis Patients in
Thailand: A Population-Based Cross-sectional Study

Parnreutai Chaiyasat

P-670

The Correlation Between Serum Calcium and Serum Phosphate on theBone Mineral Density in CKD Patients Who Underwent Hemodialysis and
CAPD at Saiful Anwar Hospital Malang, Indonesia

Muhammad Farid Rakhman

P-671

End-Stage Renal Disease and Pneumonia: Microbiota Profiles and theCorrelation with Length of Stay and Mortality Rates at Moewardi Hospital,
Indonesia

I Wayan Rendi Awendika

P-672

Association between Body Mass Index And Glycated Albumin in Patientswith Diabetes Undergoing Hemodialysis

P-673

Impact of Echo Evaluation on the Day After and One Week After VA Creation Kiyotaka Hoshiko
Tsuchiya General Hospitalon Primary Patency at 90 Days

P-674

DevelopmentandValidationofa PredictionModelfortheCureof
PeritonealDialysis-Associated Peritonitis:AMulticenter ObservationalStudy

Wenpeng Cui

P-675

Efficacy of Denosumab for Osteoporosis in Hemodialysis PatientsJi Hwan Kim

P-676

A Prospective Analysis of Caregiver Burden in Patients with Peritoneal
Dialysis Compared to Hemodialysis.

Divya Bajpai

P-677

The Effect of Citrate Dialysate on Intradialytic Heparin Consumption for
Heparin-dependent Haemodialysis Patients: A Paired Pilot Study

Ka Man Ho

P-678

EFFECT OF GARLIC EXTRACT SUPPLEMENTATION ON HEMODIALYSISADEQUATION IN PATIENTS WITH CHRONIC HEMODIALYSIS

Kiagus Muhammad Yusuf Arief Akbar

P-679

Dialysis-related nonarteritic anterior ischemic optic neuropathy inmaintenance hemodialysis patient

Pardis Specialized Wellness Institute,IranGuangdong Provincial People's Hospital

Wei Yang

109

Department of Nephrology, School of Medicine,
University of Electronic Science and Technology,
Sichuan Academy of Medical Sciences, Sichuan
Provincial PeoplesHospital,Chengdu610072, China

Hsin-Ju Huang
Divisions of Nephrology, China Medical University
Hospital, Taichung, Taiwan

Ting Xiang
West China Hospital of Sichuan University

Department of Nephrology, West China Hospital of
Sichuan University, Chengdu, China

Triam Udom Suksa School

Medical Faculty of Univesitas Brawijaya

Sebelas Maret University

Kumiko Momoki
Tokyo Dialysis Frontier Ikebukuro Station North Clinic

The Second Hospital of Jilin University

Hallym University Sacred Heart Hospital

Seth G.S.M.C. and K.E.M. Hospital, Mumbai

Queen Elizabeth Hospital, Hong Kong

Universitas Sriwijaya

Dayeong Kang
Hanmaun Internal Medicine ClincPoster Exhibition
P-680

Correlation of Neutrophil-Lymphocyte Ratio (NLR) with Serum Albumin
Level, Body Mass Index (BMI) and Erythropoetin Resistant Index (ERI) in
Patients Undergoing Hemodialysis

P-681

Explorations of the correlation of initial peritoneal function test on the
prognosis of peritoneal dialysis patients

P-682

Association between responsiveness to an erythropoiesis-stimulating
agent and body composition in maintenance hemodialysis patients bybioelectrical impedance analysis

P-683

Risk Factors Investigation and Risk Assessment Model Construction forFirst-time Peritonitis in Peritoneal Dialysis Patients

Shengnan Wei

P-684

A Review of the Modified Training Syllabus for Teaching Peritoneal Dialysis
in Sengkang General Hospital (Singapore)

Peishan Lee

P-685

Survival Analysis of Elderly Patients on Maintenance Hemodialysis: a Single- Inthira Srichaichana
Bhumirajanagarindra Kidney Institute Hospital,
Center Retrospective Study.
Bangkok.

P-686

Epidemiology of End-Stage Renal Disease Among Dialysis Patients: Pre,
During, and Post-COVID-19 Pandemic Era in Klaten Islamic General Hospital

Nurul Dwi Utami

P-687

Effects of A Single Session of Hemodialysis On Lung Function In Chronic
Hemodialysis Patients

Achmad Fikry Faridin

P-688

Correlation Between Hemodialysis Adequacy and Hemoglobin Levels in
Patients with Chronic Kidney Disease

Akhmad Ulil Albab

P-689

Removal efficiency and safety of high-dose post-dilution hemodiafiltration
using Clearum HSF

Tomohiro Hitomi

P-690

Unveiling the Patient Journey: Navigating Diverse Paths to Peritoneal
Dialysis in Nepal

Nabin Bahadur Basnet

P-691

The Impact of Remote Monitoring on Quality of Life, Mental Health, andClinical Outcomes in Automated Peritoneal Dialysis Patients During the
COVID-19 Pandemic

Donghui Shin

P-692

Symptom clusters using dialysis symptom index waray version among
chronic kidney disease patients on out-patient maintenance hemodialysis
at the hemodialysis unit of a level 2 teaching hospitalFrancine Diloy-Bertis

P-693

Clinical Outcomes Of Culture-Negative And Culture-Positive Peritonitis
Among Patients On Peritoneal Dialysis In Tertiary Hospital In East Coast
Malaysia: A Retrospective Study

P-694

Analysis of risk factors for failure of autologous arteriovenous endovascular
fistula in patients on maintenance hemodialysis

P-695

The Association among Carotid IMT, PWV and Recurrent Access Failure in
Hemodialysis Patients

P-696

Infection surveillance status of peritoneal dialysis care providers

110

Syahpri Putra Wangsa
Universitas Sriwijaya

Woan-Jean Lin
National Taiwan University Hospital

Yuwei Kang
Department of Nephrology, Sichuan Provincial
Peoples Hospital, University of Electronic Science andTechnology of China, Chengdu, Sichuan, China

The second Hospital Affiliated of the PLA Military
Medical University

Sengkang General Hospital, Singapore

Klaten Islamic General Hospital

Faculty of Medicine, Hasanuddin University

Sebelas Maret University

Enjinkai Suzuki Clinic

National Kidney Centre, Nepal

Wonju Severance Christian Hospital

Remedios Trinidad Romualdez Hospital

Tee Tat Khoo
Hospital Raja Perempuan Zainab II, Kota Bharu

Dong Wan
China-Japan Friendship Hospital

Seok-hyung Kim
Chuncheon Sacred Heart Hospital

Uuganerdene Amarbold
First center Hospital of Mongolia

Poster Exhibition
Suthiya Anumas

P-697

The efficacy of Hemp-containing cream versus placebo in the treatment of
uremic pruritus: A Double-Blind, Randomized Control Trial.

P-698

Association between anemia and peritoneal dialysis withdrawal in stable
peritoneal dialysis patients

P-699

Study on correlation between fatigue,frailty and sleep in hemodialysis
patients

Dong Wan

P-700

A SLEEP DISORDER among hemodialysis PATIENTS AT SHINONMEDHOSPITAL in Mongolia

Naranamgalan Bold

P-701

Effects Of Temporary Hemodialysis Before Insertion Of A Peritoneal Dialysis A Young Kim
Yeungnam University Medical Center
Catheter

P-702

Study on the Effectiveness and Safety of Specially Designed Porous Hollow
Carbon Spheres for Adsorbing Large Molecular Toxins in Uremia

Chong Wang

P-703

Factors affecting survival analysis of hemodialisis patients at OKU Timur
Hospital

Deddy Primadona Mulia

P-704

The New Era for Travel Dialysis : Development of Travel Dialysis Platform

Dong Hyung Lee

P-705

Biomolecular Characteristics of Peritoneal Membrane Evaluated by
Synchrotron Light Spectroscopy

Chatchai Kreepala

P-706

Survival analysis of patients on long-term maintenance hemodialysis
patients.

Sayali Kondkar

P-707

Interdialytic Weight Gain and Mortality in Hemodialysis Patients:
Association with Serum Albumin and Nutrition Parameters: A One-Year
Prospective Cohort Study

P-708

Frailty Prevalence and Short-Term Outcomes Among Younger End-Stage
Renal Disease Patients on Maintenance Hemodialysis

Edna Jane Adelee Magboo Ii

P-709

A prospective registry to evaluate safety and efficacy of Hativ
electrocardiogram monitoring on patients with hemodialysis

Jung Nam An

P-710

Analysis of the Impact of Management Strategy of Scheduled Monthly
Review on Compliance and Clinical Indicators of Hemodialysis Patients

Jing Lou

P-711

Hepcidin Levels and Erythropoietin Resistance Index Correlation Among
Patients On Routine Hemodialysis

Chronic Kidney Disease Research Group, Nephrology
and Hypertension Division, Faculty of Medicine
Udayana University, Prof. IGNG Ngoerah General
Hospital, Denpasar-Bali

P-712

Decision-Making in Renal Replacement Therapy Among the Elderly
Patients: An Exploration of Influencing Factors and Survival Outcomes

Yan Ling Christine Tay

P-713

Prevalence and Factors Associated with Renal Hyperparathyroidism Among Bai Ramlyn Solaiman
Southern Philippines Medical Center
Dialysis-Requiring Patients

Chulabhorn International College of Medicine,
Thammasat University

Kenta Torigoe
Nagasaki University Hospital

China-Japan Friendship Hospital

ACH international Hospital

School of Clinical Medicine, Tsinghua University

Mohammad Hoesin Hospital/ Universitas Sriwijaya
Palembang

Beomil Yonsei Clinic & Hemodialysis Center

Suranaree University of Technology, Thailand

National Board of Examinations New Delhi

Stephanie Joyce Liao
Chong Hua Hospital

Perpetual Succour Hospital

Hallym University Sacred Heart Hospital

The First Affiliated Hospital of Zhengzhou University
Nephrology Department

Yenny Kandarini

111

Department of Internal Medicine, Singhealth,SingaporePoster Exhibition
P-714

Catheter-Related Infection in Continuous Ambulatory Peritoneal Dialysis:
A Challenge in a Health Care System

Hastin Mutiara Surga

P-715

Recurrent Ascites in Hemodialysis Patients: Clinical Features, Causes andOutcomes

Rommel Bataclan

P-716

Effectiveness of Replete Patient Care To improve The Quality Life Of
Hemodialysis Patient

Umamaheswari Pakkirisamy

P-717

Quality of Sleep and the Quality of Life in Chronic Kidney Disease Patients
Undergoing Hemodialysis in A Tertiary Hospital in the Philippines

Joe Patrick Jamelo

P-718

Quality of Life in Hemodialysis Patients

P-719

Peritoneal Dialysis Related Peritonitis Rate and Outcomes: An Experiencefrom A Tertiary Center in Indonesia

P-720

Analysis Of Drop-Out Rate In Peritoneal Dialysis: Insights From A 3-Year
Retrospective Study Of PD Unit In Sub-Urban District Hospital In Malaysia

Nurul Izah Ahmad

P-721

Comparative study of changes in the vital signs during surgery undergeneral anesthesia in hemodialysis patients

Nakashima Takahiro

P-722

Dialysis patients' variations in nutritional status and hand strength before
and after dialysis treatment

Munkh-Od Battsogt

P-723

Sensorineural Hearing Loss In Patients Of Chronic Renal Failure

P-724

Factors Influencing the Incidence of Intradialytic Hypotension

Rizqy Aulia

P-725

Correlation The Types of Vascular Access with Dialysis Adequacy in Chronic
Hemodialysis Patients

Santy Ayu Puspita Perdhana

P-726

Clinical Outcomes of Hemoperfusion using HA330 Filter among patientswith Severe and Critical COVID-19 at the University of Santo Tomas Hospital: Juan Miguel Dizon
University of Santo Tomas Hospital
A One Year Retrospective Study

P-727

Prevalence and Outcomes of Tuberculous Peritonitis Among CAPD Patientsin National Kidney and Transplant Institute from January 2016 to January
2023

P-728

Elderly Patients on Peritoneal Dialysis Peritonitis-Analysis of Risk Factors
and Preventive Strategies.

P-729

The Influence of Nursing Care Quality Using Sodium Profiling for
Intradialysis Hypotension in Hemodialysis Patients

P-730

Impact of early-onset peritonitis on long-term mortality in patientstransitioning from peritoneal dialysis to hemodialysis

Moewardi Hospital

University of the East Ramon Magsaysay Medical
CentreCollege of Nursing, Government Medical College
JalaunPhilippine Society of Nephrology

Saruultuvshin Adiya
Mongolia Japan Hospital Mongolian National
University of Medical Sciences

112

Lucas Welfried Pandjaitan
Cipto Mangunkusumo National Central General
Hospital

Hospital Kajang

Department of Clinical Engineering, Kagoshima
University Hospital

Mongolian National University of Medical Science

Enkhjin Sukhbaatar
Medvic Dialysis Center, Ulaanbaatar, Mongolia

Mayapada Hospital Jakarta Selatan

Dr Moewardi Hospital, Surakarta. InaSN.

Maria Angelica Carrene Garcia
National Kidney and Transplant InstituteChiu-Ping Liao
National Taiwan University Hospital, Taipei, Taiwan

Hui-Chung Tsai
Kaohsiung Chang Gung Memorial Hospital

Hae Eun Jeon
Chung-Ang University HospitalPoster Exhibition
P-731

Exploring the Effectiveness of Exogenous Melatonin as a Therapy toEnhance Sleep Quality in Hemodialysis Patients: A Systematic Review

Aulia Zhafira

P-732

Water Quality of Dialysate and Dialysate Solution Using a Hot Water
Disinfection Dialysis System for Home Hemodialysis

Kanako Fukasawa

P-733

Pet Dog-Related Pantoea agglomerans peritonitis: A Rare Cause of
peritoneal dialysis related Peritonitis

Jeong Geon Lee

P-734

The Role of Lateral Flow Lipoarabinomannan (LF LAM) Urine in Making the
Diagnosis of Peritoneal Tuberculosis in CAPD Patients

Ayu Cahya Andhayani

P-735

A Case Report Of Brevibacterium Sanguinis Peritoneal Dialysis-Associated
Peritonitis

Yon Quan Chan

P-736

Hypnotheraphy in Chronic Kidney Disease Patient Undergoing Continuous
Ambulatory Peritoneal Dialysis (CAPD) with Depression and Psychogenic
Pain

P-737

Multi-Organ Recurring Thromboembolism Related to Anti-thrombin III andProtein C Deficiency in a Patient on Routine Hemodialysis

Bhanu Kumar

P-738

A 45 Years Old Male with Acute Kidney Injury Due to Weil's Disease Treatedwith Hemodialysis

Yuscha Anindya

P-739

Navigating Complexities: A Case Study on Peritoneal Dialysis Related
Peritonitis in a Patient with End-Stage Kidney Disease and Clostridium
Difficile Infection

Lee Soon Leng

P-740

Direct Hemoperfusion Treatment Using an Adsorptive Column, Rheocarna,
During Conventional Hemodialysis Therapy Is Effective for Chronic Limb
Threating Ischemia (CLTI)

Miruki Tamada

P-741

Chronic Kidney Diseases Patient With Pulmonary Edema And VascularAccess Problem Manage With Acute Peritoneal Dialysis

Safitri Ammarie

P-742

Catheter Adhesions in the Fallopian Tubes And Uterus as a Cause of CAPD
Malfunction

Siti Hadjar

P-743

Catheter Related Infective Endocarditis in Patient with Chronic Kidney
Disease Undergoing Regular Hemodialysis

Vika Wirdhani

P-744

Chronic Kidney Disease G5A3 ec Chronic Glomerulonephritis, Renal
Anemia, Chronic Hypertension And Chronic Hepatitis C In G3P2A0 Single
Living Fetus: Case Report

Novandra Abdillah

P-745

Microbacterium Peritonitis in Peritoneal Dialysis: A Case Report

Hae Ri Kim

P-746

A concerning case of headache emerging during dialysis.

P-747

Brown Tumor in Association with Secondary Hyperparathyroidism in CKD
stage 5 Chronic Hemodialysis: a Case Report

113

Sebelas Maret University Hospital

University of Yamanashi Hospital

Soon Chun Hyang University Cheonan Hospital

Dr.H. Abdul Moeleok General Hospital Lampung
Province

Hospital Queen Elizabeth

Isa Browijoyo
Indonesian society of internal medicine

University of Indonesia

Sebelas Maret University, Moewardi General Hospital

HOSPITAL SULTANAH AMINAH JOHOR BAHRUOda medical clinic

medical faculty hasanuddin University, makassar,
south sulawesi, Indonesia

medical faculty, hasanuddin university, makassar,
south sulawesi, Indonesia

Faculty of Medicine University of Indonesia

Mohammad Hoesin General Hospital / Medical
Faculty, Sriwijaya University Palembang

Chungna National University Sejong Hospital

Kornchanok Vareesangthip
Renal Division, Department of Medicine, Faculty of
Medicine, Siriraj Hospital, Mahidol University, Thailand

I Wayan Nariata
University of Indonesia

Poster Exhibition
Sherzod Abdullaev

P-748

The first case of successful pregnancy and natural birth in a dialysis patientin Uzbekistan

P-749

Defying Death: A Survival Case Report on Infective Endocarditis in a
43-Year-Old Female with Chronic Kidney Disease

Kelvin Kenn Magdaraog

P-750

A Case Report of Chronic Kidney Disease Patient and Morbus Hansen with
Second Degree Disability

Asticha Erlianing Sari

P-751

Unusual Complication of Continous Ambulatory Peritoneal Dialysis:
Multiple Cholelithiasis with Peritonitis

Devinda Villarsi

P-752

A Case Report Of Enterococcus Casseliflavus Peritoneal Dialysis-Associated
Peritonitis

Sze Mun Tan

P-753

Successful Repair of Tunnel-Type Blood Dialysis Catheter Leur Interface
Leakage: A Case Report

Xiaoxia Gu

P-754

Spontaneous Retroperitoneal Bleeding In Haemodialysis Patient: Series Of
Unfortunate Events.

Suryati Yakob

Republican specialized scientific and practical
medical center of nephrology and kidneytransplantation

Remedios Trinidad Romualdez Hospital

Sebelas Maret University

Faculty of Medicine, Universitas Sumatera Utara,
Indonesia

Hospital Queen Elizabeth

Nurse

Clinical Research Center

Interventional Nephrology
Board No.

P-756

Title

Presenting Author

Comparison between the Frequency of Interventional Procedures for Flowrelated Dysfunction in Tapered Grafts and Straight Grafts: Analysis Basedon the Korean National Health Insurance Database from 2011 to 2018

Jin Ha Jang
Hallym University Sacred Heart Hospital

P-757

Endovascular Treatment of Chronic Superficial Chronic Total Occlusion
Lesions in the Cubital Fossa in Hemodialysis Patients with Radiocephalic
AVF

P-758

Radiation Exposure Levels in Vascular Access Interventions by Interventional Sangeon Gwoo
Lifeline Clinic
Nephrologists

P-759

Patency Rates of Arteriovenous Fistula Created Endovascularly in Singapore Shi Yun Tan

P-760

Clinical evaluation of Drug Coated Balloon; DCB for frequently repeatedvascular access stenosis

Masayuki Itakura

P-761

Effect Of Desmopressin In Reducing Post Kidney Biopsy Bleeding
Complications In Patients With Reduced Renal Function

Uttayan Chakrabarti

P-762

Desmopressin Reduces Bleeding Risk after Percutaneous Kidney Biopsy: A
Randomized Controlled Study

Deependra Yadav

P-763

Establishment and Evaluation of a Comprehensive Interventional
Nephrology Fellowship Program

In Soo Kim

P-764

The utility of post-angioplasty brachial artery flow rates to predict clinicallysignificant AVF stenosis.

Yi-Ting Ong

Sangeon Gwoo
Lifeline Clinic

Singapore General Hospital

114

Vascular Access Treatment Center, Kaikoukai Central
Clinic, Kaikoukai Healthcare Corporation

All India Institute of Medical Sciences Jodhpur

Sanjay Gandhi Post Graduate Institute of Medical
Sciences

Hallym University Sacred Heart Hospital

Singapore General HospitalPoster Exhibition
P-765

Nationwide Survey Reveals Encouraging Arteriovenous Fistula Prevalence
for Hemodialysis in Nepal

Nabin Bahadur Basnet

P-766

A case report and review of available literature in the utility of a transhepatic hemodialysis access in end stage renal disease

Earnest Caiser Dela Cruz

P-767

A Comparative Analysis of Tunneled Hemodialysis Catheter Exchange via
Over-the-Guide-Wire and De Novo Approaches

Hyeran Park

P-768

Comparative Analysis of Predictive Criteria for Unassisted Maturation of
AVF Using Post-Operative Ultrasound Measurement: UAB vs NKF-KDOQI

Seung Yun Chae

P-769

Role of renal vascular coordinator on access flow dysfunction: A quality
improvement initiative on improving patency rate and reducing urgent
interventions

P-770

Functional differences depending on right or left insertion of femoral veincatheterJi Yong Hwang

P-771

Immediate and Short-term Outcomes of Endovascular Thrombectomy ofArteriovenous Access with Vacuum-assisted Thrombectomy Device

Yi Lin Ong

P-772

Clinical Outcomes of Tunneled Central Venous Hemodialysis Catheter inVery Elderly Patients

Seyoung Ryou

P-773

Clinical Study on the Effect of Arterial-fistula Diameter Ratio of
Hemodialysis Fistula on Secondary Patency Rate after PTA

P-774

the Stent Graft Viabahn Has the Better Patency Rate Than by Arteriovenous
Graft Replacement (Comparison of Two Treatments for Frequent Stenosis
Near the Venous Side Anastomosis after Operation)

P-775

Ultrasound-guided Thrombolysis for Thrombotic Occlusion of the AVF
Using the CHAMELEON PTA Balloon Catheter: A Case Report

Toshihide Naganuma

P-776

Doppler Ultrasound Evaluation for Proximal Artery Occlusive Disease in a
Hemodialysis Patient with Recurrent Thrombosis

Huiyun Jung

P-777

Compartment syndrome induced by outflow venous stenosis in ahemodialysis patient with Brachiobrachial forearm U loop AVG

Sangeon Gwoo

P-778

Diagnosis of Volume Insufficiency Presenting as Painful Arteriovenous
Fistula During Hemodialysis by Point-of-Care Ultrasound

P-779

Renal Abscess Caused by Klebsiella Pneumoniae in Patient with Diabetic
Kidney Disease

Hana Indriyah Dewi

P-780

A Bullet In My Heart

Yusuf Abu Shamsi

P-781

Clinical and Blood Flow Improvement in Chronic Kidney Disease Patient on
Hemodialysis with Central Venous Stenosis after Angioplasty Procedure: aCase Report

Arlentina Bentivolia Simamora

National Kidney Centre, Nepal

Baguio General Hospital and Medical Center

The Catholic University of Korea Seoul St. Mary's
Hospital

The Catholic University of Korea Seoul St. Mary's
Hospital

Allen Yan Lun Liu
Khoo Teck Puat Hospital

Yeungnam University Medical Center

Singapore General Hospital

The Catholic University of Korea Seoul St. Mary's
Hospital

Xuyang Luo
Department of Nephrology, School of Medicine,
Sichuan Academy of Medical Sciences, Sichuan
Provincial People's Hospital, University of Electronic
Science and Technology of China, Chengdu, Sichuan

Junichi Iida
Vascular Access Center, Tomakomai Nissho Hospital

Osaka Metropolitan University

Hallym University Sacred Heart Hospital

Lifeline Clinic

Eunjung Kim
Dongtan Sacred Heart Hospital

dr. Moewardi Hospital

Hospital Canselor Tuanku Muhriz

115

Universitas Brawijaya

Poster Exhibition
P-782

A case of successful PTA using the Rendezvous technique in a patient withtotal occlusion of the basilic vein and cephalic vein

Heeryong Lee

P-783

Use of Focused Cardiac Ultrasound to Verify the Tip Location of Central
Venous Catheter During Hemodialysis

Eunjung Kim

P-784

Artificial blood clot removal that overcomes 3 hurdles (arterial puncture
pseudoaneurysm, apex stent-graft, venipuncture pseudoaneurysm)

Heeryong Lee

P-785

The Target Urine Volatile Organic Compounds Biosensor Platform for
Genitourinary Malignancy Detection

Vichayut Suthat Na Ayutaya

LEESIN HEMODIALYSIS AND INTERVENTION CLINIC

Dongtan Sacred Heart Hospital

LEESIN HEMODIALYSIS AND INTERVENTION CLINIC

Institute of Medicine, Suranaree University ofTechnology

Diabetic Kidney Disease + Metabolic Abnormality-related Kidney Disease
Board No.

P-786

Title

Presenting Author

Inhibition of PCSK9 attenuates renal lipotoxicity by activating the AMPKPGC-1a-FoxO3a signaling in diabetic kidney disease

Yu Ah Hong
The Catholic University of Korea Daejeon St. Mary's
Hospital

P-787

The Impact of Dynamic Kidney Function prior to Sodium-Glucose CoTransporter 2 Inhibitor Initiation on Following Renal Function Progression
In Type 2 Diabetes Patients

P-788

Efficacy Of Finerenone In Asian Patients With Type 2 Diabetes And Chronic
Kidney Disease: A FIDELITY Analysis

Amaninder Mann

P-789

Targeted Anti-IL-1beta Bacteroides fragilis Outer Membrane Vesicles
Alleviate Inflammatory Injury in Diabetic Nephropathy

Liang Li

P-790

Trajectories in blood glucose and the incidence of chronic kidney disease : a Hee Won Park
Chungnam National University Hospitalnationwide population-based study

P-791

5-lipoxygenase inhibition ameliorates diabetic kidney disease byattenuating renal tubular epithelial cell ferroptosis

Min Heui Ha

P-792

Antihypertensive effects of endothelin receptor antagonists on a diabetic
nephropathy-induced SDT fatty rat with hypertension

Takahiro Shirozu

P-793

Causal Effect of Kidney Function on Lipid Metabolism: an Integrated
Population-scale Observational Analysis and Mendelian Randomization
Study

P-794

Genome-wide DNA methylation association study identify DNA
methylation associated with end stage renal disease

P-795

Safety Outcomes Of Finerenone In Asian Patients With Type 2 Diabetes And Satoshi Yamashita
Bayer Yakuhin, Ltd.
Chronic Kidney Disease: A FIDELITY Analysis

P-796

Exploring causal association between circulating inflammatory cytokinesand diabetic nephropathy: A bidirectional Mendelian randomization study

P-797

Copper Oxide Nanoparticles as Antioxidants: Alleviating Kidney Injury andPromoting Autophagy Flux in a Cellular Model of Palmitate-Induced Lipid
Accumulation

116

Yen-Chen Chiu
Kaohsiung Medical University

Bayer Pharmaceuticals Pvt Ltd

Institute of Nephrology, Zhong da Hospital, School of
Medicine, Southeast University

CHA Bundang Medical Center

Fujita Health University

Minsang Kim
Seoul National University Hospital

Xiaohong Zhou
Guangdong General Hospital

Xu Li
Peking University People's Hospital

Eun Kyung Kim
Konyang University HospitalPoster Exhibition
P-798

Elucidating Asprosin's Role as an Intracellular Metabolism Regulator in
Diabetic Kidney Disease

Yaeni Kim

P-799

Spatially Resolved Transcriptomics Profiling for Glomerular andTubulointerstitial Gene Expression in Human Diabetic Kidney DiseaseJae-ik Oh

P-800

Total Kidney Volume as a Risk Factor of Outcomes in Diabetic Kidney
Disease (DKD)

Masashi Mizuno

P-801

Dapagliflozin Alleviates Diabetic Kidney Disease via Hypoxia Inducible
Factor 1/Heme Oxygenase 1-Mediated Ferroptosis

Yihui Wang

P-802

Machine learning-based utilization of lipid panels improves thepredictability of kidney dysfunction

Soie Kwon

P-803

Urinary proteome profiling reveals complement cascade as a progressor oftype 2 diabetic kidney disease

Donghwan Yun

P-804

A virtual diagnosis of diabetic nephropathy using proteomics in place ofkidney biopsy

Da Woon Kim

P-805

Causal effect of gut microbiota and diabetic nephropathy: a Mendelianrandomization study

P-806

Clinical implications of diabetic retinopathy in patients with histologicallydiagnosed diabetic nephropathy

P-807

Low interstitial fluid glucose among type 2 diabetes patients with chronic
kidney disease; a concern despite appropriate glycated haemoglobin
targets

P-808

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 685509,
a Soluble Guanylate Cyclase Activator, in Healthy Chinese and Japanese
Males: a Randomised, Single-Blind, Placebo-Controlled Multiple Rising
Dose Trial

P-809

HDAC8 inhibition ameliorates hypertension by inhibiting sympathetic
nervous system and angiotensin II

P-810

Association Analysis between Extracapillary Hypercellularity, Segmental
Sclerosis and Clinical Features of Diabetic Kidney Disease

Shanzhi Yang

P-811

Proteomic analysis of urinary extracellular vesicles in patients of diabetic
kidney disease

Donghyeong Lee

P-812

Associations between Markers of Inflammation and Mitochondrial
dysfunction with Continuous Glucose Monitoring (CGM) metrics in Diabetes Jack Ng
The Chinese University of Hong Kong
Kidney Disease

P-813

A Combined Study of Renal Lipidome in db/db Mouse using LC-MS/MS andImaging Mass Spectrometry

Hyun Ji Lim

P-814

Kidney biopsy can help to predict renal outcomes of patients with type 2
diabetes

Taehoon Oh

117

The Catholic University of Korea Seoul St. Mary's
Hospital

Seoul National University Hospital

Nagoya City University

Peking University First Hospital

Chung-Ang University Hospital

Seoul National University Hospital

Pusan National University Hospital

Ganyuan He
Guangdong Provincial People's Hospital (Guangdong
Academy of Medical Sciences), Southern Medical
University

Dong Eon Kim
Pusan National University Hospital, Pusan

Jason Choo
Singapore General Hospital

In-Jin Jang
Seoul National University Hospital

Gwan Beom Lee
Keimyung University School of Medicine

Guangdong Provincial Peoples Hospital

Soonchunhyang University

Kyung Hee University

Soon Chun Hyang University Cheonan HospitalPoster Exhibition
P-815

Machine Learning Prioritizes the Development of Novel 1,3,5-TriazineUdaya Pratap Singh
Thiazolidinedione Hybrids as Protective Agent Against Diabetic Nephropathy Sam Higgibottom University of Agriculture,
Technology and Scienes
in Rats via Hypoglycemic Effect and Activating Nrf-2/Ho-1 Pathway

P-816

The association of longitudinal trajectories of metabolic clusters and therisk of major adverse kidney events

P-817

Association of NAFLD with Cardiovascular and Kidney Outcomes in Patients
Cheol Ho Parkwith Chronic Kidney Disease G3-G4: A Nationwide Cohort Study of South
Severance Hospital
Korean Adults

P-818

Osteoactivin and PlGF levels are correlated with renal dysfunction inpatients with diabetic chronic kidney disease

Hyeongwan Kim

P-819

Clinicopathological predictors of rapid kidney function decliners withbiopsy-proven diabetic kidney disease in type 2 diabetes

Yiyang Zhao

P-820

Targeting N-Acetyltransferase 10 with Remodelin Ameliorates Renal
Oxidative Stress in Diabetic Mice

So Young Lee

P-821

Clinical Outcomes for Newly Diagnosed Diabetes Patients in Korea: A
National Health Insurance Data

Samel Park

P-822

The Impact of Alkaline Phosphatase on All-Cause Mortality in Patients with
Diabetic Kidney Disease: A Multi-Nation Retrospective Cohort Study

Yaerim Kim

P-823

Comparative Treatment Effects of Dapagliflozin and Empagliflozin on
Kidney Outcomes in Type 2 Diabetes Patients: A Retrospective MultiInstitutional Study

I-Ning Yang

P-824

Non-alcoholic fatty liver disease is associated with microalbuminuria
in Korean patients using the Korea national health and nutritional
examination survey data

Han Jak Ryu

P-825

The Association of Sodium Intake with Chronic Kidney Disease Using
Ansan-Ansung Cohort Study

Chanyoung Park

P-826

Promoter Genetic Variants Of ELMO-1 rs rs13242914 as risk for Diabetic
Kidney Diseases in Jambi Malayan Ethic, Indonesia.

Namira Amanda G

P-827

Predicting risk factor of worsening kidney function in elderly Veteran
population according to glycemic status

Jin Seon Jeong

Mei-Yi Wu
Shuang Ho Hospital

Chonbuk National University Hospital

Peking University First Hospital

The Catholic University of Korea Yeouido St. Mary's
Hospital

Soon Chun Hyang University Cheonan Hospital

Keimyung University Dongsan Medical Center

Division of Nephrology, Department of Internal
Medicine, Chi Mei Medical Center, Tainan, Taiwan

Catholic Kwandong University International St. Mary's
Hospital

Korea University

Mitra Hospital Jambi

VHS Medical Center

Sherzod Abdullaev
Republican specialized scientific and practical
medical center of nephrology and kidneytransplantation

P-828

Effect of SGLT2 Inhibitors on Anemia and Inflammation In CKD

P-829

Case Report: Multiple Pulmonary Thromboembolisms Following Permanent So Min Lee
Chosun University Hospital
Catheter Insertion in Anti-Phospholipid Syndrome

P-830

UCP1 regulates cardiolipin metabolism and mediates mitochondrial
homeostasis maintenance of ANXA1 in diabetic nephropathy

Zihan Li

P-831

Clinical implication of peri-renal fat on the kidney function in patients withearly diabetic kidney disease

Da Woon Kim

118

Peking University First Hospital

Pusan National University HospitalPoster Exhibition
P-832

Exploring the Relationship Between Socioeconomic Status and CKD
Progression in DM Nephropathy Patients Treated at a Tertiary Center

Seonmin Kim

P-833

Onset of Diabetes And Hypertension And Risk of End-stage Kidney Disease
in Nationwide Adult Cohort With Coexisting Diabetes And Hypertension

Kyungho Lee

P-834

Transmembrane protein 72, expressed in the distal convoluted tubule, may
play a potential role in diabetic kidney disease

Weiting He

P-835

Intensive uric acid-lowering improved renal outcomes in type 2 DM withchronic kidney disease: a multicenter, retrospective, real-world cohort
study

Weiting He

P-836

immunological inflammatory markers in Diabetic Nephropathy:
Correlations with Clinical Outcomes and Diagnostic Utility

Xiaohui Sun

P-837

Nogo-B may mediate the glomerular endothelial cell injury of hypertensive
nephropathy by enhancing the inflammatory phenotype

P-838

Deficiency of GADD45a Expression Mediated Tubulointerstitial Injury in
Diabetic Nephropathy

Xueqi Li

P-839

Predictive factors of non-diabetic kidney disease in patients with Type 2
diabetes mellitus and kidney disease

Pin Hui Ho

P-840

Clinical Characteristics of Non-albuminuric Kidney Disease Compared withAlbuminuric Kidney Disease in Patients with Type 2 Diabetes

Bancha Satirapoj

P-841

The Impact of SGLT-2is' Effects on Cardiovascular Outcomes Among AdultCKD Patients

Ching-Wen Chiu

P-842

Prevalence of Chronic Kidney Disease in Adults with Type 2 Diabetes
Mellitus in Mongolia

Suvd Bukhbat

P-843

Urinary Cystatin C as a Potential Risk Marker for Predicting Kidney
Outcomes in Type 2 Diabetes Mellitus

Bancha Satirapoj

P-844

Risk factors of chronic kidney disease incidence as per data from the
National Health Insurance Corporation in Korea : focus on patients withdiabetes

P-845

Total kidney volume and albuminuria in youth with type 1 and type 2
diabetes

Emily Sell

P-846

Nogo-B promotes endoplasmic reticulum stress-mediated autophagy inendothelial cells of diabetic nephropathy

Shanzhi Yang

P-847

Role of cystatin C in the development and progression of heart failure inpatients with diabetes mellitus

Volha Vasilkova

P-848

Role of histopathological findings in predicting rapid Progression of
Biopsy-proven Diabetic kidney disease

119

Soonchunhyang University Bucheon Hospital

Samsung Medical Center, Sungkyunkwan University
School of Medicine

Guangdong Provincial Peoples Hospital, Guangzhou,
China.

Guangdong Provincial Peoples Hospital, Guangzhou,
China.

The First Affiliated Hospital of Zhengzhou University

Shanzhi Yang
Guangdong Provincial Peoples HospitalSoutheast University

Lee Kong Chian School of Medicine

Phramongkutklao Hospital

Taipei Medical University

Intermed Hospital

Phramongkutklao Hospital

Ho Joon Ko
Chungnam National University Hospital

Section of Endocrinology, Department of Pediatrics,
University of Colorado School of Medicine

Guangdong Provincial Peoples Hospital

Gomel State Medical University

Mohan V Bhojaraja
Department of Nephrology, Kasturba Medical
College, Manipal, Manipal Academy of Higher
Education, Manipal, Karnataka, India

Poster Exhibition
P-849

Correlation between Urine TGF- Levels and Decreased in Kidney Function
in Type-2 Diabetes Mellitus Patients: A Non-Invasive Marker Candidate.

Elfiani Elfiani

P-850

Diabetic nephropathy aggravation prevention program in the Ise city of
Mie Prefecture, Japan

Takahiro Onishi

P-851

Exploring the Association Between Peripheral Blood Monocytes andPrevalence of Diabetic Kidney Disease in diabetes mellitus: Analysis of the
NHANES 2005-2016

P-852

Non-invasive Prediction Tool Of Non-diabetic Kidney Diseases In Patients
With Type-2 Diabetes Mellitus Derivation and Validation

Vamsidhar Veeranki

P-853

Obesity as a Key Predictor of Chronic Kidney Disease in Adults A Comprehensive Systematic Review and Meta-Analysis

Jessica Novia Hadiyanto

P-854

High Parathyroid Hormone Associated with Lower Calcidiol Serum in
Pre-dialysis Diabetic Kidney Disease Patients

Ardityo Rahmat ArdhanyP-855

Evolution of Mitochondrial Dynamics in progression of Diabetic Kidney
Diseases

Ankita Singh

P-856

Prevalence of microalbuminuria in patients with Diabetes mellitus type II

Tsatsral Erdenebayar

P-857

DIABETIC KIDNEY DISEASE WITH MULTIPLE INFECTION, MULTIPLE
ANTIMICROBIAL RESISTANCE, AND GERIATRIC SYNDROME: A CASE REPORTEvi Nurhayatun

P-858

A case of chronic kidney disease and dyslipidemia caused byhypothyroidism

P-859

Right kidney pseudotumor and glomerulo-nephritis type Focal Segmental
Glomerulo Sclerosis in a patient with type 2 diabetes

P-860

Mixed Hearing Loss in Diabetic Kidney Disease and Post-Tuberculosis Lung
DiseaseP-861

Rare Case Report: A Challenging Case of Pulmonary TB with Rifampicin
Resistant, DKD Stage V Dialysis, Type 2 Diabetes Mellitus and Heart Failure
Patients

P-862

Potential Diagnostic Role of Serum Activin A Level in Patients with Chronic
Kidney Disease: A Meta-analysis

Rukesh Yadav

P-863

Association of high triglyceride-glucose index with the development ofdiabetic nephropathy: a meta-analysis

Neil David Cayanan

P-864

Correlation between the Triglyceride Glucose (TyG) index and Diabetic
Kidney Disease in Patients with Type-2 Diabetes Mellitus

Rizki Fajar Utami

P-865

Association between the quantity and quality of abdominal fat depots andsolid organ assessed by computed tomography and metabolic syndrome
severity score

P-866

Prognostic value of hemoglobin concentration on renal outcomes withdiabetic kidney disease: A retrospective cohort study.

120

Sriwijaya University

Ise Red Cross Hospital

Zhu Wenjuan
The University of Hong Kong - Shenzhen Hospital

Assistant Professor

Diponegoro University

Dr. Soetomo General Academic Hospital, Faculty of
Medicine, Universitas Airlangga, Surabaya

SGPGIMStegsh mend Hospital

Department of Internal Medicine, Faculty of Medicine,
Universitas Sebelas Maret

Yun Ji Lee
Ajou University Hospital

Rery Tf Yuniarti
UNIVERSITAS SRIWIJAYA

Teodorus Tomy Saputra
Sebelas Maret University - Moewardi Hospital

Aspuri Sekartika Dien
dr. Moewardi Regional Hospital of Surakarta

Maharajgunj Medical Campus, Institute of Medicine,
Tribhuvan University, Nepal 44600

Angeles University Foundation

Yogyakarta State University

Kootae Park
Soon Chun Hyang University Seoul Hospital

Weiting He
Guangdong Provincial Peoples Hospital, Guangzhou,
China.

Poster Exhibition
Renal Conservative Care + Geriatric Nephrology + Sarcopenia
Board No.

P-867

Title

Presenting Author

Development of Dialysis Patient Exercise Therapy Support System I-Proposal for the Continuation of Exercise Therapy-

Tokuo Umeda

P-868

Genetic Evidence Unveils a Causal Link Between Kidney Damage andFrailty: Implications for Targeted Interventions

Sumin Wu

P-869

Muscle Mass as a Predictor of Mortality in Autosomal Dominant Polycystic
Kidney Disease Patients

Dha Woon Im

P-870

Role of NRF2 in Adenine-induced CKD Model with Sarcopenia

Min Jee Jo

P-871

Mildly to moderate impairment of renal function and cardiovascular or
kidney outcomes in an older population

Junseok Jeon

P-872

1,25-Dihydroxyvitamin D is Independently Associated with Sarcopenia in
Patients with Pre-dialysis Chronic Kidney Disease

Kyu Won Jang

P-873

The association of the combination of handgrip strength andcardiorespiratory fitness with incident chronic kidney disease: A UK biobank Keonhwa Kim
Severance Hospitalobservational study

P-874

CD25+ Tregs are associated with cardiac remodeling and prognosis in older
patients with chronic kidney disease

P-875

The subtype of sarcopenia and physical frailty, cachexia in older patients
undergoing hemodialysis: A preliminary, observational study in Japanese
dialysis facilities

P-876

Differential Composition of CT-derived Visceral and Subcutaneous Fat inSarcopenic Chronic Kidney Disease Patients

P-877

The impact of skeletal muscle mass on BMD in ESRD patients initiating
hemodialysis

Hwajin Park

P-878

Development of Dialysis Patient Exercise Therapy Support System II -Trial
Production of Function to Promote Continuation of Exercise Therapy-

Akiko Okawa

P-879

Socioeconomic Disparities in the Relationship Between Chronic Kidney
Disease and Mental Health in Indonesian Households

Rodhiah Umaroh

P-880

The Impact of Body Mass Index on Mortality in Accordance with Age in
Hemodialysis Patients: Data from Korean Renal Data System (KORDS)

Hyunglae Kim

P-881

Preferences for DNR and Hospice in Patients with End-Stage Renal Disease:
A Preliminary Report

Chan-Shiuan Kuo

P-882

Long-Term Renal Prognosis In Urologic Cancer Patients After Nephrectomy

Suk Min Chung

121

Former Kitasato University

The Seventh Affiliated Hospital, Sun Yat-sen
University

Uijeongbu Eulji Medical Center, Eulji University

Korea University Guro Hospital

Samsung Medical Center, Sungkyunkwan University
School of Medicine

Pusan National University Yangsan Hospital

Ganyuan He
Guangdong Provincial People's Hospital (Guangdong
Academy of Medical Sciences), Southern Medical
University

Masakazu Saitoh
JUNTENDO UNIVERSITY

Seok-hyung Kim
Chuncheon Sacred Heart Hospital

The Catholic University of Korea Daejeon St. Mary's
Hospital

Mie Prefectural College of Nursing

Faculty of Economics and Business, Universitas
Pembangunan Nasional Veteran Yogyakarta

The Catholic University of Korea St. Vincent's Hospital

National Taiwan University Hospital, Taipei

Korea University Anam HospitalPoster Exhibition
P-883

Use of Colchicine and Adverse Cardiovascular Events in Patients with Gout:
A Nationwide Nested Case-control Study in South Korea

Hyung Woo Kim

P-884

Sleep problems in adults with chronic kidney disease: a scoping review ofsystematic reviews

Ginger Chu

P-885

Renal insufficiency was associated with a higher incidence of hip fracture,
but not vertebral fracture.

Sungmin Kim

P-886

Association between CKD and frailty, nutritional status, and cognitive
impairment and their impact on clinical outcome

P-887

DOES THE GLOMERULAR FILTRATION RATE ESTIMATED BY SERUM CYSTATINC TRULY DECREASE IN GERIATRIC PATIENTS WITH DIABETES?

Thanh-Tam Tran-Thai

P-888

Assessing FGF-23 Gene Expression in Anemic Chronic Kidney Disease: A
Biomarker Perspective

Henkie Isahwan Ahmad Mulyadi Lai

P-889

Assessing the Impact of Rooftop Gardens on the Quality of Life of Kidney
Transplant Recipients in Urban Environments

P-890

Challenges in the Shadows: Invasive Fungal Infections in Geriatric Chronic
Kidney Disease Patients

Archit Goel

P-891

Purple Urine Bag Syndrome in an Elderly Female with Cerebrovascular
DiseaseKatrina Pattaguan

Severance Hospitalnurse academic

Korea University Guro Hospital

Yoomee Kang
Gyeongsang National University Changwon Hospital

Can Tho University of Medicine and Pharmacy

University College MAIWP International

Sahnaz Vivinda PutriInternational University Semen Indonesia

All India Institute of Medical Sciences Bathinda

Veterans Memorial Medical Center

Fluid, Electrolyte and Acid-base Disorder
Board No.

P-892

Title

Presenting AuthorInteraction of the miR-466-699 clusters and Wnt signaling in cellproliferation of the aldosterone-sensitive distal nephron

Hyo-Ju Jang

P-893

Clinical impacts of the fluid protocol and the overcorrection of preexisting
hyponatremia in critically ill patients receiving continuous renal
replacement therapy

Hojin Jeon

P-894

Association between urine sodium to potassium ratio and control ofhypertension in Korean Adults: From the Korea National Health andNutrition Examination Survey 2007 to 2020

P-895

Validating the Effectiveness of Masked Autoencoder for Dyskalemia
Detection from Electrocardiograms

P-897

Reliability Comparison between a Large Language Model and Nephrologist So Young Lee
The Catholic University of Korea Yeouido St. Mary's
in Analyzing Acid-Base Disorders in Critically Ill Patients
Hospital

P-898

Comparison and Evaluation between second-generation PTH assay and LCMS/MS for PTH

P-899

Chronic Kidney Disease Patients' Acceptance and Adherence to Oral
Sodium Bicarbonate - a Malaysian Experience

122

Kyungpook National University, School of Medicine

Samsung Medical Center, Sungkyunkwan University
School of Medicine

Jongin Choi
Haenam Woori Hospital

Jung Nam An
Hallym University Sacred Heart Hospital

Min-Sun Kim
Soon Chun Hyang University Cheonan Hospital

Jaime Yoke May Chan
Universiti Kebangsaan Malaysia, Kuala Lumpur,
MalaysiaPoster Exhibition
P-900

Sodium Bicarbonate Supplementation may be Harmful in Septic patientswith Severe Lactic Acidosis: a Retrospective Analysis.

P-901

Novel Genetic Variants in Koreans causing Gitelman Syndrome

P-902

Transitional Care for Chronic Kidney Disease with Fluid Overload: from
Hospital to Home

P-903

24-hour Urinary Mineral Excretion and Its Developmental Trajectory andLongitudinal Changes in Relation to Renal Deterioration in Patients with
CKD

Xinru Guo

P-904

A Case of Type I Renal Tubular Acidosis with Type I Diabetes Mellitus

Lucky Joy Alcabedos

P-905

CASE REPORT OF GENETICALLY CAUSED SEVERE HYPOKALEMIA

P-906

An Interesting Case of Mineralocorticoid Deficiency and Progressive Kidney Hye Jun Lee
Wonkwang University School of Medicine & Hospital
Insufficiency after Unilateral Adrenalectomy

P-907

A Solution to Continuous Kidney Replacement Therapy in a Background of
Hyponatremia with Limited Technical Support: A Case Series

P-908

Loss of Consciousness after Ingestion of an Oral Sulfate Tablet for Bowel
Preparation for Colonoscopy

Min Seok Shin

P-909

Hiccup-Induced Syndrome of Inappropriate Antidiuretic Hormone
Secretion Leading to Severe Hyponatremia

Sunmin Lee

P-910

Use of Tolvaptan in the Management of Tumor Lysis Syndrome in a patient Abigayle Therese Guiritan
diagnosed with Myelofibrosis with Acute Myeloid Leukemia transformation St. Luke's Medical Center Quezon City

P-911

A case of Gitelman syndrome with SLC12A3 gene mutation

P-912

Hypokalemic Periodic Paralysis due to Distal Renal Tubular Acidosis: Case
Report in A Female Adult

P-913

Refractory Hypokalemia Periodic Paralysis in Type 1 Renal Tubular Acidosis

P-914

A Rare Case of a 34-Year old Filipino Male with Sporadic Gastric Spindle Cell
Carcinoma presented with Diabetes Insipidus

Hazel Ann Gianelli Cu

P-915

Hypokalemic periodic paralysis and renal tubular acidosis in autoimmune

Department of Internal Medicine, Faculty of Medicine,
University of North Sumatra, Medan, Indonesia

P-916

A 72-year-old Woman with Metabolic Acidosis, Acute Kidney Injury, and
STEMI Complications : A Rare Case of Liquid Rodenticide Intoxication

P-917

Leontiasis Ossea - A Case Report on Sagliker Syndrome in a 55-Year-Old
Female123

Dong Eun Yang
Dong-A University HospitalJi Won Lee
Konyang University Hospital

Zhihua Huang
Singapore General Hospital

Medical School of Nankai University

Ospital ng Maynila Medical Center

Janibek Baimurat
State Second Central Hospital

Kuan Yee Lim
Nephrology Unit, Department of Medicine, Hospital
Canselor Tuanku Muhriz, Faculty of Medicine,
Universiti Kebangsaan Malaysia

Soon Chun Hyang University Cheonan Hospital

Hanyang University Guri Hospital

Yi-An Huang
China Medical University, Taiwan

Edy Nur Rachman
Universitas Sriwijaya

Yohanna Fransisca Sinuhaji
Faculty of Medicine, Universitas Sumatera Utara,
Indonesia

St Luke's Medical Center

Muhammad Fikri

Melinda Didi Yudhanti
Yogyakarta Regional General HospitalFrances Eunice AlcoberRemedios Trinidad Romualdez HospitalPoster Exhibition
P-918

The third-day blood lactate levels and APACHE III are important forpredicting mortality in intensive care patients: Analysis from Physionet
data

P-919

Revealing Silent Polyuria in Pregnancy : from Refractory Hypokalemia andHypomagnesemia to a Challenging Diagnosis of Diabetes Insipidus

124

Wonsuk An
Dong-A University Hospital

Putri Ardiyanti
Brawijaya University, Internal Medicine Department

Sponsors & Exhibition
Sponsors List
DIAMOND

PLATINUM

WHITE GOLD

GOLD

125

SILVER

BRONZESUPPORTER

126

Exhibition Layout
Date

Operating Hours

June 13 (Thu)

10:00-17:00

June 14 (Fri)

08:00-17:00

June 15 (Sat)08:00-17:00

June 16 (Sun)08:00-10:30

Exhibition

127

LocationHall D (3F)

No.

CompanyNo.

Company

1Astellas Pharma Korea

28

AY Trading Co.,Ltd2

Hanmi Pharmaceutical Co., Ltd.

29

MS MEDICAL

3

Boehringer Ingelheim Korea / Lilly Korea

30

JW Pharmaceutical

4

Chong Kun Dang Pharm.

31

Sanofi5

Vera Therapeutics

32

Daiichisankyo

6

SK Chemicals

33

Transonic (HAJOO)

7DAEWON

34

Firson Healthcare

8

Astrazeneca Korea

35

National Hospice Center

9

VUNO Inc.

36

George Clinical

10

BORYUNG37

QuidelOrtho

11

Organon Korea

38

Jiangxi Sanxin Medtec Co., Ltd

12

HANDOK

39

MECOBI

13

Yuhan

40

Gyeongju Hwabaek Convention Center (HICO)

14

Korea Otsuka Pharm.

41

KOONJA

15

Fresenius Medical Care

42

HealthBreeze

16

KYOWA KIRIN43

VITALLINK

17

NIPRO

44

Rgenorgano Biotechnology

18

Bayer

45

Panmun Education

19

Baxter46

Fresenius Kabi Korea

20

HK inno.N

47

Roche Korea

21

The Korea United Pharm48

Pfizer22

ALVOGEN KOREA

49

Dow Biomedica Inc.

23

Synopex Inc.

50

B. Braun Korea

24

ROKIT HEALTHCARE

51

Everest Medicines Korea

25

Modunuri HealthCare

52

Kwangdong

26

EATMAPL

53

Novartis Korea

27

Samjin Pharm

54

Bain Medical/BL Korea

Professional Societies' Corner
Join us at the APCN & KSN 2024 Congress for the "Professional Societies' Coner", held alongside the exhibition for affiliatednephrology societies. This dedicated space will feature participation from various esteemed organizations, including theInternational Society of Nephrology (ISN) and the International Society for Peritoneal Dialysis (ISPD). Take advantage of thisunique opportunity to learn more about these societies and explore potential collaborations within the nephrology community.

128

Industry Symposium
June 13 (Thu) 12:30-13:30 | ROOM 02 (GBR 103)
Chair(s)Eun Young Seong (Pusan National University Hospital)
Ki Ryang Nah (Chungnam National University Hospital)

Speaker(s)Optimal Comorbidity Management for CV Protection in Hypertensive
Patients With Dyslipidemia
Hyun Suk Kim (Hallym University Chucheon Sacred Hearth Hospital)
Ideal Treatment Option to Manage LDL-C in CKD PatientsJi Yong Jung (Gachon University Gil Medical Center)
Discussion

June 13 (Thu) 12:30-13:30 | ROOM 03 (GBR 104-105)
Session Title: Targeting the Source of IgA Nephropathy: Focus on BAFF and APRIL Pathways
Chair(s)Adrian Liew (Mount Elizabeth Novena Hospital)
Sydney Tang (The University of Hong Kong)

Speaker(s)Introduction
Adrian Liew (Mount Elizabeth Novena Hospital)
Overview of the Pathogenesis and The Role of Cytokines BAFF and APRIL
in IgAN
Sydney Tang (The University of Hong Kong)
Atacicept: Investigative Therapies Targeting BAFF and APRIL
Adrian Liew (Mount Elizabeth Novena Hospital)
Q&A

June 13 (Thu) 12:30-13:30 | ROOM 04 (201)
Chair(s)Seungyeup Han (Keimyung University Dongsan Medical Center)

Speaker(s)What Is the Optimal Tacrolimus Trough Level to Maintain Renal Functionin Transplant Recipients?
Hanbi Lee (The Catholic University of Korea, Seoul St. Mary's Hospital)

June 14 (Fri) 12:00-13:00 | ROOM 01 (GBR 101-102)
Chair(s)Kwon Wook Joo (Seoul National University Hospital)

Speaker(s)Clinical Implications of Uremic Toxins and AST-120
Ran-hui Cha (National Medical Center)

129

June 14 (Fri) 12:00-13:00 | ROOM 02 (GBR 103)
Chair(s)Yong-Lim Kim (Kyungpook National University Hospital)

Speaker(s)The Future of PD: PD in 2024 and Beyond
Rajnish Mehrotra (University of Washington School of Medicine)
Remote Monitoring, Maximizes Patient Management | Sharesource &MyPD
Yong Chul Kim (Seoul National University Hospital)

June 14 (Fri) 12:00-13:00 | Room 3 (GBR 104-105)
Chair(s)Eun Hui Bae (Chonnam National University Hospital)

Speaker(s)Uremic Toxins as a Potential Therapeutic Target for Kidney, Heart, andBeyondJwa-kyung Kim (Hallym University Sacred Heart Hospital)

June 14 (Fri) 12:00-13:00 | ROOM 04 (201)
Chair(s)Ho Sik Shin (Kosin University Gospel Hospital)

Speaker(s)Nafamostat as an Anticoagulant on CRRT
Jung Nam Ahn (Hallym University Sacred Heart Hospital)

June 15 (Sat) 12:00-13:00 | ROOM 01 (GBR 101-102)
Chair(s)Masaomi Nangaku (The University of Tokyo Graduate School of Medicine)

Speaker(s)Opening Remarks
A Time to Act: How Early Identification of CKD in T2D Improves
Outcomes
Sung Gyun Kim (Hallym University Sacred Heart Hospital)
MRAs in 2024: Still All the Same?
Rajiv Agarwal (Indiana University School of Medicine)
The Ripple Effects: How NS-MRAs’ Unique Mechanisms are Driving
Clinical Benefits
Rajiv Agarwal (Indiana University School of Medicine)
From Bench to Practice: The Clinical Application of NS-MRAs in theManagement of CKD in T2D
Minghui Zhao (Peking University First Hospital)
Q&A and Closing Remarks

130June 15 (Sat) 12:00-13:00 | ROOM 02 (GBR 103)
Session Title: Individualized Care for Patients Undergoing Dialysis At-Home and In-Center:
The Right Therapy, Right Place, Right Time
Chair(s)Bum Soon Choi (The Catholic University of Korea, Eunpyeong St. Mary's Hospital)

Speaker(s)Home Dialysis: Empowering Patients at Home: Why, Who and How?
Yeoungjee Cho (Princess Alexandra Hospital)
The CONVINCE Study: Recognizing the Benefits of High-Volume
Hemodiafiltration for Enhanced Patient Outcomes
Bernard Canaud (Montpellier University)

June 15 (Sat) 12:00-13:00 | ROOM 03 (GBR 104-105)
Chair(s)Yong-Lim Kim (Kyungpook National University Hospital)

Speaker(s)A New Era of Calcimimetics in Asia
Masafumi Fukagawa (Tokai University)

June 15 (Sat) 12:00-13:00 | ROOM 04 (201)
Chair(s)Yon Su Kim (Seoul National University Hospital)

Speaker(s)Online HDF vs Super High Flux HD
Hideki Kawanishi (Tsuchiya General Hospital)

131

Exhibitor Spotlight
Exhibitor spotlight is theater presentations held in Exhibition Hall.
Exhibitors will be conducting one-hour sessions during the exhibit hall hours to meet with attendees and discuss an array of topics.

JUNE 14 (FRI) 09:00-09:30 | Exhibition Hall (HALL D, 3F)
Speaker(s)The role of dual BAFF/APRIl inhibition in autoimmune glomerulonephritis
Jonathan Barratt (University of Leicester)June 14 (Fri) 10:00-11:00 | Exhibition Hall (HALL D, 3F)
Chair(s)Bum Soon Choi (The Catholic University of Korea, Eunpyeong St. Mary's Hospital)

Speaker(s)A disease-modifying effect in the treatment of IgA nephropathy
Jonathan Barratt (Leicester General Hospital)

June 14 (Fri) 11:00-12:00 | Exhibition Hall (HALL D, 3F)
Chair(s)Sung Gyun Kim (Hallym University Sacred Heart Hospital)

Speaker(s)Beyond Glucose Control: Empagliflozin in Renal Management
Janani Rangaswami (George Washington University School of Medicine)

June 14 (Fri) 13:10-14:10 | Exhibition Hall (HALL D, 3F)
Chair(s)Eun Hui Bae (Chonnam National University Hospital)

PANER(S)PANEL DISCUSSION
Evidence-based Strategies for Optimized CKD Management in Patientswith T2D
Non-steroidal MRA in Clinical Pratice: Who, When and How?
ASK THE EXPERTS
Practical Considerations in the Management of Patients with CKD and
T2D with Non-steroidal MRAs
Rajiv Agarwal (Indiana University School of Medicine)
Wenpeng Cui (Bethune Second Hospital of Jilin University)
Yingyos Avihingsanon (Chulalongkorn University)132June 15 (Sat) 10:00-11:00 | Exhibition Hall (HALL D, 3F)
Chair(s)Duk-Hee Kang (Ewha Womans University Seoul Hospital)

Speaker(s)ADPKD introduction and Clinical implication of Tolvaptan
Hyunsuk Kim (Hallym University Chuncheon Sacred Heart Hospital)

June 15 (Sat) 11:00-12:00 | Exhibition Hall (HALL D, 3F)
Speaker(s)Recent recommendations for management of ANCA-associated vasculitis
Tae Hyun Ban (The Catholic University of Korea, Eunpyeong St. Mary's Hospital)

June 15 (Sat) 13:10-14:10 | Exhibition Hall (HALL D, 3F)
Speaker(s)Trends and Prospects of AI-medical devices leveraging Bio-signals
Sunghoon Joo (VUNO Inc. CTO), Seokhun Lim (VUNO Inc. CSO)

133

Creating a future worth living.
For patients. Worldwide. Every day.
services for individuals with renal diseases of which around 4.1 million
patients worldwide regularly undergo dialysis treatment. United by a sharedpurpose of creating a future worth living for chronically and critically ill people,
we care for more than 332,000 dialysis patients around the globe. Theirwell-being always comes first.

Korea office: Fresenius Medical Care Korea Ltd.
(07320) 14F, FKI Tower, 24 Yeoui-daero, Yeongdeungpo-gu, Seoul, Republic of Korea · Phone: +82 2 2146-8800
www.freseniusmedicalcare.kr
Document Number : KR-Misc-000001© 2024 Fresenius Medical Care Deutschland GmbH

Fresenius Medical Care is the world’s leading provider of products andMyPD Patient Mobile App
Your link to all your PD patients
MyPD is a patient mobile app that expands the proven clinical benefits of Sharesource
remote patient management (RPM) to all-APD and CAPD-patients

REMOTE MONITORING

KO-RC42-240015

Access To Accurate Data
Through The Sharesource Platform

A Better Choice ofHyperphosphatemia
Treatment

References 1. Lee, et al. J Nephrol. 2015;28(1):105-113. 2. Ganz T, et al. Drugs. 2019;79(9):957-968.

NEPHOXIL® Capsule 500mg (Ferric citrate hydrate) product information summary

11F, Asia Tower, 430, Nonhyeon-ro, Gangnam-gu, Seoul, 06223, Korea
TEL +82-2-3471-4321 https://www.kyowakirin.com/kr/

KR403-2312NEPHOX-AD04[DOSAGE FORMS AND STRENGTHS] Capsule: Ferric citrate hydrate 500mg (equivalent to 105mg ferric iron) [INDICATION] For the control of hyperphosphatemia in adult patients with chronic kidney disease undergoing hemodialysis [DOSAGE AND ADMINISTRATION] The recommended starting dose of Nephoxil is 4 g/day with a maximum dose of 6 g/day and should be taken three times daily with meals or immediately after meals.
During the treatment, the dose should be adjusted based on the concentration of serum phosphorus, 1 g (2 capsules) daily per increment or decrement, until serum phosphorus concentration reaches the target range;
and afterwards regular monitoring should be maintained and dose adjustments should be made at intervals of one week or more. [WARNING] Accidental overdose of iron-containing products in children under six yearsof age may lead to fatal poisoning. This drug should be stored in a place not accessible to children. In case of accidental overdose, please contact a doctor or medical organization immediately. [CONTRAINDICATION] 1)
Patients with hypophosphatemia 2) Patients who are allergic to ferric citrate 3) Patients with abnormal iron metabolism or symptoms of excessive iron e.g. hemochromatosis. For further information, please refer to thelatest prescribing information at https://nedrug.mfds.go.kr

For healthcare professional

For patients with CKD in T2D
A different pathway leads to different possibilities1,2

RENAL INFLAMMATION AND FIBROSIS

are associated with deterioration of kidney function and eventual ESKD.3-6
For patients with CKD and T2D, even with well controlled blood pressure and glycemic management,
they are still at risk of CKD progression

CKD: chronic kidney disease; ESKD: end-stage kidney disease, T2D: type 2 diabetes
References: 1. Duckworth W, ea al; VADT investigators. N Engl J Med. 2009;360(2):129-139. 2. The ACCORD Study Group. N Engl J Med. 2010;362(17): 1575-1585. 3. Tesch GH, et al. Front Pharmacol. 2017;8:313.
dol:10.3389/fphar. 2017. 00313. 4. Alicic RZ, et al. Clin J Am Soc Nephrol. 2017;12(12):2032-2045. 5. Toth-Manikowski S, et al. J diabetes Res. 2015:2015:697010. doi:10. 1155/2015/697010. 6. Black LM, et al. J
Histochem Cytochem. 2019;67(9):663-681.

Kerendia® 10 mg

Kerendia® 20 mg
Kerendia® Product Information
For more detailed product information, please refer to the full product leaflet linked by QR code or the Bayer website, http://www.bayer.co.kr If you would like to report an adverse
event or quality- related complaint, please contact your healthcare professional (e.g., physician or pharmacist), the Korea Ministry of Food and Drug Safety or the Korea Instituteof Drug Safety & Risk Management. You can also report to Bayer Korea website: http://www.bayer.com/ko/kr/k orea-contact-us/

Bayer Korea Ltd.
108, Yeoui-daero, Yeongdeungpo-gu, Seoul (Parc1, Tower2) (zip code 07335)
Tel. 02-829-6600 http://www.bayer.co.kr I PP-KER-KR-0096-1

만성콩팥병 환우의 더 건강한 삶을 위해 ‘옳은 일’ 을 합니다.

신장의 한 수요독배출에는 크레메진 속붕정크레메진 속붕정은 연하곤란 및 수분섭취가 제한된 만성콩팥병 환우분들을 위해소량의 물로 입안에서 빠르게 풀어져 복용이 편리합니다.
전문의약품[제품명] 크레메진 속붕정 [성분 및 함량] 1정 중 구형흡착탄 500mg [효능·효과] 만성신부전(진행성)에 대한 요독증 증상의 개선 및 투석 도입의 지연[용법·용량] 성인 1일 3회, 1회 구형흡착탄 2g(4정) 복용 [사용상의 주의사항] 1. 다음 환자에는 투여하지 말 것 - 소화관 통과 장애가 있는 환자 (배설에 지장을 초래할 염려가 있다.)※ 기타 자세한 사항은 제품설명서를 참고하십시오.

에이치케이이노엔주식회사
충청북도 청주시 흥덕구 오송읍 오송생명 2로 239 ┃ 서울지사: 서울특별시 중구 을지로 100 파인에비뉴 6,7,8층 ┃ 080-700-8802 ┃ www.inno-n.com

자세한 복약안내와 설명은
QR코드로 확인하세요.

서울시 종로구 대학로12길 31, 6층
T. 02-762-3444

만성 콩팥병 환자의 혈청 인 조절제1대조약과 혈중 P, Ca, Ca x P, iPTH, Bicarbonate,
Lipid profile 유의한 차이 없음 입증2

3

D 상
C
E
이
O 국 매4개 판0가
3
허【제품명】 인벨라정(세벨라머탄산염) 【원료약품 및 그 분량】 이 약 1정 중 인벨라정 유효성분: 세벨라머탄산염(별규)…800mg 【효능·효과】 1. 투석을 받고 있는 만성 신장질환환자의 혈청 인 조절 2. 투석을 받고 있지 않은 만성 신장질환 환자 중 혈청 인 농도가 5.5 mg/dl 이상인 환자의 혈청 인 조절 【용법·용량】 이 약은 1일 3회 식사와 함께복용하여야 한다. 1) 인산결합제를 복용하고 있지 않는 환자에 투여하는 경우 (중략)•혈청인 5.5~7.5mg/dL: 1회 1정, 1일 3회 식사와 함께 복용•혈청인 7.5mg/dL 이상: 1회 2정,1일 3회 식사와 함께 복용 (후략) 【사용상의 주의사항】 1. 다음 환자에는 사용하지 말 것: 1) 이 약의 주성분 및 부형제에 과민한 환자 2) 저인산혈증 환자 3) 장폐색 환자(이 약은장관내에서 팽윤하여 장관천공을 일으킬 우려가 있다.) 2. 다음 환자에게는 신중히 투여할 것: 장관협착 또는 변비가 있는 환자(이 약은 장관 내에서 팽윤하여 장폐색, 장관 천공을일으킬 우려가 있다.) 【제조자】 Synthon Hispania SL Castello 1 Poligono Las Salinas 08830 Sant Boi de Llobrgat, Barcelona Spain 【소분제조자】 에스케이케미칼(주) 충청북도청주시 흥덕구 산단로 149 【판매자】 에스케이케미칼(주) 경기도 성남시 분당구 판교로 310
2023.09.20 개정※ 처방하시기 전 제품설명서 전문을 참고하십시오. 최신 허가사항에 대한 정보는 ‘식품의약품 안전처 의약품안전나라 (https://nedrug.mfds.go.kr/index)’에서 확인할 수 있습니다.
References 1. 의약품안전나라, 의약품등 정보검색(검색어: 인벨라정). Available at https://nedrug.mfds.go.kr/searchDrug. Accessed on 1 of Nov 2023. 2. [Data on file] 인벨라정 3상임상결과보고서. SK케미칼. 2013
OECD. OECD member countries. Available at http://www.oecd.org/about/ Accessed on 1 of Nov 2023. 4. [Data on file] Worldwide registrations of sevelamer carbonate 800mg film-coated tablets. Synthon 2023

3.

INV-HA05-202312-05

인벨라정제품요약정보1

Astellas,
only PROgraf

Prograf Cap.
1mg

Prograf Inj.
5mg프로그랍캡슐0.5, 1밀리그램(타크로리무스수화물), 프로그랍주사액5밀리그람(타크로리무스수화물)수입자: 한국아스텔라스제약㈜, 서울특별시 강남구 테헤란로 521, 파르나스타워 7층

MAT-KR-PRO-2023-00095

Prograf Cap.
0.5mg

Targeting the Sourceof IgA Nephropathy:
Focus on BAFF and APRIL
Pathways
Thursday June 13, 2024
12:30–13:30 KST
Room 3 (GBR 104-105)
CO-CHAIRS
Adrian Liew, MD

Senior Consultant Nephrologist & Director
The Kidney and Transplant Practice, Mount Elizabeth Novena Hospital, Singapore

Sydney Tang, MBBS, MD, PhD

Chair of Renal Medicine, Yu Professor in Nephrology, Hon. Consultant (Medicine)
Deputy Chairperson, Department of Medicine, University of Hong Kong
President, Asian Pacific Society of Nephrology

AGENDA
Overview of the Pathogenesis and the Role of
Cytokines BAFF and APRIL in IgA Nephropathy
Emerging Disease-Modifying Therapies Targeting
BAFF and APRIL
Q&A© 2024 Vera Therapeutics, Inc.

CKD 환자의 질환 치료를 위해

1,2미쎄라 와 렌벨라 가한독으로 하나가 되었습니다.
®

®

체내 흡수 및 축적되지 않는
2,4비칼슘계열 인결합제CKD 환자의
안정적인 Hb level1,3관리를 위해미쎄라 프리필드주

렌벨라정(세벨라머탄산염)미쎄라®의 제품정보는 QR코드를 통해확인하시기 바랍니다.
(문헌개정년월일 2023.05.08)

렌벨라정의 제품정보는 QR코드를 통해확인하시기 바랍니다(문안개정년월일 2023.06.20).

Ⓡ

CKD, chronic kidney disease; Hb, hemoglobin(주)한독 서울시 강남구 테헤란로 132
TEL 02-527-5114 FAX 02-527-5001
www.handok.co.kr(주)한국로슈 서울특별시 서초구 서초대로 411,17층 (서초동, 지티타워(이스트)) (우: 06615)
TEL: 02) 3451-3600 FAX: 02) 561-7201(주)사노피-아벤티스 코리아서울특별시 서초구 반포대로 235 (반포동)Tel .02)2136-9000 Fax. 02)2136-9099

KR.SEV.23.08.03

References 1. 미쎄라®프리필드주 국내허가사항 (as of 2023-08-08) 2.렌벨라®정 국내허가사항 (as of 2023-08-08) 3. Locatelli F, et al. Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with
Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials. Adv Ther. 2016;33(4):610-625. 4. Rodríguez-Osorio L, et al. Use of sevelamer in chronic kidney disease: beyond phosphorus
control. Nefrologia. 2015;35(2):207-217.

Additional control
Hyperglycaemia※ Not an actual patient.
※ The tablet size is different from the actual size.

Original Linagliptin

7

Original Empagliflozin(linagliptin) 5mg tablets

Empagliflozin and Linagliptin in a Single Pill Combination strategy
encompasses these considerations both as initial or add-on therapy for T2DM.4
FDC includes empagliflozin* and linagliptin, which provide cardio-renal
benefits.5-7

Trajenta®
Product
information

Jardiance® 10mg
Product
information

Jardiance® 25mg
Product
information

Esgliteo® 10/5mg
Product
information

Esgliteo® 25/5mg
Product
information

PC-KR-104273,(2024.02)※ Promotional material made for HCPs, this material is prohibited from any unauthorized alteration or copying and distribution.
Empagliflozin is not indicated for the reduction of cardiovascular events and kidney disease in patients with type 2 diabetes with cardiovascular disease. Empagliflozin is not indicated for the reduction of
kidney disease in patients with chronic heart failure. Chronic heart failure and chronic kidney disease indication is only for Empagliflozin 10 mg.
Linagliptin is not indicated for the reduction of cardiovascular or renal events*Study outcomes in EMPA-REG OUTCOME- CARDIOVASCULAR OUTCOMES: The primary composite outcome: death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. The key secondary composite outcome: theprimary outcome plus hospitalization for unstable angina.
- GLYCEMIC CONTROL
T2DM, type 2 diabetes melitus; FDC, fixed dose combination.
References 1. DeFronzo RA, et al. Diabetes Care. 2015;38:384–393. 2. Søfteland E et al. Diabetes Care 2017; 40(2): 201-209. 3. Tinahones FJ et al. Diabetes Obes Metab, 2017;19(2):266–274. 4. Esgliteo®
Product information. 5. Zinman, M.D., et,al. N Engl J Med. 2015; 373:2117-2128. 6. Rosenstock J, et al., JAMA. 2019;321:69-79. 7. Rosenstock J, et al. JAMA. 2019;322(12):1155-1166.

보건의료전문가용

Patients with aHUS can be at continuous
risk of the life-threatening consequences of
unpredictable complement-mediated TMA1,2Chronic, uncontrolled complement activity in aHUS leads to ongoing endothelial
injury, organ damage, and sudden death2,3

aHUS, atypical Hemolytic Uremic Syndrome; TMA, Thrombomicroangiopathy
References: 1. Laurence et al. Atypical Hemolytic Uremic; Essential Aspects of an Accurate Diagnosis. Clin Adv Hematol Oncol. 2016 Nov;14 Suppl 11(11)2-15. 2. Legendre, C. M. et al. Terminal Complement Inhibitor
Eculizumab N Engl J Med N Engl J Med 2013;368 2169-81. 3. Noris et al. STEC HUS, atypical HUS and TTP are all, Nat. Rev. Nephrol. 2012 8, 622 633
prescribing information전문의약품[성분·함량] 1바이알(30mL)중 유효성분 : 에쿨리주맙(별규) 300mg 첨가제 : 염화나트륨, 인산수소나트륨 칠수화물, 인산이수소나트륨수화물, 주사용수, 폴리소르베이
트80 [효능·효과] 1) 발작성 야간 혈색소뇨증(PNH : Paroxysmal Nocturnal Hemoglobinuria): 용혈을 감소시키기 위한 발작성 야간 혈색소뇨증(PNH : Paroxysmal
Nocturnal Hemoglobinuria) 환자의 치료. 수혈 이력과 관계없이, 높은 질병 활성을 의미하는 임상 증상이 있는 환자의 용혈에 임상적 이익이 확립되었다. 2) 비정형 용혈성요독 증후군(aHUS : atypical Hemolytic Uremic Syndrome): 보체 매개성 혈전성 미세혈관병증을 억제하기 위한 비정형 용혈성 요독 증후군(aHUS : atypical Hemolytic
Uremic Syndrome) 환자의 치료 (사용제한: 시가(Shiga) 톡신 생성 대장균에 의한 용혈성 요독 증후군(STEC-HUS) 환자 대상의 적용을 권장하지 않는다. 3) 시신경 척수염범주 질환(Neuromyelitis optica spectrum disorder): 항아쿠아포린-4(AQP-4) 항체 양성인 환자의 시신경 척수염 범주 질환(NMOSD : Neuromyelitis optica spectrum
disorder)의 치료 [용법·용량] 심각한 감염에 대한 위험을 줄이기 위해서 환자들은 최신의 백신 접종 지침(Advisory Committee on Immunization Practices(ACIP) recommendations)에 따라 백신 접종을 해야 한다.(사용상의 주의사항 1. 경고 항 참고) 이 약은 정맥투여되어야 하며 급속정맥투여(IV push) 또는 일시정맥투여(IV bolus)로
투여해서는 안된다. <성인> 1) 발작성 야간 혈색소뇨증(PNH) - 첫 4주간은 매 7일마다 600 mg을 투여한다. 네 번째 용량 투여 7일 후에 다섯 번째 용량으로 900 mg을 투여하고, 그 후부터는 매 14일마다 900 mg을 투여한다. 이 약은 권장 투여량과 일정에 맞게 투여, 혹은 예정된 일정의 2일 전/후로 투여 되어야 한다. 2) 비정형 용혈성 요독증후군(aHUS) 및 시신경 척수염 범주질환(NMOSD) - 첫 4주간은 매 7일마다 900 mg을 투여한다. 네 번째 용량 투여 7일 후에 다섯 번째 용량으로 1200 mg을 투여하고,그 후부터는 매 14일마다 1200 mg을 투여한다. <소아> 1) 비정형 용혈성 요독증후군(aHUS) 만 18세 미만의 aHUS 환자일 경우, 체중에 따라 다음의 일정으로 투여한다.
[표 1] 만 18세 미만 환자에서의 권장 투여법환자 체중
40 kg 이상30 kg이상 40 kg 미만
20 kg 이상 30 kg 미만
10 kg 이상 20 kg 미만
5 kg 이상 10 kg 미만초기 용량
4 주간 매 7일마다 900 mg 투여2주간 매 7일마다 600 mg 투여2주간 매 7일마다 600 mg 투여첫 주에 600 mg 투여첫 주에 300 mg 투여유지 용량5주차에 1200 mg, 이후 매 14일마다 1200 mg 투여
3주차에 900 mg, 이후 매 14일마다 900 mg 투여
3주차에 600 mg, 이후 매 14일마다 600 mg 투여2주차에 300 mg, 이후 매 14일마다 300 mg 투여2주차에 300 mg, 이후 매 21일마다 300 mg 투여이 약은 권장 투여량과 일정에 맞게 투여, 혹은 예정된 일정의 2일 전/후로 투여되어야 한다. <혈장교환요법 및 신선 동결혈장투여시>성인 및 소아 비정형 요독증후군과 성인 시신경 척수염 범주질환 환자에 대해 PE/PI(혈장 교환 요법(plasma exchange 또는 plasmapheresis), 또는 신선 동결 혈장 투여(fresh frozen plasma infusion))와 같은 부수적 시술을 받는 경우 추가 용량 투여가 필요하다. [표 2] PE/PI 이후 이 약의 추가적 투여법부수적 시술의 종류혈장 교환 요법(plasma exchange orplasmapheresis)신선 동결 혈장 투여(fresh frozen plasma infusion)최근 사용한 이 약의 용량
300 mg부수적 시술 시 이 약의 추가 투여 용량혈장 교환 요법 시행시마다 300 mg씩

600 mg 또는 그 이상혈장 교환 요법 시행시마다 600 mg씩

300 mg 또는 그 이상신선 동결 혈장 투여 시마다 300 mg씩

추가 투여 시점혈장 교환 요법 이후 60분 이내신선 동결 혈장 투여 60분 이전[사용상의 주의사항] 1. 경고 중대한 수막구균 감염: 작용기전으로 인하여 이 약의 사용은 중대한 수막구균 감염(패혈증 그리고/또는 뇌수막염)에 대한 환자의 감수성을 증가
시킨다. 이 약의 투여 환자에게서 치명적이고 생명을 위협하는 수막구균 감염이 발생하였다. 수막구균 감염은 어느 혈청군에 의해서도 발생할 수 있지만, 이 약의 투여 환자들은 흔하지 않은 혈청군(X 등)에 의한 질환이 발생할 수 있다. 감염의 위험성을 낮추기 위하여, 이 약의 치료가 지연됨으로 인한 위험성이 수막구균 감염 발생의 위험성보다 큰경우를 제외하고는 모든 환자들은 반드시 이 약의 투여 시작 최소한 2주 전에 수막구균 백신을 투여 받아야 한다. 만약 접종 받지 않은 환자가 긴급히 이 약의 치료를 받아야하면, 최대한 빨리 수막구균 백신을 투여 받도록 한다. 수막구균 백신 접종 이후 2주 이내 이 약을 투여할 경우, 4가 수막구균 백신 접종 이후 2주 동안 적절한 예방적 항생요법으로 치료 받아야 한다. 흔한 병원성 수막구균 혈청군을 예방하기 위하여 가능하다면 혈청군 A, C, Y, W135, B에 대한 백신이 권장된다. 환자들은 백신 사용을 위한 최신의백신 접종 지침(Advisory Committee on Immunization Practices(ACIP) recommendations)에 따라 백신을 접종 혹은 재접종 받아야 한다. 백신 접종은 보체를 더욱 활성화시킬 수 있다. 결과적으로, PNH, aHUS, 불응성 gMG 및 NMOSD를 포함한 보체 매개 질환을 가진 환자들은 용혈(PNH의 경우)이나 혈전성 미세혈관병증(TMA; aHUS의 경우) 또는 중증 근무력증의 악화(불응성 gMG의 경우)또는 재발(NMOSD의 경우)과 같은 그들의 기저 질환의 징후 및 증상이 증가하는 경험을 할 수 있다. 따라서, 지침에 따른백신 접종 이후 질환의 증상에 대해 면밀히 관찰되어야 한다. 백신 접종은 수막구균 감염 위험을 줄일 수 있지만, 완전히 없애지는 않는다. 적절한 항생제 사용에 대한 공식 지
침(예: 국내 성인 세균성 수막염의 임상진료지침 권고안 등)을 고려하여야 한다. 수막구균 감염의 초기 징후나 증상이 나타나는지 면밀히 관찰하고, 감염이 의심되면 즉시 검사받아야 한다. 환자는 이러한 징후와 증상 및 즉시 치료를 받는 절차에 대해 안내 받아야 하며, 담당 의사는 반드시 환자와 이 약의 치료의 위험과 이익을 상의하여야 한다. 수막구균 감염은 초기에 발견하고 치료하지 않으면 급격히 치명적이고 생명을 위협하게 될 수 있다. 중대한 수막구균 감염을 치료받는 환자는 이 약의 투여를 중지하도록 한다.
2. 다음 환자에는 투여하지 말 것 1) 이 약의 주성분, 뮤린 단백질 또는 기타 구성성분에 과민반응이 있는 환자 2) 치료되지 않은 중대한 수막구균(Neisseria meningitidis)감염 환자 3) 수막구균(Neisseria meningitidis) 백신을 현재 접종하지 않은 환자 또는 백신 접종 이후 2주 동안 적절한 예방적 항생요법으로 치료를 받지 않은 환자(이 약의 치료를 늦추는 것이 수막구균 감염을 일으키는 것보다 중대하지 않은 경우) 개정년월일: 2024년 02월 13일 ※ 보다 자세한 사항은 제품설명서 전문을 참고하시기 바
랍니다. aSOL20240213

KR-16193 l Exp. 2026-04(Prep. 2024-04)한 국 아 스 트 라 제 네 카 서울 강남구 영동대로 517 아셈타워 21층 전화: (02)2188-0800 팩스:(02)2188-0852

022026-KMT-24-468402

Healthcare Professionals Only
Ethical drug

The 1st released
Calcium polystyrene
sulfonate agent
in Korea1,*

The most
prescribed
treatment agent forHyperkalemia
in Korea2
Threeformulations
developed inconsideration oftaking convenience(Powder/Granule/
Suspension)1

Treatment agent forHyperkalemia

KALIMATE
Powder / Granule / Suspension

REFERENCES
1. KalimateⓇ Powder, Granule, Suspension product information, Available at:https://nedrug.mfds.go.kr/searchDrug (accessed 18 Jan 2024).
2. Based on IQVIA MAT 3Q 2023, V03G
* KalimateⓇ Powder is the 1st released calcium polystyrene sulfonate agent in 1984 in Korea, through the licensing with the originator,
Nikken(now Kowa) from Japan.
* Based on IQVIA MAT 3Q 2023, V03G (Oral administration)수입자 (카리메트®현탁액)

7th Floor, Yeongdongdae-ro 302, Gangnam-gu, Seoul, Korea, 06177
Tel : +82-80-851-4800

KalimateⓇ Powder

KalimateⓇ GranuleKalimateⓇ Suspension판매자 (카리메트® 산/과립/현탁액)5F, GT TOWER, 411, Seocho-daero, Seocho-gu, Seoul, Korea, 06615
Tel : +82-2-2047-7700

Comfortable Dialysis to patients
Easy Operation to Medical Staff
Safety and Reliability for Treatment

%BJJDIJ 4BOLZP $P -5%<೐‫߄ۄ‬झఋ౯ա౟‫>ܬ‬ড֙੄৉ࢎܳ૑‫۽߄ݫצ‬஘>㈅㉙ス@ ), JOOP/<౸‫ݒ‬ਗ><ҕ‫ز‬౸‫ݒ‬ਗ>֙ਘੌ

P23-136-2025.06-V11[References] 1. Endo, Akira. “A historical perspective on the discovery of statins.” Proceedings of the Japan Academy. Series B, Physical and biological sciences vol. 86,5 (2010): 484-93. doi:10.2183/pjab.86.484
2. Kishida, Y et al. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan vol. 111,9 (1991): 469-87. doi:10.1248/yakushi1947.111.9_469

CKD 진행 지연 3,4만성콩팥병의 진행을지연시키는 단백아미노산제제

1,2

투석 시작 연기 3,4,5
대사이상 개선 3,5

1. Aparicio M et al. Semin Dial. 2013 Nov-Dec;26(6):714-9. 2. Am J Nephrol 2005;25(suppl 1):1–28. 3. Mircescu G et al. J Ren Nutr. 2007 May;17(3):179-88. 4. Garneata L et al. Nephrology Dialysis Transplantation 2019;34; doi.org/10.
1093/ndt/gfz096.FO012. 5. Garneata L et al. J Am Soc Nephrol. 2016 Jul;27(7):2164-76.

KETO-2024-04 (EXP 01/01/2025)[성상] 긴 타원형의 광택이 있는 황색 필름 코팅정[원료약품 및 그 분량] 총량: 1정 중 800밀리그램(총 칼슘으로서 49.7밀리그램, 1정 중 총 질소함량 36밀리그램), L-히스티딘(EP)38.0밀리그램, α-케토-DL-이소류신칼슘(DL-3-메틸-2-옥소-발레르산칼슘)(별규)67.0밀리그램,α-케토류신칼슘(4-메틸-2-옥소-발레르산칼슘)(별규)101.0 밀리그램, L-트립토판(EP)23.0밀리그램, α-히드록시 -DL-메티오닌칼슘(DL-2-히드록시-4-메틸티오-부티르산칼슘)(별규)59.0밀리그램, L-티로신(EP)30.0밀리그램, L-리신아세트산염(L-리신으로서 75밀리그램)(EP)105.0밀리그램, L-트레오닌(EP) 53.0 밀리그램, α-케토페닐알라닌칼슘(2-옥소-3-페닐-프로피온산칼슘)(별규)68.0밀리그램, α-케토발린칼슘(3-메틸-2-옥소-부티르산칼슘)(별규)86.0밀리그램.
[첨가제] 포비돈,퀴놀린황색E104,탈크,이산화티탄E171,삼초산글리세롤(트레아세틴),스테아르산마그네슘,콜로이드성이산화규소,크로스포비돈,마크로골6000,옥수수전분,염기성부틸레이티드메타아크릴레이트공중합체
[효능·효과] 성인 기준으로 1일 식이 단백섭취량이 40g 이하로 제한되어 있는 만성 신부전환자에서 불완전한 단백질 대사로 인한 손상감소[용법·용량] 통상적으로 70kg 성인을 기준으로 저단백식이(단백질 0.3-0.4g/kg/day)와 병용하여, 1회 4-8정씩, 1일 3회 식사 중에 씹지 말고 그대로 복용한다.
[사용상의 주의사항] 1. 다음 환자에는 투여하지 말 것 가. 고칼슘혈증 환자 나. 아미노산 대사 장애 환자 다. 이 약의 성분에 대해 과민반응을 보이는 경우 라. 페닐케톤뇨증 대사 장애가 있는 경우(이 약에는 페닐알라닌이 함유되어 있음) 2. 이상반응 2.1 이상반응 가.
고칼슘혈증: 고칼슘혈증이 나타날 수 있으므로 이런 경우에는 비타민 D의 섭취를 줄인다. 만약 고칼슘혈증이 지속된다면 이 약과 다른 칼슘원의 양을 줄인다. 나. 소화기장애: 드물게 상복부 불쾌감이 나타날 수 있다. 2.2 국내 시판 후 조사 국내에서 재심사를 위하여 6년
동안 638명의 환자를 대상으로 실시한 시판 후 조사 결과 이상반응의 발현 증례율은 인과관계와 상관없이 2.19%(14명/638명,19건)로 보고되었다. 이 중 약물과의 인과관계를 배제할 수 없는 이상반응 발현율은 1.25%(8명/638명, 13건)이며 다음과 같다. 소화불량,오심이 각 0.47%(3명/638명)로 가장 많았으며, 변비, 복통이 각 0.31%(2명/638명),구토, 설사, 두통이 각 0.16%(1명/638명)로 나타났다. 예상하지 못한 약물 이상반응은 소화불량, 오심이 각 3건, 변비, 복통이 각 2건, 구토, 설사, 두통이 각 1건씩으로 보고되었다. 3.
다른 약제와의 상호작용 가. 이 약과 다른 칼슘함유 제제를 병용했을 때 혈청 칼슘 농도가 증가되거나 강화될 수 있다. 나. 이 약을 투여하여 혈액 칼슘 농도가 올라가면 강심배당체의 작용을 증가시켜 심장 리듬 장애 위험을 증가시킬 수 있다. 다. 이 약 투여 중 혈청 인산농도가 감소하므로 인산결합제(예, 수산화알루미늄)의 용량을 줄여야 한다. 라. 칼슘과 결합하는 약물들(예, 테트라사이클린, 시프로플록사신, 노르플록사신과 같은 항생제, 철분, 불소, 에스트라머스틴 함유 제제)의 흡수를 방해하지 않기 위해서, 이 약과의 병용 시 적어도
2시간 이상의 간격을 두어야 한다. 마. 이 약 이 외 다른 약물을 복용하고 있는 경우에는 담당 의사 및 약사에게 알려 상담한다. 4. 소아, 임부 및 수유부에 대한 투여 소아, 임부 및 수유부에 투여한 경험은 없다. 5. 적용상의 주의사항 가. 저단백식이와 병용하여 복용할 것.
나. 단백질 섭취의 저하는 에너지 섭취의 저하를 일으키므로 35kcal/kg/day와 동등하거나 그 이상 되는 높은 열량섭취를 유지해야 한다. 다. 고칼슘혈증의 위험이 있으므로 혈청 칼슘농도가 정기적으로 모니터링 되어야 한다. 라. 이 약은 아미노산과 관련한 적절한흡수와 대사를 위해 식사 중에 복용되어야 한다. 6. 보관상의 주의사항 가. 영유아의 손이 닿지 않는 곳에 보관한다. 나. 25℃를 넘지 않는 온도에서 보관한다. 다. 포장 개봉 후에도 습기를 피해 건조한 곳에 보관한다.
[저장방법] 기밀용기, 25℃ 이하에서 보관

Certican,advance transplantation outcomes tomorrow

2-4

References. 1. 써티칸�정. 식품의약품안전처. 의약품안전나라 의약품통합정보시스템 (https://nedrug.mfds.go.kr). 2. Eisen HJ, et al. Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial. Am J Transplant.
2013;13(5):1203-16. 3. Saliba F, et al. Renal function at two years in liver transplant patients receiving everolimus: Results of a randomized, multicenter study. Am J Transplant. 2013;13(7):1734–1745. 4. Tedesco-Silva H Jr., et al. Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients. Am J Transplant. 2010;10(6):1401-13.

KR2301127089

Hemodialysis

Transonic HD03
Hemodialysis Monitor®

“Gold Standard”Surveillance

The battery-operated, portable HD03 Monitor& Flow/dilution Sensors Measure:k Delivered Blood Flowk Vascular Access Recirculationk Vascular Access Flow
Measurements take less than 5 minutes per patient.
Results are displayed immediately on the Monitor.

1,386648902330
3,395

2022 Sep13

PP-RAP-KOR-0023-21SEP2024

2022.06.10

2,080[최초품목허가일] 2006.03.25 (1 mg), 2009.8.31 (2 mg), 2012.07.30 (0.5 mg) [최종변경허가일] 2022.06.10

Throughout our history, we have always been
focused on solving healthcare’s most complex
challenges. We advance science so that we all
have more time with the people we love.
www.roche.com(주)한국로슈
서울특별시 서초구 서초대로 411, GT tower (East) 빌딩17층(06615) Tel. 02.3451.3600 https://roche.co.kr

M-KR-00002636

Extraordinary
medicine requires
extraordinaryscience.

George Clinical is the
Global Kidney CRO
Science. Service. Solutions.

Scientific ExpertiseFounded in Asia-Pacific and driven by scientificexpertise and operational excellence, George ClinicalFacilitated by a kidney site network considered to be
one of the strongest in the world, especially in theis a leading, global clinical research organization
with more than 500 people in 40 locations able to

Asia Pacific region, George Clinical owns an enviable
position as a trusted partner in kidney and metabolic

manage clinical trials in 70 geographies throughout the
Asia-Pacific region, USA and Europe. As therapeutic
specialists in kidney and metabolic, oncology,

clinical research around the globe. Our scientificexpertise collaborates with sponsors to develop new
strategies for the prevention and management ofneuroscience, endocrinology, vascular and respiratory,
our unmatched scientific leadership provides the full

kidney and metabolic disease specifically including
dialysis, chronic kidney disease (CKD), focal segmental

range of clinical trials services to pharmaceutical,
medical device and diagnostic customers for all trial
phases, registration and post-marketing trials.

glomerulosclerosis (FSGS), diabetic kidney disease,acute kidney injury and IgA nephropathy as well as theutility of genetics in drug development and discovery.

At a GlanceGeorge Clinical leverages the in-depth expertise of

Global network of distinguishedscientific leaders with expertisein chronic disease.
Leading Asia-Pacific full service
CRO with global capabilities
tested over more than 20 years.
Driver of the Global Kidney Patients
Trials Network (GKPTN) which
accelerates kidney research into practice.
Access to the Clinical Research Network(CRN) infrastructure supporting clinicalresearch in the UK and European Union.

our scientific leadership to design effective studies,select the best sites from more than 20 countries,
and accelerate recruitment. Our scientific leadersgenerate strong evidence to implement real change intreatments, clinical practice and policy.

Assays as
unique as
yourresearch
As a trusted manufacturer of high-value
assays for bone health research for morethan a decade, we provide researcherswith the ELISA kits, reagents andantibodies they need to conduct
innovative research.
Bone/renal healthComplement system• FGF-23/klotho axis
• Phosphate regulation• Acute kidney injury• Chronic kidney disease• Glomerulonephritis• Transplant rejection

For a full list of productofferings, including
FGF-23 and klotho
antibodies and ELISAs,
please visit:

quidelortho.com©2024 QuidelOrtho Corporation
PR-105909-ASPAC-EN-GB-v1


    

  
 
    

     

 
   

www.bainmedical.com